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Abstract 
In response to the global threats of emerging infectious diseases and bioterrorism events, 
public health surveillance developed analytical methods to cluster early health indicators from 
multiple data sources into “syndromes” for rapid and efficient disease detection.  Syndromic 
surveillance has become well established in public health, using many different health 
indicators from multiple sources.  In animal health, the timeliness and efficiency of disease 
detection in early warning surveillance systems has been enhanced by including syndromic 
surveillance methods.  Animal health syndromic surveillance improves disease detection 
through the analysis of pre-diagnostic data collected for other purposes, from sources such as 
laboratories, veterinary clinics, abattoirs, farms and pharmacies.  However, the data are 
inherently non-disease specific compared to traditional surveillance and require analyses to 
ensure that syndromes represent significant diseases as accurately as possible.  Syndrome 
classification is an analytical process that identifies, collates and validates pre-diagnostic 
indicators within a data source into accurate and viable syndromes.  
The goals of this thesis were as follows: a) Review surveillance systems and methods to 
understand the scale, complexity and validity of different syndromic surveillance approaches.  
b) Describe and evaluate six years of swine laboratory submission data to Veterinary Diagnostic 
Services (VDS) in the province of Manitoba, Canada, for the purpose of syndromic surveillance. 
c) Finally, identify and validate the most appropriate syndromes from pre-diagnostic data 
within the submitted swine cases.   
An initial systematic review of public health syndromic surveillance was conducted with 81 
studies meeting the criteria. The variety and frequency of populations under surveillance, 
information sources, pre-diagnostic indicators, syndromes and reported values were recorded.  
The predominant methods for syndrome classification, temporal and spatial analysis and 
aberration detection were also described.   
21,665 swine laboratory submissions from January 2003 to March 2009, including 4726 
pathology cases, were evaluated. The frequency and distributions of the predominant pre-
diagnostic indicators, test requests and specimen types, were described.  The most common 
pathology diagnoses and organ system involvement were reported for the pathology 
submissions.  For syndrome validation, a Multiple Correspondence Analysis was conducted to 
cluster multiple pathology diagnoses per case into four diagnostic groups based on organ 
systems; Respiratory, Multisystemic, Gastrointestinal and “Other”.   
Syndrome classification was completed, first using agglomerative hierarchical clustering to 
classify syndromes from 30 test requests and 34 specimen types.  For validation, the 
syndromes were used as predictive variables in a multinomial logistic regression model applied 
to training and test data sets.  The overall model sensitivity, specificity and predictive values for 
each organ system outcome were estimated.  The individual syndromes were compared using 
relative risk ratios and marginal effects.  Five syndromes were identified as having a 
significantly higher predictive association with one organ system group (compared to the other 
three): Respiratory, GI, Reproductive, Joint and PCV (specific to porcine circovirus associated 
disease).   
The methods in this thesis identified a simplified analytical approach for syndrome 
classification of laboratory test requests and specimen types within swine submissions. 
Alternative algorithms for syndrome grouping, establishment of temporal baselines and 
exploration of automated aberration detection were identified as areas for future research.  
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Chapter 1: Thesis Introduction 
1.1 Animal Health Surveillance: Descriptions, Purposes and Activities  
Effective animal health surveillance is an essential part of evidence based decision making 
required to protect animal and public health, to provide assurance of a healthy food supply, to 
support economical and sustainable livestock production and to protect the intrinsic value of 
animals for the public good (Hasler et al, 2011; Hyder et al, 2011; Lysons et al, 2007).  Animal 
health surveillance provides descriptive information and detailed analysis of animal health 
hazards in defined populations through systematic (continuous or repeated) measurement 
(Hoinville et al, 2013).   It also links to and informs risk mitigation and promotes intervention 
with the intent of reducing the overall negative impacts of disease (Hasler et al, 2011) .  The 
core purposes of animal health surveillance can be described as follows; (1) to provide early 
detection of zoonotic, exotic or emerging disease, (2) to detect change in the epidemiology, 
pathogenicity and / or infectivity of endemic animal diseases, (3) to substantiate freedom from 
disease, (4) to describe changes in population risk factors and (5) to define further 
opportunities to assist in disease control or eradication (Hoinville et al, 2013).  The increasing 
demand for effective animal health surveillance has been driven by the significant negative 
impacts that animal and zoonotic diseases have had on animal health, public health, the 
economy and the environment (Lysons et al, 2007). Globally, endemic, emerging, re-emerging 
and exotic diseases have been occurring with increasing frequency across a greater number 
geographic regions: bovine spongiform encephalopathy (BSE) foot and mouth disease (FMD), 
highly pathogenic avian influenza, pandemic influenza, salmonellosis and porcine epidemic 
diarrhea (PEDv) are recent examples of disease that have had large scale geographic and 
economic impacts(Gibbens et al, 2008; Hasler et al, 2011; Huang et al, 2013; Hyder et al, 2011; 
Kosmider et al, 2011).  Animal health surveillance involves a wide range of activities, 
components and systems. Figure 1 represents the most recent concepts and terminology used 
to describe and evaluate animal health surveillance activities, components and systems 
(Hoinville et al, 2013; Salman 2003; Stark et al, 2006). 
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Figure 1: Examples of surveillance activities and components in different surveillance systems. 
 
Hazard specific surveillance encompasses the investigator directed, “active” surveillance 
methods used in disease control or eradication programs, outbreak response, documentation 
of freedom from disease for international trade and estimation of the occurrence (prevalence 
and/or incidence) of endemic diseases within specified regions or time frames.  The activities 
include many established surveillance methods such as systematic serological surveys, sentinel 
herd testing, hazard or risk factor questionnaires and at risk population testing during 
outbreaks.  Risk based surveillance may be viewed as enhanced methods of hazard specific 
surveillance where the plan, design and/or the interpretation of results are adjusted by the 
probability of occurrence and the magnitude of impact (biological and/or economical) of 
specific health hazards.  
 
Early warning surveillance encompasses surveillance methods that evaluate indicators, reports 
or observations that occur with routine animal health and economic activities for rapid 
detection of threats in defined populations or regions.  These methods are considered a more 
timely and efficient means of indentify threats from emerging, re-emerging or exotic diseases, 
or significant changes of endemic diseases, when compared to hazard specific surveillance 
(Dupuy et al, 2013a; Hoinville et al, 2013): Early warning surveillance systems and components 
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are more likely to detect undefined or unexpected threats because the information analysed 
and the resources used are applied to a broad range of animal health activities and do not 
focus only on specific hazards.  Observer initiated disease reporting through an organized 
veterinary infrastructure have traditionally been the primary means of early warning 
surveillance (Kellar, 2005; Lysons et al, 2007; O'Toole, 2010; OIE 2013).  The practical 
application of observer initiated information requires targeted funding, coordination, collation, 
standardization and analysis by investigators to provide effective and timely surveillance. This 
integration of observer/investigator roles has led to the proposed definition, enhanced passive 
surveillance and may be used to inform hazard based surveillance for improved accuracy and 
for focused intervention and mitigation strategies (Hasler et al, 2011; Hoinville et al, 2013).  
However, even with integration, traditional early warning surveillance methods have significant 
limitations in the areas of reporting, time between onset and diagnosis, sensitivity, availability 
of data and effective use of resources.  These issues may be interpreted as the primary reasons 
why these methods have struggled to keep pace with the increasing global threat of emerging 
and re-emerging diseases (Dorea et al, 2011; Dupuy et al, 2013a; Kosmider et al, 2011; Shaffer 
et al, 2008).  The expansion of advanced information systems and development of new 
analytical methods have improved the integration and evaluation of different types of health 
related indicators from large amounts of data across multiple sources (Bravata et al, 2004; 
Dorea et al, 2011).  New surveillance methods, such as syndromic surveillance have utilized the 
combination of informatics and analytical tools to improve the timeliness and sensitivity of 
early warning surveillance systems and components.  
  
1.2 Syndromic surveillance in public and animal health 
Syndromic surveillance classifies health related indictors such as clinical observations, 
laboratory test requests, telephone consultations, internet searches and pharmaceutical sales 
into pre-diagnostic “syndromes”.  Changes in the incidence or prevalence of syndromes are 
followed over time to rapidly signal potentially detrimental changes in the health of human or 
animal populations.  Effective syndromic surveillance must provide adequate sensitivity and 
specificity compared to traditional surveillance methods and should improve upon the 
timeliness of disease detection.  The intent is not to replace traditional surveillance, but rather 
enhance overall surveillance for improvements in investigation and response to significant 
disease events (Dorea et al, 2011; May et al, 2009). Enhancing overall sensitivity, specificity and 
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timeliness of disease detection by incorporating syndromic surveillance underscores several 
key characteristics of these methods:  Syndrome classification for the development of sensitive 
indicators of disease from data that has been collected for other purposes and does not readily 
indicate any specific disease or group of diseases; temporal and/or spatial analysis that 
accurately record the occurrence of syndromes from the population under surveillance;  
aberration detection methods that analyze the temporal and spatial occurrence of the 
syndromes to detect significant clusters of disease;  finally, the validation of the syndromic 
surveillance methods at determining significant health events from retrospective or 
prospective data. 
 
Syndromic surveillance methods and systems were developed in public health to detect global 
threats from emerging infectious diseases, such as severe acute respiratory syndrome (SARS), 
pandemic influenza and avian influenza, and from bioterrorism threats, such as anthrax 
(Bravata et al, 2004; Katz et al, 2011).  With the ability to employ advanced analytical tools on 
multiple health related information streams in near real time, syndromic surveillance has 
become an efficient, rapid and well established means for public health epidemiologists to 
detect and respond to clusters of disease (Hiller et al, 2013; Hurt-Mullen and Coberly, 2005; 
Katz et al, 2011).  The scope of these systems and methods have expanded beyond emerging 
disease and bioterrorism threats; greater efficiency has been obtained by including detection of 
outbreaks in endemic diseases such influenza and acute gastrointestinal diseases (Hiller et al, 
2013; Ivanov et al, 2002).  Additionally, to increase population coverage and improve “real 
time” or “near real time” availability of data for analysis, the sources for electronic syndromic 
surveillance have expanded beyond emergency room and medical clinic sources. Pharmacies, 
ambulance dispatch, telehealth/telemedicine centres, diagnostic laboratories and medical 
information web sites are frequent sources (Bravata et al, 2004; Hiller et al, 2013; Hurt-Mullen 
and Coberly, 2005; Kashiouris et al, 2013).  Finally, public health surveillance administrators and 
researchers have developed guidelines, defined characteristics and established validation 
methods to determine consistency, applicability and overall performance of syndromic 
surveillance systems and methods (Kashiouris et al, 2013; Katz et al, 2011; Leal and Laupland, 
2008).   
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In animal health, syndromic surveillance methods have increased with the increasing use of 
animal health information systems that collect a variety of early disease indicators, including 
clinical observations, laboratory submissions, carcass condemnations and mortality rates 
(Figure 1) (Alton et al, 2012; del Rocio et al, 2010; Dorea et al, 2013; Dupuy et al, 2013b; 
Gibbens et al, 2008; Van Metre et al, 2009; Vourc'h et al, 2006).  A recent review of veterinary 
syndromic surveillance in Europe identified 27 different systems in 12 countries (Dupuy et al, 
2013a).  These systems include information collected from laboratories, abattoirs, rendering 
plants, veterinary clinics, farms and pharmacies with the primary objectives of general health 
surveillance and/or outbreak detection.   As in public health, the systems and methods are 
directed to the early detection of emerging, zoonotic or reportable diseases, or significant 
changes in endemic diseases (Dupuy et al, 2013a).  Also like public health, the initiatives focus 
on specific ways to conduct syndromic surveillance such as notification of atypical cases, 
analysis of all clinical cases, or notification of public health concerns  such as zoonoses (Dorea 
et al, 2011; Rabinowitz et al, 2010).   Animal health syndromic surveillance has several key 
challenges that differ from public health:  The use, coverage and integration of information 
systems is not on the same scale in animal health, animal health information systems are often 
not able to provide data in “real time” (within 24 hours) and globally recognized standardized 
nomenclature of disease (e.g. World Health Organization’s International Classification of 
Diseases) are not readily available for syndrome development (Bartlett et al, 2010; Dupuy et al, 
2013a; Hoinville et al, 2013).   However, the opportunities to expand animal health syndromic 
surveillance and address key challenges are improved through reviews and analyses of the 
public health systems and methods.  Furthermore the “One Health” approach of sharing 
knowledge and developing synergies between human and animal health provides a framework 
for implementation of complimentary syndromic surveillance activities that may enhance 
sensitivity and timeliness of detecting human and animal threats (Dorea et al, 2011; Dupuy et 
al, 2013a; Shaffer et al, 2008; Vrbova et al, 2010).   
 
1.3 The role of animal health laboratories in traditional and syndromic surveillance. 
Animal health laboratories are key components of national veterinary infrastructure that exist 
in three sectors; public laboratories usually associated with government agriculture 
departments, schools of veterinary medicine, and private commercial laboratories (Shaffer et 
al, 2008).  Animal health laboratories, veterinary diagnostic pathologists and laboratory 
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technologists have a primary role of providing diagnostic and pathology services to clinical 
veterinary practice and food production systems.   They also provide an important secondary 
public veterinary role through diagnostic capacity for hazard specific surveillance and pathology 
expertise for identification of emerging or re-emerging diseases in traditional early warning 
surveillance (Gibbens et al, 2008; O'Toole, 2010; Pasick et al, 2007; Schmitt, 2003).  To further 
support both roles, animal health laboratories typically maintain current and historic laboratory 
data in digital format and provide a limited degree of data standardization; laboratory 
information management systems (LIMS) contain records in standard formats that include 
species, specimens submitted, test orders and results, pathology diagnoses, submission date 
and a geographic references (Shaffer et al, 2008).  Additionally, animal health laboratories 
frequently separate and classify submissions into diagnostic and non-diagnostic reasons, 
particularly for food animal production (Gibbens et al, 2008).  The separation provides further 
detail where diagnostic reasons support early warning surveillance through disease 
identification, disease follow up and suspicion of a notifiable disease and non-diagnostic 
reasons support hazard specific surveillance through health status determination, vaccine 
response, export or domestic sale, research and notifiable disease screening (Dorea et al, 2011; 
Schmitt, 2003). 
 
Surveillance activities conducted through laboratories have considerable imperfections such as 
voluntary under reporting of disease, biases through clinical decisions regarding case 
submissions and economic factors influencing submission decisions (O'Sullivan et al, 2012; 
Sintchenko and Gallego, 2009).  However, animal health laboratory submissions remain an 
important component of early warning surveillance as veterinary clinicians and pathologists are 
more likely to submit and investigate unexpected or unknown adverse animal health events 
(Gibbens et al, 2008; O'Sullivan et al, 2012; O'Toole, 2010; Zurbrigg and Van den Borre, 2013).  
The early warning surveillance role has been enhanced through laboratory based syndromic 
methods involving regional animal health laboratories and over specific animal populations 
(Dorea et al, 2012; Hyder et al, 2011; Kosmider et al, 2011; Odoi et al, 2009; Shaffer et al, 
2008).  The role has been further expanded by involving animal health laboratories in broad 
based veterinary syndromic surveillance initiatives (Dupuy et al, 2013a).    
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Several key factors have led to the exploration and development of syndromic systems and 
methods using animal health laboratories:   
• Public support through direct infrastructure funding, operational grants or partial 
coverage of specific case submissions (particularly food animal) provides incentive for 
access and utilization of core animal health data to support broader public surveillance 
initiatives.   
• Animal health laboratories typically provide centralized service to larger geographic 
regions and animal populations, providing greater coverage through a single data 
source when compared to veterinary clinic data.  Additionally, national systems for 
public and animal health have linked animal health laboratories to varying degrees. The 
linkages have expanded use of surveillance methods, provided multi jurisdictional 
surveillance coverage and have created greater levels of data standardization (Kloeze 
et al, 2012; Lysons et al, 2007).  
• Pre-diagnostic indicators, such as test requests and specimen types (Figure 1) are 
available for syndrome development and classification (Dorea et al, 2013; Hyder et al, 
2011; Odoi et al, 2009; Shaffer et al, 2008).   While not as timely as clinical data, pre-
diagnostic laboratory data are often, as noted above, more accessible and is believed 
to have greater specificity, as it is closer to a final outcome (test results or diagnoses) 
(Dorea et al, 2011; Shaffer et al, 2008). 
• LIMS contain both pre-diagnostic indicators, as well as diagnostic outcomes such as test 
results and pathology diagnoses (Figure 1) that may be used to estimate syndrome 
sensitivity.  LIMS also provide access to large amounts of data that allow use of 
advanced analytic tools for classification and cluster detection (Dorea et al, 2012; 
Hyder et al, 2011; Kosmider et al, 2011; Odoi et al, 2009; Shaffer et al, 2008). 
• Within animal health infrastructures, laboratories frequently have data standardization 
and numerical coding of disease nomenclature that will improve the ability for data 
classification compared to other information sources.  The ability to classify data across 
laboratories also improves when standard nomenclature is established within an 
integrated national animal health network (Gibbens et al, 2008; Lysons et al, 2007).  
However, standardized animal disease nomenclatures remain infrequently used across 
animal health laboratories even when available through standards such as Standard 
Nomenclature for Veterinary Diseases and Operations (SNVDO), Logical Observation 
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Identifiers Names and Codes (LOINC), Health Level Seven International (HL7) or 
Systemized Nomenclature of Human and Veterinary Medicine (SNOMED) (Bartlett et al, 
2010; Dorea et al, 2011). 
 
1.4 The importance of the swine industry and swine health; Global, Canadian and Manitoba 
perspectives 
Pork is a significant food source in many regions of the world, especially in countries where 
increasing personal wealth and changes in cultural preferences have led to overall increases in 
the demand for meat and associated livestock production (FAO 2013) .  In meeting the 
demand, global swine production represents the largest volume of world meat production, 
increasing from 72 to 108 million metric tons between 1993 and 2013 (FAO 2013).  The trend is 
also represented in the global population of swine which has increased from 848 million in 
1993 to 977 million in 2013.  The majority of swine production occurs in China (49.3%), 
followed by the European Union (15.0%), North America (8.0%) and South America (6.4%).  
However, with the exception of China, world swine production has remained constant or with 
only marginal increases since 2006-2007 in spite of an increasing global population (FAO 2013).  
North American and Canadian swine production has followed the trends with marginal 
increases between 1.3 and 1.7% per year over the same time frame (FAO 2013).  However 
increases in sow productivity and increases in carcass size has led to increases in pork produced 
without concurrent increase in the inventory of pigs held. 
 
The Canadian swine industry, as with swine production in all of North America has significantly 
changed over the last decade, moving away from smaller mixed independent operations to 
greater vertical integration and contractual production (Kliebenstein and Lawrence, 1995; 
MacDonald, 2003). Farms are highly specialized, where there is individual and/or centralized 
control over the different levels of production, including genetics, feed supply and even 
slaughter capacity.  The Canadian hog industry is the fourth largest agriculture industry in 
Canada, worth 9.8 billion annually and represented by 12.7 million head on 7,341 farms 
(Brisson Y 2014).  Canada is the fifth largest global exporter of pork, at just over 1 million 
tonnes. The United States is the primary importer of pork and live pigs from Canada at over 
25% of total swine industry exports (Brisson Y 2014).  Other significant importers of Canadian 
pork are China, Japan, Russia and South Korea.  The province of Manitoba contains a significant 
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proportion of the Canadian swine industry: Manitoba swine producers export the most live pigs 
and have developed the third largest pork industry overall in Canada.   The Manitoba swine 
industry has 590 farms on approximately 1100 sites and is the largest livestock industry in the 
province.  Total annual production is approximately 8 million pigs per annum with 2.6 million 
held on farms at any given time and a sow herd of 318,000.  It represents a total value to the 
Manitoba economy of $1 billion or 1.5% of Gross Domestic Product (Brisson Y 2014; Honey J 
2012).    
 
From 2006 to present, the Canadian and Manitoba swine industries have experienced 
significant challenges due to economic, trade and environmental impacts, as well as disease 
occurrences.  Manitoba swine production has been particularly affected due to the high degree 
of export dependency and a province wide government moratorium on industry development 
(Anon 2007; Honey J 2012; Whiting et al, 2011).  Major contributing factors preventing growth 
include an elevated Canadian/US exchange rate, trade disruptions such as Country Of Origin 
Labeling (COOL), elevated feed prices related to drought conditions and high oil prices, and the 
public perception of the environmental impacts of large scale livestock production (Brisson Y 
2014; Honey J 2012; Thevenaz 2011).   
  
As with other animal populations, swine populations in Manitoba, Canada and globally have 
been increasingly affected by emerging, endemic and zoonotic diseases(Amezcua et al, 2013; 
Dupuy et al, 2013a; Vourc'h et al, 2006).  Over the past 15 years, Manitoba and Canadian swine 
health and production have been impacted by diseases such as porcine circovirus associated 
disease (PCVAD), porcine reproductive and respiratory syndrome (PRRS), swine influenza (SIV) 
pandemic influenza (panH1N1) and porcine epidemic diarrhea (PED) (Carman et al, 2008; 
Gagnon et al, 2007; Huang et al, 2013; Pasma, 2008; Pasma and Joseph, 2010; Poljak et al, 
2010; Young et al, 2010).   The disease impacts, along with a strong focus on high health 
standards and the greater degree of vertical integration has led to a considerable use of 
veterinary infrastructure and increasing reliance on animal health surveillance (Amezcua et al, 
2013; O'Sullivan et al, 2012; Pasma and Joseph, 2010;Verdon et al. 2012).  In Canada, 
specialized private clinical practice, with public veterinary coordination and diagnostic 
laboratory services form the core components of surveillance (both early warning and hazard 
specific), risk mitigation and intervention.  This is well represented in Manitoba, where 
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veterinary services to the swine industry are through a combination of industry employed 
veterinarians, independent swine only practice and mixed animal practitioners.  Swine health 
services are further supported by public sector components such as the provincial Chief 
Veterinary Office (CVO) and the federal Canadian Food Inspection Agency (CFIA).  Laboratory 
services are primarily provided through a full service regional animal health laboratory, 
Veterinary Diagnostic Services (VDS) with additional services provided by university and private 
enterprise.  VDS and the CVO are part of the Agri-Industry Development and Innovation branch 
of the provincial department of Agriculture, Food and Rural Development (MAFRD).  VDS, with 
veterinary clinics, and the CVO form the veterinary infrastructure in Manitoba responsible for 
surveillance, risk mitigation and intervention of endemic, provincially notifiable and emerging 
diseases within the province.  The provincial veterinary infrastructure is also an integral part of 
the Canadian Animal Health Surveillance Network, a network of federal, provincial and 
university laboratories,  public veterinary agencies and animal health research groups that 
focuses on the early detection of zoonotic and notifiable diseases (Kloeze et al, 2010).  
 
The purpose of the thesis is to explore the opportunities to expand the surveillance capacity for 
swine health in the province of Manitoba using syndromic methods.  The focus will be on data 
collected through a regional animal health laboratory, VDS.  VDS meets the key factors 
described above for exploration of syndromic surveillance: VDS is a part of the public 
infrastructure and public funding provides 70% of the financial costs for all diagnostic and non-
diagnostic testing conducted at the laboratory on livestock and poultry from farms within 
Manitoba.  Public funding ensures access to core information collected by VDS.  Public funding 
also provides incentive for regular use by veterinary practitioners for diagnostic services 
provided to Manitoba swine herds.  While out of province laboratory services may be utilized 
for specialized testing, the centralization, proximity and public funding for diagnostics makes 
VDS the primary diagnostic service provider to the Manitoba swine industry.  This is especially 
true for the rapid necropsy and histopathological services necessary for investigating disease 
events.  VDS has well established case submission protocols that ensure laboratory submissions 
occur under the supervision of clinical veterinarians and are reflective of singular health events 
occurring within defined groups of animals.  The core case submission data along with the 
diagnostic and pathological outcomes are maintained within the VDS LIMS.  Veterinary selected 
pre-diagnostic indicators (test requests and specimen types) indicative of significant animal 
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health events can be effectively accessed for syndrome development and subsequent 
comparison to final outcomes.  Finally, while VDS does not follow any particular standardized 
disease nomenclature, standard methods for diagnostic reporting and for pathology diagnoses 
have been incorporated in the LIMS. 
The thesis has involved an extended progression from 2009 to present that included a review 
of syndromic methods, data description and collation, syndrome development, and analysis of 
syndrome classification.  The second chapter represents a systematic review and description of 
the initial public health syndromic surveillance methods that are the basis for many syndromic 
methods and systems used in public and animal health.  Chapter 3 provides a description of 
pathology and non-pathology submissions to VDS from 21665 swine submissions over a six year 
period from 2003 to 2009.  This chapter also includes Multiple Correspondence Analysis (MCA) 
and hierarchical clustering exercises to collate final pathology diagnostic outcomes into four 
key groups. The fourth chapter is a description of unsupervised learning method, agglomerative 
hierarchical clustering, to classify pre-diagnostic indicators from pathology cases into 
syndromes.  The chapter also provides a multinomial logistic regression analysis of syndrome 
predictions compared to grouped pathology outcomes from Chapter 3, using both a sample 
and a test dataset.  The chapter concludes with syndrome validation conducted using relative 
risks and predictive probabilities.  The thesis conclusion (Chapter 5) provides a discussion of the 
methods applied in the preceding chapters, including their utility and limitations in the context 
of syndrome classification for animal health surveillance.  Future potential steps for animal 
health syndromic surveillance from laboratory data in Manitoba are included, specifically 
opportunities for temporal analyses and aberration detection utilising the syndrome 
classifications. 
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Chapter 2:  Systematic review of syndromic surveillance in public health 
2.1 Introduction 
Effective organized and ongoing animal health surveillance is thought to improve the detection 
of and the response to zoonotic, reportable or emerging disease or changes in the 
epidemiology, pathogenicity and / or infectivity of endemic animal diseases.  Effective animal 
health surveillance covers a wide range of activities including both passive and active methods 
such as surveys, sentinel practices, clinical observations, laboratory diagnostics and abattoir 
monitoring. 
 
Pre-diagnostic (or syndromic) surveillance has been developed and utilized as a method of 
early disease detection in public health for greater than a decade.  Essentially, this is the 
grouping of data from non-traditional sources, often collected for other purposes, into 
meaningful classifications (or syndromes) that can be monitored for temporal and spatial 
change.  The primary purpose is for rapid detection of disease often before any specific 
diagnosis can be made (Leal and Laupland, 2008; van den Wijngaard et al, 2008). 
 
The key components of any syndromic surveillance method are the classifications (or make up) 
of the syndromes, the analysis of temporal and spatial change in these syndromes, the 
methods of detecting significant aberrations in temporal or spatial changes and validation of 
the surveillance methods in determining significant health events. 
 
In veterinary medicine, disease surveillance has focused on regulatory programs and efforts to 
eradicate specific diseases (Kellar, 2005; Shaffer et al, 2008).  To achieve greater efficiency and 
prioritization, animal disease surveillance has made considerable improvements by focusing on 
“at risk” populations or activities (Paiba et al, 2007; Stark et al, 2006).  Access to “at risk” 
populations or activities relies on the availability and selection of potential information sources 
that represent these populations or activities.  Animal health data collected for purposes other 
than surveillance, from a variety of sources, may be useful to detect significant health events 
from these populations or activities.  Furthermore, the increased use of information 
management systems for data collection, storage and access has increased the amount, type 
and availability of information available for animal disease surveillance (Paiba et al, 2007).  
Identification and classification of significant indicators within these data sources is necessary 
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for effective use, making pre-diagnostic methods an appealing approach.  Syndromic 
surveillance has not been used extensively in the veterinary context but has been recognized as 
a valid approach to the detection of emerging and zoonotic diseases, as a method for 
determining change in endemic disease and as an important contributor to public health 
surveillance. (Gibbens et al, 2008; Glickman et al, 2006; Vourc'h et al, 2006)   
 
One of the information sources that may advance animal health surveillance is submission 
information to veterinary diagnostic laboratories.  It is hypothesized that animal health 
laboratories not only contain data essential for animal health diagnostics but also for rapid 
detection and a potentially early response (Gibbens et al, 2008; Lysons et al, 2007; Schmitt, 
2003).  While it is recognized that laboratory submissions are only part of the veterinary 
contact with adverse animal health events, it is assumed that in a risk-based manner, 
veterinary practitioners are more likely to submit to a diagnostic laboratory when unexpected 
or unknown adverse health events are presented to them. 
 
In public health, a considerable amount of effort has been directed towards syndromic 
surveillance to rapidly detect emerging diseases or bioterrorism attacks.  Recent disease 
threats from severe acute respiratory syndrome (SARS) and influenza and from bioterrorism 
events such as the 2001 anthrax attacks in the United States have demonstrated the need for 
rapid detection and response (Bravata et al, 2004). Recent research into public health 
surveillance has focused on pre-diagnostic or syndromic surveillance.  Key areas under study 
include accuracy in detecting significant events, classification of non-traditional data into useful 
syndromes, methods for monitoring syndromes over space and time and methods for 
determining significant events or signals.  The purpose of the following study was to gain 
understanding of the important aspects of syndromic surveillance in public health for the 
development and application of syndromic methods to animal health data.  The review 
included areas such as: populations and associated data sources under study, methods of 
syndrome classification, methods of aberration detection, temporal and spatial analysis, and 
overall usefulness as a method of rapid disease detection.  The review was conducted as a 
significant part of the background steps taken by the author between January 2009 and March 
2010 to conduct an evaluation and analysis of an animal health laboratory database for the 
purposes of syndromic surveillance. 
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2.2 Methods 
2.2.1 Study description 
Published, peer reviewed studies involving syndromic surveillance in public health were sought 
to contrast and compare different approaches in data sources, populations, primary diseases / 
syndromes of interest, methods of classification and detection, statistical modeling and 
reported values.  The United States Centre for Disease Control developed guidelines which 
include a checklist for evaluating public health surveillance systems (Buehler et al).  The 
guidelines cover many broad categories that exceeded the specific objectives of this review.   
The guidelines did provide input on how to evaluate surveillance system for timeliness, to look 
for positive predictive value (PPV), sensitivity and specificity.  However, the guidelines do not 
focus on methods of classification and analysis, which were also of interest in this study. This 
review followed a systematic process; two databases of peer reviewed articles (Medline and 
CAB abstracts) were searched in July 2009 and March 2010 using an identical search strategy. 
For this study, the key topics of interest were: Description of the population under study and 
the associated data sources, the methods of syndromic surveillance conducted, the syndromes 
or pre-diagnostic indicators under surveillance, the analyses conducted and the reported 
outcomes. A Boolean method was used to search the databases where the four broad 
categories listed above were linked by “AND” and the individual search terms within each 
category were linked by “OR”. The search terms are presented in Table 1.  Many of the search 
terms have similar meanings and are more simply described by general terms (see bolded 
terms in Table 1).  However, to limit the possibility of missed articles during database 
searching, each search term within each category was linked individually. 
 
2.2.2 Study selection and data abstraction 
Titles and abstracts were reviewed under the following relevance screening criteria: Study 
purpose, descriptions of population under surveillance, descriptions of the types and sources of 
data used, syndromic or pre-diagnostic indicators, recording of spatial and/or temporal 
information, methods of analysis and reported results. Only primary research articles that 
focused on public health surveillance through syndromic or pre-diagnostic methods were 
included.  Traditional surveillance methods, including surveys, were included if a pre-diagnostic 
method (e.g. clinical diagnoses) was part of the method and analysis. Studies with the following 
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were excluded: Clinical trials and case prediction scoring systems for specific diseases, 
surveillance system descriptions with no further discussion on surveillance methods or 
analyses, and algorithm descriptions (classification or aberration detection) without examples 
from real or simulated data. 
Table 1: Search terms for syndromic surveillance in public health.  
Population and 
data sources 
Hospital (general, public, private, emergency, medical clinic, doctor’s 
office) Emergency services (Emergency ward, trauma center, ambulance, 
emergency phone system), Pharmacy (clinical, hospital) Telemedicine, 
Telenursing, Medical information system, Laboratory (clinical, hospital, 
core) Health care utilization, Health center, Intensive care, Nursing home, 
Work place, School (university, college, public school, day care) 
Methods of 
syndromic 
surveillance 
Surveillance (disease, syndromic, diagnostic, pre-diagnostic, electronic), 
Health survey, Medical informatics (public health, medical data 
processing), Geographic information systems, Outbreak/epidemic 
detection, Algorithm (classification, learning) Information processing 
(artificial intelligence, bioinformatics, information system, causal modeling, 
computer analysis, computer prediction, computer simulation, constant 
comparative methods, critical incidents methods, content analysis, data 
analysis, system analysis, data extraction, data synthesis, decision tree, 
machine learning) 
Pre-diagnostics 
/Syndromes 
under 
surveillance 
Symptomology (syndrome, symptom, clinical feature, disease marker), 
Case definition, Non prescription pharmaceuticals (utilization, sales of), 
Hospital admission, Absenteeism, Laboratory (submission, diagnosis, 
result), International Classification of Diseases, Diagnostic tests, 
Prescription, Bioterrorism, Emerging disease, Infectious disease 
(communicable, tropical, viral, bacterial, zoonotic), Zoonosis 
Analytical 
methods and 
outcomes 
reported 
Evaluation, Statistical analysis, (spatial, temporal, regression, model, etc), 
Geographic distribution, Validation, Specific measures (sensitivity, 
specificity, positive predictive value, ROC, Area under ROC, WSARE, BCD, 
BARD, Statistical process control) 
 
To generate descriptive statistics, a database was established using Access 2007 (Microsoft 
Corp WA), to collect data from articles that passed the relevance screening criteria for the 
purpose.  The data was grouped into seven broad categories with specific topics addressed in 
each category (see Table 2).  The categories chosen were similar to those evaluated by other 
researchers (Bravata et al, 2004) or as key categories for evaluating syndromic surveillance 
(Buehler et al).  Focus was placed on collecting descriptive data for categories deemed relevant 
to advance animal health syndromic surveillance, specifically types of data sources used and 
information collected in broad categories of analysis. Multiple topics in each category were 
recorded if present in each study.  
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Data sets that were restricted to a specific demographic were identified as not directly 
representative of the general population.  For example, data sets from public schools, military 
hospitals or pediatric hospitals, while possible to consider as proxies for the general population, 
were identified as separate from the general population.  No occupation status was assigned to 
cases from neonatal or pediatric hospitals databases. 
Table 2: Categories for collection of data from relevance screening 
Categories Topics 
I. Study Demographics 
1. Location City or Region, State or Province, Country 
2. Population 
General or Gender specific, Elderly, Adult, Youth, Child 
All Occupations or Health care, Military/police, 
Education/social services, General trades, Other  
II. Information sources 
1. Data Purpose Infectious disease, Emerging disease, Bioterrorism event, 
Accident/injury, Metabolic disease, Other 
2. Data Class Emergency room, Clinic/outpatient, Laboratory, Pharmacy, 
Telephone help, Internet help, Other 
3. Data Source Single data source, multiple sources 
III.  Syndrome Classification Chief complaints, number of complaints, complaint 
description, Types of coding (ICD-9-CM, Laboratory, clinical 
findings, other),  
IV. Syndromes  Number of syndromes, descriptions 
V. Analyses Components Classification, Temporal, Spatial, Aberration detection, 
Validation 
VI. Analytical Methods  
1. Classification Supervised or unsupervised methods, Bayes classifier, 
professional opinion, regression analysis, MCMC 
2.  Temporal Time series, ARIMA, EMWA, space-time scan statistic 
3. Spatial Spatial clustering, space time scan statistic 
4. Aberration WSARE, BARD, EARS, CUSUM, Other 
VII. Reported values Frequency, Probability, OR, RR, Kappa, Sensitivity, Specificity, 
PPV, ROC curve, Area under ROC Curve, Correlation 
Coefficient, Time intervals, Cusum values 
 
Descriptive statistics were generated for the seven categories and where applicable, compared 
across categories. Core pieces of data were tabulated and compared using statistical software 
(Stata 11, StataCorp 2009) for key descriptive pieces. 
 
2.3 Results  
A total of three hundred thirteen (313) articles were identified through the search protocol. 
Due to the relatively small number of articles received through the initial search, each article 
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was screened once in a systematic fashion.  Review of the abstract and title effectively 
removed the clinical trials, review articles and most system or algorithm descriptions that did 
not use data to evaluate.  Review of the materials and methods and results removed articles 
without a pre-diagnostic component or those not directed towards public health surveillance.  
Subsequent to this assessment, a total of eighty-one articles met the inclusion criteria and were 
subjected to detailed evaluation.  The primary areas of focus for surveillance in the articles that 
met criteria were multiple sources within large urban centres; thirty-nine articles reported 
surveillance systems or methods with broad coverage in twenty-one urban centres; ten centres 
within the United States and eleven centres in other countries including Australia (two), Canada 
(two), China, France, India, Italy, Japan, South Africa and the United Kingdom.   The urban 
centres of Boston, MA and New York, NY were the most reported with seven studies each, 
evaluating a variety of surveillance systems and methods.  Ten articles reviewed surveillance 
methods from single sites, primarily hospital emergency rooms or health care clinics with five 
of the ten relating to US hospitals.   Public health surveillance methods and systems specifically 
covering US states (seven), US counties (seven) and an Australian state (one) were also 
evaluated.  Finally, several large multi-region or national surveillance methods were evaluated 
including six within the US and one each in Australia, French Guiana, Israel, Italy, Japan, 
Singapore and Taiwan. 
 
2.3.1 Study Demographics 
The population descriptions were as follows: seventy-two (89%) studies had adequate 
descriptions of the populations represented by the data (Aggarwal and Kumar, 2004; Ang et al, 
2005; Ansaldi et al, 2008; Besculides et al, 2005; Betancourt et al, 2007; Boak et al, 2008; 
Bourgeois et al, 2006; Burr et al, 2006; Carrico and Goss, 2005; Chapman et al, 2004; Chapman 
et al, 2005a; Chapman et al, 2005b; Chen et al, 2005; Chen et al, 2006a; Clothier et al, 2005; 
Clothier et al, 2006; Cooper et al, 2009; Das et al, 2003; Das et al, 2005; Davies and Finch, 2003; 
Dembek et al, 2004; Derby et al, 20050; Flamand et al, 2008; Fleischauer et al, 2004; Ford et al, 
2007; Greenko et al, 2003; Guasticchi et al, 2009; Haodo et al, 2005; Heffernan et al, 2004; 
Hoabo et al, 2005; Hogan et al, 2007; Irvin et al, 2003; Ivanov et al, 2002; Ivanov et al, 2003; 
Jefferson et al, 2008; Kaufman et al, 2007; Kawana et al, 2006; Kleinman et al, 2005; Kulldorff 
et al, 2007; Lazarus et al, 2002; Lemay et al, 2008; Lenaway and Ambler, 1995; Levin and 
Raman, 2005; Lewis et al, 2002; Magruder et al, 2005; Mathews et al, 1998; Mikosz et al, 2004; 
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Moore et al, 2008; Murphy and Burkom, 2008; Muscatello et al, 2005; Nordin et al, 2004; 
Ohkusa et al, 2005; Osaka et al, 2002; Overhage et al, 2008; Pattie et al, 2009; Piriyawat et al, 
2002; Pokorny et al, 2006; Reis and Mandl, 2003; Reis and Mandl, 2004; Scholer et al, 2007; 
Sloane et al, 2006; Steiner-Sichel et al, 2004; Tappero et al, 1996; Terry et al, 2004; Tokars et al, 
2009; Travers et al, 2007; Turner et al, 2006; van den Wijngaard et al, 2008; Wagner et al, 2004; 
Wang et al, 2005; Wang et al, 2006; Wu et al, 2008; Yin et al, 2008). Of these, fifty-eight studies 
utilized data sets that were representative of general populations in the areas where they 
occurred.  Fifty-eight studies utilized data sets that were representative of all age groups in the 
areas where they occurred.  The remaining fourteen studies were limited to specific age 
groups: Six were limited to adults either because they utilised individual prescriptions, were 
specific to active military personnel or focused on sexually transmitted disease syndromes 
(Aggarwal and Kumar, 2004; Chen et al, 2006a; Davies and Finch, 2003; Jefferson et al, 2008; 
Mathews et al, 1998; Yin et al, 2008). Eight studies were specific to children and / or youth; six 
involved data from neonatal or pediatric hospitals (Bourgeois et al, 2006; Ford et al, 2007; 
Ivanov et al, 2003; Levin and Raman, 2005; Reis and Mandl, 2003; Wang et al, 2005) and two 
used data from public school systems (Besculides et al, 2005; Lenaway and Ambler, 1995).  
Seven studies were limited to specific occupations; four were military personnel or their 
immediate families (Chen et al, 2006b; Jefferson et al, 2008; Lewis et al, 2002; Pattie et al, 
2009), two represented students in public education (Besculides et al, 2005; Lenaway and 
Ambler, 1995), and one represented a single trade (market vendors) (Yin et al, 2008). One 
study was directed to women in rural populations (Aggarwal and Kumar, 2004), representing all 
occupations, but only adults.  Two studies represented all age groups but were specific to 
military personnel and their families (Lewis et al, 2002; Pattie et al, 2009). The majority of 
studies had data that represented all populations. Nine studies used primarily simulated data 
sets or modeling and therefore did not represent distinct populations (Barthell et al, 2004; 
Burkom et al, 2005; Fricker, Jr. et al, 2008; Gierl and Schmidt, 2005; Hutwagner et al, 2005a; 
Hutwagner et al, 2005b; Kleinman and Abrams, 2006; Kleinman and Abrams, 2008; Wong et al, 
2003).   
 
2.3.2 Information sources 
The primary classes of data source identified in the selected articles are listed in Table 3. 
Twenty-five articles identified more than one data class included for surveillance. Emergency 
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department and critical care data were the most common class reported.  Miscellaneous data 
classes included data from house calls (Flamand et al, 2008), mortality records (Boak et al, 
2008), school absenteeism (Besculides et al, 2005; Lenaway and Ambler, 1995) work 
absenteeism (van den Wijngaard et al, 2008), medical insurance use (Gierl and Schmidt, 2005; 
Lazarus et al, 2001; Lazarus et al, 2002; Nordin et al, 2004; Tokars et al, 2009), medical locum 
service (Clothier et al, 2006; Turner et al, 2006), hospital discharge (Ford et al, 2007), disease 
specific monitoring (Aggarwal and Kumar, 2004; Kawana et al, 2006; Overhage et al, 2008; 
Pattie et al, 2009; Piriyawat et al, 2002), and ambulance dispatch (Greenko et al, 2003). Thirty-
nine articles reported more than one data source, with either single or multiple data classes.  
Eighteen studies utilized multiple data classes and multiple data sources (Boak et al, 2008; 
Burkom et al, 2005; Clothier et al, 2005; Clothier et al, 2006; Davies and Finch, 2003; Greenko 
et al, 2003; Ivanov et al, 2003; Lemay et al, 2008; Levin and Raman, 2005; Lewis et al, 2002; 
Magruder et al, 2005; Murphy and Burkom, 2008; Overhage et al, 2008; Pattie et al, 2009; 
Piriyawat et al, 2002; Tokars et al, 2009; Turner et al, 2006; van den Wijngaard et al, 2008).  
Studies with multiple data sources and classes commonly conducted comparisons for effective 
surveillance between the data classes or used one data class as a “gold standard” to validate 
surveillance with another data class (e.g. Laboratory confirmation of clinical diagnoses).  
Twenty-one studies used a single data class from multiple sources (Barthell et al, 2004; 
Besculides et al, 2005; Betancourt et al, 2007; Carrico and Goss, 2005; Chapman et al, 2005a; 
Das et al, 2003; Das et al, 2005; Dembek et al, 2004; Ford et al, 2007; Heffernan et al, 2004; 
Kaufman et al, 2007; Mikosz et al, 2004; Moore et al, 2008; Muscatello et al, 2005; Ohkusa et 
al, 2005; Osaka et al, 2002; Reis and Mandl, 2004; Steiner-Sichel et al, 2004; Terry et al, 2004; 
Wagner et al, 2004; Wu et al, 2008). Databases and electronic records from multiple hospital 
emergency departments in an urban centre or region was the most common occurrence of a 
single data class with multiple sources.  Seven studies used a single data source with multiple 
data classes (Bourgeois et al, 2006; Derby et al, 20050; Guasticchi et al, 2009; Kawana et al, 
2006; Kulldorff et al, 2007; Mathews et al, 1998; Yin et al, 2008). Clinic, laboratory and 
miscellaneous data classes were commonly included in single regional data sources managed 
by a single agency or health authority. 
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Table 3: Data classes in syndromic surveillance 
 All studies 
(N=81) 
Studies with multiple 
data classes (N=25, 
% of all studies 
Studies with multiple 
data sources (N=39), 
% of all studies 
Data  Class Freq Percent Freq Percent  Freq Percent 
Emergency / Critical care 50 61.7% 16 32.0% 29 58.0% 
Clinic / Outpatient 21 25.9% 17 81.0% 14 66.7% 
Laboratory 13 16.1% 12 92.3% 8 61.5% 
Pharmacy 7 8.6% 4 57.1% 6 85.7% 
Telemedicine 6 7.4% 4 66.7% 1 16.7% 
Internet Medical 1 1.2% 1 100.0% 1 100.0% 
Miscellaneous 20 24.7% 11 55.0% 12 60.0% 
 
A comparison of the most common data classes combined for surveillance purposes is 
presented Figure 1.  It was evident that emergency room data was not commonly combined 
with other data classes. Emergency room data (with or without laboratory or miscellaneous 
data classes) was combined with clinic / out patient data types in ten studies, with laboratory 
data in seven studies and miscellaneous data types in nine studies.  Clinic and laboratory 
studies were often combined as noted in nine of the thirteen studies that included laboratory 
data.  As noted above, this was often for comparison purposes.  Miscellaneous data, when 
combined, were combined with emergency room or clinic data with exception of one study 
when state mortality records were compared to internet death notices.  All four common data 
classes were combined in four studies.  
 
Interestingly many data types which were considered alternative to primary health care data, 
such as telemedicine, pharmacy data and most of the miscellaneous data types were not 
necessarily combined with primary health care data for surveillance purposes.   When primary 
health care data types were included with alternate data types, it was often to estimate the 
predictive values and sensitivity of the alternate data types. 
 
In the United States, the Electronic Surveillance System for the Early Notification of 
Community-Based Epidemics (ESSENCE II) is a broad-based public health surveillance system 
that utilized multiple data types and sources (Lombardo et al, 2003).  Many of the studies have 
analyzed or utilized components or syndrome groupings from ESSENCE. 
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Three studies that used simulated data did not describe the simulations representing any 
particular type or source, such as emergency room data (Fricker, Jr. et al, 2008; Kleinman and 
Abrams, 2006; Kleinman and Abrams, 2008). 
 
The primary disease categories under surveillance in all studies were infectious diseases, 
bioterrorism events, emerging diseases, metabolic disease and accidents / injuries.  Infectious 
diseases were by far the most common disease category under surveillance across all disease 
categories in all studies and focused on diseases known to be present in the area and 
population undersurveillance (Figure 2). The category represented either a broad base of 
infectious diseases such as respiratory or gastro intestinal viruses or was specific and directed 
towards diseases such as influenza, salmonellosis, measles, or others. The most common 
bioterrorism agent under surveillance was anthrax, in particular the respiratory form.  
Surveillance for emerging diseases focused primarily on SARS or pandemic influenza.  The other 
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disease category encompassed many other health conditions, such as mortality (cause not 
identified), drug/alcohol abuse and poisoning. 
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Figure 2: Percent of disease classes under prediagnostic surveillance
Infectious Disease Emerging Disease
Bioterrorism Accident / Injury
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2.3.3 Syndrome classification and Syndromes  
Syndromic / pre-diagnostic surveillance methods in public health surveillance often utilized 
chief complaints to assign cases to specific syndromes, especially those that involved primary 
or front line medical care, such as emergency departments, outpatient clinic or telemedicine.  
Systems that utilized chief complaints either collected all complaints to assign to specific 
syndromes (15 studies) or limited what chief complaints were captured (40 studies) (Table 4). 
When no limits were placed on chief complaints, the number of chief complaints routinely 
collected or the most common chief complaints were not often reported. Surveillance that 
limited the number of chief complaints recorded focused primarily on respiratory complaints 
linked to either infectious diseases (e.g. influenza) or bioterrorism events (21 studies).  Other 
chief complaints routinely captured were linked to gastrointestinal, a combination of 
gastrointestinal and respiratory, fever and sexually transmitted diseases.   
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Inclusion of limits on chief complaints was consistent with a limited number of syndromes 
available for surveillance (primarily a single syndrome), while use of all chief complaints 
typically led to greater number of syndromes under surveillance (Table 4, Figure 3).   
The overall number of syndromes under surveillance for each study was recorded.  Seventy-
three studies reported the number of syndromes with a mean of 4, a maximum of 15 and a 
minimum of 1 (Table 4).  Forty-four studies included definitions of the syndromes under 
surveillance.  Twenty-nine studies referenced descriptions of the syndromes but did not 
specifically include them.  Eight studies analysed pre-diagnostic surveillance methods but did 
not describe or report the number of syndromes under surveillance.  These studies focused on 
different methods of detecting significant changes in temporal or spatial results; four studies 
evaluated aberration detection methods and used simulated data (Fricker, Jr. et al, 2008; 
Hutwagner et al, 2005a; Kleinman and Abrams, 2006; Kleinman and Abrams, 2008) that 
generated signals for detection.  The four remaining studies compared different detection and 
reporting methods from existing data that had generated prior signals (Burkom et al, 2005; 
Gierl and Schmidt, 2005; Overhage et al, 2008; Wong et al, 2003).  Thirty-eight studies reported 
one syndrome for surveillance purposes, as noted above, single syndromes were primarily 
respiratory, directed most commonly at influenza, SARS and anthrax-related diseases.  The 
remaining thirty-five studies ranged between two and fifteen syndromes with five to eight the 
most common (Figure 4). Among the studies with multiple syndromes, respiratory and 
gastrointestinal were the most common.  Many also included fever, along with non-traumatic 
neurologic conditions, especially paralysis, rash/dermatologic conditions and undifferentiated 
fever. 
 
Table 4: Number of Pre-diagnostic classifications and chief complaints 
  
Freq. Percent  Mean SD Min Max 25% 75% 
Chief Complaints  55  ----- ----- ----- ----- ----- ----- 
with limits 
(% of chief complaints) 40 72.7% 3.9 6.3 1 30 1 3 
Pre-diagnostic Classifications 
/ Syndromes 73  4.0 3.9 1 15 1 7 
all Chief Complaints 55 75.3% 3.6 3.9 1 15 1 6 
With limits 40 54.8% 2.0 2.6 1 13 1 1 
With no limits 15 20.6% 8.1 2.9 4 15 6 10 
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Systematic approaches to pre-diagnostic or syndrome classification included coding methods.  
The primary coding methods included were as follows; 
• Clinical codes, based on clinical examination findings such as chief complaint, body 
temperature, blood pressure and presenting symptoms. Several types were reported, 
most commonly were methods from the Center For Disease Control. 
• Clinical diagnoses through International Classification of Diseases, 9th revision – Clinical 
Modifications (ICD-9-CM). 
• Laboratory codes, such as classification of microbial culture results  
• Other coding methods such as pharmaceutical classes, poisonous substances classes or 
coding for absenteeism.  
 
Sixty-seven studies defined classification codes for pre-diagnostic methods, thirty-eight used a 
single coding method; clinical (20 studies), ICD-9-CM (9 studies), Other (8 studies) or Laboratory 
(1 study) (Figure 5). The most common combination of coding was clinical with ICD-9-CM (16 
studies) followed by clinical with laboratory (5 studies). 
 
 
2.3.4 Analysis Components, Analytical methods and Reported values 
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Analysis in syndromic surveillance was categorized into four components, including if more 
sophisticated methods of analysis were employed (Figure 6);  
• Temporal methods to monitor changes in syndromes over time. 
• Spatial methods to monitor changes in syndromes over a geographic region. 
• Classification methods to estimate the most accurate and sensitive pre-diagnostic or 
syndromic categories. 
• Aberration detection methods to estimate significant signals that may be generated by 
surveillance data. 
Validation methods represented a fifth component of analysis and were used to estimate the 
effectiveness of the syndromic surveillance methods when compared to other pre-diagnostic 
methods or to more traditional methods. 
 
 
The use of components of analysis across all studies was compared, including whether a 
validation method was applied or not (Figure 7a and 7b).  A large number of studies focused 
primarily on the definition and comparison of syndromes or pre-diagnostic groups; twenty-two 
of fifty-five studies had only a classification component.  Specific classification algorithms were 
utilized in thirteen of the fifty-five studies with a classification component.  The most common 
algorithm was a naive Bayesian free text classifier that primarily grouped free text chief 
complaints.  Time to detection compared to traditional methods and detection of significant 
events over time were significant components of syndromic surveillance.  Temporal 
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components were therefore common across all studies and were also more likely to include 
detailed analysis (Figure 6).  Time series analysis using cumulative sum control chart (CUSUM), 
auto regressive integrated moving average (ARIMA) and exponentially weighted moving 
average (EWMA) were the most common.   Aberration components were primarily used to 
determine significant signals found in temporal or spatial analysis.  These components were 
primarily included with three other key groups; temporal, classification/temporal, and 
spatial/temporal.   
 
Spatial components occurred in large-scale surveillance systems that involved multiple data 
sources in an urban center or larger geographic area.  These larger systems were also more 
likely to include more in-depth analysis due to both the larger number of observations and 
likelihood of receiving multiple data types (Besculides et al, 2005; Burkom et al, 2004; Carrico 
and Goss, 2005; Das et al, 2003; Heffernan et al, 2004; Hogan et al, 2007; Kleinman and 
Abrams, 2008; Kulldorff et al, 2007; Steiner-Sichel et al, 2004; Wu et al, 2008).  The spatial scan 
statistic was the common advanced analytical method used for spatial analysis.  Validation 
methods were used in conjunction with both classification methods for comparing pre-
diagnostic groups and temporal methods for determining effectiveness of the early warning 
component. 
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Regression analysis, including fixed models such as Poisson, and mixed models such generalized 
linear mixed models (GLMM) was used frequently in comparisons between atypical pre-
diagnostic groups, such as absenteeism, prescriptions, telemedicine calls and more traditional 
data sources such as clinical diagnoses and laboratory results (Cooper et al, 2009; Das et al, 
2005; Ohkusa et al, 2005; Pattie et al, 2009; van den Wijngaard et al, 2008). Regression analysis 
was also utilized in several simulation studies that evaluated various monitoring tools and 
methods (Burkom et al, 2005; Kleinman and Abrams, 2006; Kleinman and Abrams, 2008).  
Twenty of the eighty-one studies used regression analysis as part of the analytical process 
applied to the surveillance methods. 
 
Sensitivity, specificity, positive predictive values (PPV) were considered key measurements of 
statistical validity and accuracy for public health surveillance (Buehler et al).  These values were 
the most common results reported from statistical analysis (Figure 8). Measurements of 
precision and agreement were also common when studies included a classification and 
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validation component. Correlation coefficient and kappa statistics were the most common and 
were used to compare syndrome classification methods in seventeen studies.  Other 
agreement results reported included Cochrane’s Q statistic. Several studies also reported 
probabilities, odds ratios or risk ratios when comparing the likelihood of individuals with a 
specific syndrome having a disease to a base population without the syndrome. 
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Figure 8: Measures of accuracy and agreement for prediagnostic surveillance
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Reporting of sensitivity was also compared to the different analytical components; 55% with a 
classification component 48% of studies with a temporal component, 47% with a spatial 
component and 52% with an aberration detection component.  
 
Analysis conducted for temporal purposes produced a variety of different results especially 
when in combination with aberration detection.  The common time series analysis results 
reported were, the time interval to detection (time from above base line to a significant signal), 
the more sophisticated time to detection rate, the number of cases that had exceeded a set 
standard deviation (typically two) from the mean and   CUSUM values, such as z scores.    
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2.4 Discussion 
Systematic reviews of public health surveillance have identified the capacity of surveillance 
systems to utilize information from a broad public scope collected routinely for administrative, 
business or case management needs and stored electronically (Bravata et al, 2004; Leal and 
Laupland, 2008).  The systems provide a potentially inexpensive and efficient means of 
collecting and collating data from multiple sources and types, covering large geographic areas 
and often in real time or near real time.  In order to effectively use these systems, the 
information must provide adequate sensitivity and specificity compared to traditional 
surveillance methods and should meet or improve upon the timeliness of disease detection.  
The need for sensitivity, specificity and timeliness define two key challenges; first the data have 
been collected for other purposes and does not readily transfer to a sensitive indicator of a 
specific disease or group of diseases.  Information from either within a data type or across data 
types must be classified into sensitive pre-diagnostic or syndromic indicators to accurately 
detect the disease or condition under surveillance.  Second, even once a sensitive indicator has 
been developed, the amount and non-specific nature of data results in a significant number of 
trend outputs and variations that needs to be balanced between sensitivity, specificity and 
timeliness.  If the level of detection is set too high, not only will the sensitivity of the system 
decrease, but the timeliness of detection may not be sufficient to provide rapid enough 
indications.  Initial reviews of these systems identified a lack of reference standards for 
classification, a lack of comparison even between traditional surveillance methods to 
determine timeliness, an inadequate evaluation of data for sensitivity and specificity, and 
significant challenge in distinguishing between statistical anomalies and significant public 
health events (Bravata et al, 2004; Hurt-Mullen and Coberly, 2005).  Additionally, many systems 
had incorporated spatial data without evaluating whether a combination of temporal and 
spatial data provided an improvement over temporal data alone (Bravata et al, 2004).  In spite 
of the initial gaps in standards and in effectiveness, passive electronic surveillance systems 
using pre-diagnostic/syndromic methods have become well established in public health 
surveillance and are considered to be practical tools for epidemiologists in the rapid detection 
of emerging, infectious and bioterrorism related diseases (Hurt-Mullen and Coberly, 2005; Leal 
and Laupland, 2008). 
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The overall results of this review indicate that syndromic surveillance in public health has 
focused primarily on rapid detection from front line medical contact at emergency 
departments or outpatient clinics.   However, non-traditional data types including pharmacy, 
telemedicine, absenteeism, ambulance dispatch and others were explored in thirty-three of the 
studies reviewed.  While recognized as potential data for syndromic surveillance, laboratory 
data were primarily utilized for comparison and validation.  Only one study evaluated 
laboratory submission data as an pre-diagnostic indicator (Hoabo et al, 2005). The results 
support the tendency to utilize multiple data sources for broad area coverage and improved 
timeliness, but the inclusion of multiple data types in the evaluations was not as common, even 
if the system under evaluation included additional data types.  The key disease groups of 
interest to public health surveillance, infectious diseases, emerging disease and bioterrorism 
events, were reflected in the studies reviewed.  
 
Classification of pre-diagnostic or syndromic indicators was found to be a critical part of 
syndromic surveillance.  When studies focused singularly on classification, it was primarily to 
develop and validate a specific syndrome or syndrome group; of the fifty-five studies with 
classification components, twenty-one did not have any additional components other than 
validation.  The initial findings at point of contact, especially chief complaints, were the key 
components of pre-diagnostic classification.  ICD-9-CM codes appeared to contribute 
significantly to classification methods, either as part of classification itself or as a part of a 
validation.  The use of more advanced techniques to classify syndromes was not as well 
developed and focuses specifically on free text chief complaints. While the use of language 
processors and support vector machines was noted, ten of the thirteen studies that described a 
sophisticated syndrome classification method used the same one; a naive Bayesian classifier 
utilized by the Real Time Outbreak Detection System laboratory at the University of Pittsburgh 
(Chapman et al, 2004; Chapman et al, 2005a; Chapman et al, 2005b; Ivanov et al, 2002; Ivanov 
et al, 2003; Mikosz et al, 2004; Moore et al, 2008; Muscatello et al, 2005; Reis and Mandl, 2004; 
Wagner et al, 2004). 
 
The number of syndromes under evaluation remained very low in this review, typically only 
one.  The most obvious reason is a focused approach to evaluation where estimating 
sensitivity, specificity and timeliness on many syndromes may be very difficult to complete in a 
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single research study.  However, from a public health perspective single syndromes with a 
respiratory basis are very important and warrant a strong focus: many of the most significant 
disease include significant respiratory components; influenza, SARs, and anthrax used for 
bioterrorism (Bravata et al, 2004; Chapman et al, 2005a; Ritzwoller et al, 2005).  Additionally, 
while less common but with potential application to veterinary medicine, single syndromes 
were utilized for focused identification of specific diseases in areas where laboratory 
confirmation is not readily available (Aggarwal and Kumar, 2004; Mathews et al, 1998; Yin et al, 
2008).  The directed approach was also consistent in limits placed on the chief complaints 
captured for syndrome classification.   When no limits on chief complaints were placed, the 
number of syndromes increased from a mean of two to a mean of eight.  The relationship 
between chief complaints and syndromes is causal only in that limits on chief complaints 
appear to be placed when the number of syndrome is limited a priori.  More importantly, this 
review suggests that if syndromic surveillance is to include multiple syndromes, the 
information necessary to classify those syndromes should be as broad as possible.  
 
Considerable emphasis was placed on the use of time series analysis and aberration detection.  
As noted above, there is a great need to distinguish between statistically anomalies and 
significant public health events.  Specific detection algorithms such as What’s Strange About 
Recent Events (WSARE) and the Bayesian Aerosol Release Detector (BARD) have been 
developed to address these concerns (Buckeridge et al, 2005; Hogan et al, 2007; Kaufman et al, 
2007).  Additionally, the inclusion of spatial analysis has attempted to provide more refined 
signals (Kulldorff et al, 2005; Kulldorff et al, 2007).  The need for advanced analysis comes in 
part because of the large numbers of selected cases and associated case data that occurs in 
public health surveillance. When case numbers were reported in the studies reviewed, selected 
cases often exceeded 60,000 for a time period of one year or less.  Multiyear studies exceeded 
400,000 cases with the largest, a nationwide pharmacy surveillance system reporting 2.6 
million.  The capacity to determine if a significant public health event has occurred through 
case follow-up may be limited by such high case numbers (Buckeridge et al, 2005; Hurt-Mullen 
and Coberly, 2005; Terry et al, 2004).  Additionally, non-traditional data sources and passive 
surveillance can be affected by weekly, seasonal and onetime events that may create signals 
that are difficult to distinguish from significant public health events (Carrico and Goss, 2005).  
Response and validation of a significant public health event from syndromic surveillance must 
38 
 
include additional levels of data analysis for effective response.  In veterinary medicine, the 
greater issue would likely be a lack of case numbers to generate sufficient baseline. However, 
sophisticated temporal and spatial analysis has been applied in veterinary surveillance (Odoi et 
al, 2009).  
 
Evaluation of syndromic surveillance has developed sufficiently to include the generally 
excepted measures of accuracy for public health surveillance.  Sensitivity was reported in forty-
five of the eighty-one studies, represented greater than 30% of all results reported and was 
indicative of method validation.  Additional accuracy results, such as specificity, PPV, and area 
under ROC were also included with sensitivity in some studies.  Measures of agreement (kappa 
or correlation coefficients) with syndrome classification demonstrated greater evaluation of 
effective syndromes. Timeliness, sensitivity and specificity of syndromic surveillance has 
reportedly improved by utilization of multiple data sources and data types (Hurt-Mullen and 
Coberly, 2005; Ritzwoller et al, 2005).  However, in this review studies with multiple data 
sources did not routinely include sensitivity as a result.  Intuitively, multiple data sources, 
especially of the same type would seem to give better surveillance over space and time.  Some 
of the difficulty comes from the rarity of events such as bioterrorism (Bravata et al, 2004; 
Buckeridge et al, 2005), but overall there is a need in public health for large multi data source 
and type surveillance systems to report sensitivities. 
 
Syndromic or pre-diagnostic surveillance has been attempted in some areas of veterinary 
medicine (Bartlett et al, 2010; Shaffer et al, 2008; Van Metre et al, 2009) but has not been 
explored to the same degree as is the case in public health.  This review has highlighted 
challenges and advantages to the application of syndromic surveillance in animal health.  
Databases containing chief complaints, clinic examinations and clinical diagnoses are not 
readily available in animal health.   Globally, systems involving animal hospital based pre-
diagnostic surveillance have been implemented, but there has been no substantive evaluation 
of their sensitivity, specificity and timeliness.   Laboratory databases are more available, but are 
often limited to a specific region or do not represent all of the animal population in a given area 
(e.g. laboratory services may be limited to only one sector of the animal population). Public 
health syndromic surveillance has explored non-traditional data sources to further expand 
surveillance capacity.  Similar approaches could be taken in animal health. 
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As in public health, animal health surveillance that utilizes syndromic methods should focus on 
the key disease categories that are of significant concern.  Emerging disease, reportable 
diseases, zoonotic diseases and significant changes in endemic diseases could form the key 
strategic categories for any animal health syndromic surveillance system. 
 
Syndromic surveillance in public health has made good use of globally accepted medical 
disease coding standards, such as the ICD-9-CM.  Systematic, generally accepted disease 
nomenclature does not exist in veterinary medicine.  Other than expert opinion, the 
classification of pre-diagnostic data into significant syndromic indicators will need to utilize 
more disparate data, rely heavily on the data source and the data itself to estimate significant 
syndrome classifications.  The ability to provide comparative data for the measurements of 
accuracy and agreement assist in developing informative classifications.  For example, 
laboratory data can provide pathological diagnoses and test results to compare to classification 
of submission information.  
 
Population demographics may also present an additional challenge in veterinary medicine 
compared to public health.  Large portions of domestic animal populations (i.e. food animal 
production) live entirely in herd/flock situations where disease contact and spread occurs 
primarily at the group level.  Animal health events are often recorded for groups of animals and 
data from single individuals are interpreted at the herd level.  Identifying and evaluating group 
level dynamics for surveillance in data collected for other purposes may be very important in 
animal health compared to public health. 
 
Timeliness of animal health data will rely heavily on how quickly and practically information can 
be submitted.  Currently, if clinic databases could be reasonably linked only companion animal 
medicine has the ability to supply case information that would compare to the real time 
approach in public health.  However, some current clinic based systems approach real time 
with daily submission of case data. As is the case in public health, laboratory submission data in 
animal health may have difficulty providing sufficient timeliness (Hoabo et al, 2005; Shaffer et 
al, 2008).  However, in regions where other sources of information for animal health 
surveillance are limited, laboratory data may represent a viable option to explore. 
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Animal health can learn from the experiences of public health surveillance and ensure that 
syndromic surveillance is developed in ways that can effectively measure and report sensitivity, 
specificity and timeliness.  Such measures will be critical to adequately informing policy and 
responding to significant animal health events. The public health experience must be further 
tempered for animal health by the amount of data available, the data sources available, the 
population demographics and the comparable lack of diagnostic references standards.  
However, the opportunity to explore syndromic surveillance further in animal health is 
considered a legitimate approach to address large scale animal health surveillance needs. The 
public health experience in syndromic surveillance reviewed in this study demonstrates the 
systematic approach necessary to move forward in animal health.  The principles of such a 
systematic approach that need to be applied are:  a) Identify and evaluate the use of clinical, 
laboratory and non-traditional data sources.  b) Develop meaningful syndrome classifications 
through methods applicable to the available data and resources. c) Determine the most 
appropriate signals and the associated timeliness.  d) Ensure an analytical approach with 
appropriate measures of association and validation to avoid false interpretations while 
capturing critical early signals. 
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Chapter 3: Exploration and evaluation of pre-diagnostic data from a regional 
animal health laboratory for the purpose of syndromic surveillance in swine 
 
3.1. Introduction  
Syndromic surveillance methods enhance traditional early warning surveillance by analyzing 
continuously acquired pre-diagnostic data for earlier detection and response of disease events 
(Dorea et al, 2013; Hiller et al, 2013; Hoinville et al, 2013; Katz et al, 2011).  The use of 
laboratory pre-diagnostic data, such as test requests and specimen types included in case 
submissions, has been identified as a viable approach for syndromic surveillance in human and 
animal health (Dorea et al, 2012; Dorea et al, 2013; Ma et al, 2005; Odoi et al, 2009; Shaffer et 
al, 2008).  Reviews of syndromic surveillance methods and systems have identified that 
effective analysis and evaluation of data sources are essential to establish appropriate 
syndrome definitions for syndrome classification, to determine the availability of continuously 
acquired baseline variables for timely aberration detection and to determine availability of 
diagnostic outcomes for validation in the form of syndrome sensitivity and aberration detection 
performance (Buehler et al, 2004; Dorea et al, 2011; Katz et al, 2011).  The evaluation of a 
syndromic surveillance data source is important for several key reasons: As syndromic 
surveillance relies on information collected for other purposes, it is essential to understand the 
reasons for the data collection so that the relevance to the health and welfare of the source 
populations can be estimated.  Additionally, the type of data, the structure and the applied 
data standards are important to determine what pre-diagnostic data are available for 
syndrome classification and for estimating syndrome sensitivity.  Finally, determining the 
timeliness of the data, what the underlying trends are and what baselines can be established, 
are essential in understanding the capability for anomaly detection and accuracy.  These key 
reasons are especially true for animal health data sources (including laboratories) where there 
are species differences, inherent multilevel clustering of certain animal populations (herds and 
flocks in food production), non-diagnostic health assessments, less complete data capture, less 
developed data standards and less overall timeliness in reporting (Amezcua et al, 2013; Dorea 
et al, 2011; Dupuy et al, 2013a; Kosmider et al, 2011).   
 
To estimate the relevance of pre-diagnostic laboratory data in animal health syndromic 
surveillance, it is important to understand the reasons for submissions (Dorea et al, 2011; 
Gibbens et al, 2008). Reasons for submissions to animal health laboratories are impacted by 
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submission bias similar to other animal health data sources, where the cases submitted may 
not fully represent the health or demographics of the source populations.  Submission bias is a 
form of selection bias where the choice by submitting veterinarians to submit samples is 
affected by reasons other than disease investigations, such as economic factors (e.g. feed 
prices, currency exchange rates, carcass values), requests for non-diagnostic testing (e.g. 
international trade, vaccine effectiveness, regular health monitoring, research) and 
professional experience (Bartlett et al, 2010; Dohoo et al. 2009).  When significant disease 
issues are presented in swine herds and other animal populations, it has been demonstrated 
that veterinarians will increase diagnostic pathology submissions to better understand the 
disease processes (Gibbens et al, 2008; O'Sullivan et al, 2012; O'Toole, 2010).  However, 
evaluating data sources for an understanding of what factors may be contributing to 
submission bias is helpful in determining the overall effectiveness of detecting significant 
disease events in animal populations using syndromic methods.  As noted above, this is 
especially true for food animal production where many factors may contribute to submission 
bias. 
 
To understand how pre-diagnostic data from animal health laboratories may be classified into 
relevant syndromes, it is important to know what data are available and how it is coded.  Many 
laboratory submissions and records do not contain or do not have ready access to all of the 
information in a recommended minimum data set proposed by Kloeze (Kloeze et al, 2012).  
Specifically, disease classification by submitters (clinical diagnoses) and/or reasons for 
submissions are not consistently provided or recorded.  Additionally, not all information is 
coded in a format that would provide a more efficient means of classifying data into syndromes 
(Dorea et al, 2011; Gibbens et al, 2008; Shaffer et al, 2008).   Data coded systematically using 
standardized definitions provides a means of mapping data clusters for syndrome classification 
or of grouping complex diagnostic outcomes for validation in syndromic surveillance(Dorea et 
al, 2011; Gibbens et al, 2008).  Standardized disease nomenclatures such as the Logical 
observation identifiers names and codes (LOINC) used in human health laboratories provide 
both well established data definitions and a means to compare data across different sources 
using the same codes (Ma et al, 2005; Sintchenko and Gallego, 2009). However, as long as the 
coding system is defined with established rules for use, a data source that has its own internal 
coding system for diagnostic data has been demonstrated to provide, at minimum semi – 
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structured data for classification and validation (Gibbens et al, 2008; Hyder et al, 2011; Shaffer 
et al, 2008).  
Validation of syndrome classification and detection algorithms has been identified as an 
important step in both clinical and laboratory syndromic surveillance methods as it establishes 
the sensitivity, specificity and diagnostic performance of the surveillance components (Dorea et 
al, 2012; Guasticchi et al, 2009; Kashiouris et al, 2013; Leal and Laupland, 2008).  Furthermore, 
it has been recognized that validation methods, if applied routinely through automated or 
manual means, may be used to keep syndromic surveillance components up to date (Dorea et 
al, 2013).  Syndromic surveillance systems in public and animal health have achieved both of 
these steps by linking the surveillance data to objective outcome data, such as laboratory 
results and to professional assessments, such as pathology diagnoses (Amezcua et al, 2013; 
Hiller et al, 2013; Leal and Laupland, 2008; Shaffer et al, 2008).  Sensitivities and positive 
predictive values for syndrome classification compared to diagnostic outcomes have been 
utilized frequently in public health to ensure the classifications are representative of the 
targeted heath conditions.  When possible, this “gold standard” approach is seen as a preferred 
option for syndrome validation (Guasticchi et al, 2009; Hiller et al, 2013; Kleinman and Abrams, 
2008; van den Wijngaard et al, 2008).  Diagnostic outcomes are easier to use as “gold 
standards” in public health data sources because the common use of standardized disease 
nomenclature to assign case outcomes. In veterinary medicine, diagnostic outcomes are also a 
preferred method of validating syndrome classification.  However, the semi structured nature 
of diagnostic outcomes in many animal health data sources require more complex analyses 
and/or further professional assessment to provide validation methods for syndrome 
classification (Dorea et al, 2011; Dorea et al, 2013).  
 
The purpose of this chapter is to analyze and evaluate the data available from a regional animal 
health laboratory for the larger intent of enhancing its contribution to early warning 
surveillance in the regional swine population by incorporating syndromic surveillance methods.  
Specifically; (a) to describe the type of submission information and the underlying trends in 
typical swine cases submitted to a regional animal health laboratory (b) to describe the types of 
specimens submitted, the diagnostic procedures requested and the outcomes of the typical 
swine cases, (c) to determine the availability and type of test requests and submitted 
specimens for use in syndrome classification for detection of significant swine health events 
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and (d) to conduct an analysis of laboratory results and pathology diagnoses that establishes 
diagnostic outcomes that may be used for validating syndrome classification. 
 
3.2. Methods 
3.2.1 Data Source 
Veterinary Diagnostic Services (VDS) is a full service animal health diagnostic laboratory in the 
province of Manitoba, Canada and is a component of the Agri-Industry Development and 
Innovation branch of the provincial department of Agriculture, Food and Rural Development 
(MAFRD).  VDS fulfils the primary animal health laboratory role of providing diagnostic and 
pathology services to practising veterinarians and their clients.  Additionally, VDS actively 
contributes to the surveillance and identification of emerging diseases through the traditional 
means described by O’Toole, especially for diseases such as porcine circovirus (PCV2) and 
porcine epidemic diarrhea (PED) (O'Toole, 2010).  Finally VDS is a full participant in two key 
animal health networks for disease surveillance and response; the Canadian Animal Health 
Surveillance Network (CAHSN) and the Canadian Animal Health Laboratory Network (CAHLN).  
As part of CAHSN, VDS is one of the network’s participating laboratories that supplies case 
submission data on a daily basis to a national animal health surveillance and disease response 
initiative (Kloeze et al, 2010).  The CAHLN involvement commits VDS to work with other 
Canadian animal health laboratories to improve standard approaches for conducting and 
reporting test results, as well as improved standardization of disease coding. 
 
VDS was estimated to receive 75 to 80% of all porcine laboratory submissions from the 
province.  The percentage of diagnostic pathology cases was estimated to be higher due to a 
centralized location, readily available expertise and the specific public funding of food animal 
laboratory submissions.   The laboratory infrastructure and operations was centred in 
Winnipeg, the largest urban centre in Manitoba.  Winnipeg is a regional commercial and 
transportation hub within close proximity to the majority of Manitoba swine production.  As a 
regional animal health laboratory, VDS maintained a high degree of in-house professional 
expertise and technical capacity in general necropsy and histopathology, diagnostic virology 
and microbiology.  This resource allowed for the interdisciplinary approach to significant 
regional animal health events promoted by O’Toole, creating a close collaboration with clinical 
veterinarians which in turn encouraged diagnostic and pathology submissions (O'Toole, 2010).  
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Public funding to VDS provided 70% of the financial costs for all diagnostic testing, non-
diagnostic testing and pathology expertise for submissions from Manitoba livestock herds and 
poultry flocks. The contribution of public funds to laboratory infrastructure and operations, in 
association with data sharing agreements provides VDS the opportunity to effectively share 
laboratory data for early warning surveillance. 
 
Swine submissions to an animal health laboratory can be categorized based on clinical 
demands: to conduct herd level monitoring of endemic diseases or hazards (e.g. antimicrobial 
resistance), to implement and adjust herd based risk mitigation procedures for endemic 
diseases (e.g. vaccine effectiveness), to confirm freedom from disease for trade purposes and 
to establish a diagnosis in an animal health event.  The differentiation between the types of 
submissions to animal health laboratories for swine health is important.  Establishing diagnoses 
for clinical disease often involves the direct intervention of veterinary pathologists.  Cases that 
are submitted for these reasons inherently imply that a change of health status has occurred in 
the affected animal or herd.  Herd level monitoring for risk mitigation or freedom from disease 
is typically done to confirm health status has changed. 
 
VDS utilized a Laboratory Information Management System (LIMS) developed and maintained 
by in-house technical staff.  The LIMS is primarily designed to maintain client information and 
laboratory results for reporting and billing purposes.  The system has limited data retrieval 
capabilities that allow for static queries of the database for other purposes, such as 
surveillance.  As with other veterinary diagnostic laboratories (Dorea et al, 2012; Gibbens et al, 
2008; Shaffer et al, 2008); (a) a common case number is given to all samples submitted and 
tests performed from an individual health event from the same location submitted on the same 
day.  (b) The case number more accurately reflects a submission number; submissions may 
represent single animal health events (or cases).  However multiple submissions on multiple 
days from the same animal health event (even at the same location) will generate different 
case numbers.  The samples submitted and the test requests for each submission are recorded 
into the LIMS on the day received.  The key variables collected and recorded routinely across all 
submissions to VDS are in table 1. Diagnoses and Organ system classifications (Table 2) are 
standardized and used within the LIMS as in other diagnostic laboratories (Dorea et al, 2012; 
Gibbens et al, 2008; Shaffer et al, 2008).  However, like many other animal diagnostic 
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laboratories, general standardized coding systems, such as SNOMED, LOINC or HL7 are not 
used (Dorea et al, 2011).  For diagnostic pathology submissions, the case diagnoses were 
represented through diagnoses and organ systems codes, assigned in order of significance; a 
primary diagnosis may be followed by up to 12 additional diagnoses.   
 
Table 1: Data Fields collected for laboratory submissions to Veterinary Diagnostic Services Laboratory 
Information Management System (LIMS) 
Submission Field Description 
Case number Submission number from a single event at a location on a given 
date 
Species  
Submission Date  
Risk Group Total group size, number at risk, number sick and number dead 
Problem duration  Duration of health event, in days or months 
Practitioner Identification Unique Practitioner and clinic identifiers, which include postal 
code and nearest city.1 
Producer Identification Unique producer identifiers including postal code and nearest 
city.1 
Submitted Animals  Number of dead and/or live animals submitted for necropsy 
Individual animal information Gender, weight and age.  Routinely collected for companion 
animal cases.  Not routinely provided for livestock cases 
Specimens submitted Description and code for all specimens submitted with a case 
Test requests Description for all tests requested for a case, including individual 
test and laboratory codes 
Diagnostic Codes Fields for diagnostic pathology submissions, in order of most 
significant findings: 12 possible fields, 2500 coded diagnoses 
Organ System Classification Organ system associated with pathology diagnoses, 12 possible 
fields.  18 organ system descriptions2 
Test Results Results for each test conducted per submission. Values and units 
specific to each test procedure, additional field for further 
comments 
1. Premises identification numbers for land locations associated with veterinary clinics and livestock operations 
are now mandatory on VDS’ LIMS.  They were not mandatory at the time the data were extracted.  Postal 
codes and nearest city were the only available geo-locations. 
2. Organ systems and associated codes are described in Table 2. 
 
 
  
Table 2: 18 organ systems available for assignment to pathology submissions 
Code Organ System Code Organ System 
1001 Bones /Joints/ Synovial tissue 1010 Male Genital 
1002 Cardiovascular 1011 Multiple Systems 
1003 Eye /Ear/ Sensory 1012 Muscle 
1004 Endocrine 1013 Nervous 
1005 Female Genital 1014 Respiratory 
1006 Hematopoietic 1015 Skin and Appendage 
1007 Lower Digestive 1016 Unknown 
1008 Lymphoreticular 1017 Upper Digestive 
1009 Liver /Bile /Pancreas 1018 Urinary 
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All available data from all species were extracted in a single query using the available query 
platform from January 1st 2003 to March 15th, 2009.  January 1st 2003 was used as a cut off 
because it represented the start of the first full year on the LIMS system that was developed in-
house.  Prior to that date, VDS had used commercial LIMS software.  
 
3.2.2 Data Evaluation 
Collation and analysis of laboratory data were attempted following the principles of a minimum 
data set for surveillance purposes (Kloeze et al, 2012).  The minimum data set was used to 
define the essential, core elements of the data from the LIMS. The data were screened and 
evaluated using statistical software(Stata Statistical Software: Release 11, 2009). Similar to the 
method described by Gibbens et al, the porcine submissions were divided into those submitted 
for pathology work up (Pathology submissions) and those submitted for limited specified 
testing (Non-pathology submissions)(Gibbens et al, 2008).  However, unlike the system 
described by Gibbens, the divisions were made based on veterinary practitioner requests and 
not on reasons for submissions; reasons for submissions were not in the data base because 
they are not directly captured (or coded) in the submission process.  Instead, these reasons are 
part of additional text comments provided by the practitioner.  Additional text comments were 
not captured in the extract and would have required text mining methods to extract 
information. 
 
Pathology submissions included tissues (from field necropsies) or full carcasses from an animal 
health event.  The submitting veterinarian had requested a full pathology work up and had 
included specific test requests for suspect diseases.  These submissions were diagnostic cases 
and the pathology work up concluded with a series of pathology diagnoses assigned to organ 
systems and in order of relevance.  The data evaluation summarized the common diagnoses 
and their classification by organ system.  It was recognized that these submissions may be 
affected by misclassification bias in that practitioners may not submit the right specimens.  
Such misclassification bias would be indicated in pathologists’ case comments, but these 
comments were not available in the extract provided.  Non-pathology submissions were also 
submitted through veterinarians, but were submitted for diagnostic or non-diagnostic reasons.  
As noted above, reasons for submission were not coded and were not available in the extract 
provided.  Pathologists’ reviewed all testing completed at VDS and provided  
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comments on the final reports.  However, these comments were not pathology diagnoses and 
were captured only in the comment fields. 
 
The distributions of specimens submitted and tests requested were determined for both 
pathology and non-pathology submissions.  The intent was to describe the variety of specimen 
types and test requests available as pre-diagnostic indicators for potential syndrome 
development, especially for pathology submissions.  To provide groupings of pathology 
outcomes for syndrome validation, pathology submissions were further evaluated to determine 
the frequency and distribution of specific diagnostic codes and organ systems across diagnostic 
variables.  The frequencies and distributions were used to estimate the extent additional 
diagnoses were assigned to pathology submissions.  The distributions across diagnostic 
categories were also used to determine the most frequently assigned organ systems and the 
most frequently assigned diagnostic codes.  The most frequently assigned organ systems were 
cross referenced with the most common diagnostic codes to compare frequent codes with 
frequent organ systems in the primary diagnosis category. A single “Other” organ systems 
group was used for grouping less frequently assigned organ systems and the diagnostic codes 
were compared with this group.  In order to further assess the viability of using test requests 
and specimen types for syndromic development, the distributions of specimen types and test 
requests across organ system groups were also determined.  For non-pathology submissions, 
the evaluation was limited to the frequency and distribution of test requests and specimen 
types. 
 
3.2.3 Data Analysis 
As noted above, the outcomes for pathology submissions may be used to form the basis of a 
validation for syndrome classification.  Since each pathology diagnosis is assigned a diagnostic 
code and an organ system category in order of priority, a simple approach may have been to 
group submissions on their primary diagnoses.  However, in order to have the most 
representative outcomes for validation, it is necessary to evaluate if additional diagnoses 
(outcomes) for each submission would impact the grouping of submissions into outcome 
variables.  Pathology submissions were evaluated for clustering across the primary and 
additional diagnoses using Multiple/Joint Correspondence Analysis (MCA) and ascending 
hierarchical cluster analyses.   MCA is a form of Multiple Factor Analysis (MFA), where, like 
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other forms of MFA, the mathematical theories of linear algebra are used to identify geometric 
associations between variables (Blasius et al, 2009; Le Roux and Rouanet 2010a).   MCA is a 
specific analysis for categorical variables with more than a binary outcome and is often used in 
social sciences to describe relationship patterns among individual answers to questionnaires 
with multiple categories of potential responses. The analysis generates coordinates for 
observations on a series of dimensions (axes) that are each weighted by the frequencies of the 
categories in each variable (principal inertia).  The coordinates form a cloud of points based on 
dimensionality where each dimension is represented by principal axes (1,2,3, etc) ranked in 
decreasing order of category contribution to the overall inertia: the first axis has the groups of 
categories with the highest percentage of contribution to inertia, the second axis the next 
highest, and so on.  Each dimension describes variation in clusters of observations within 
categories not described by the previous axis, thereby identifying differences in variation 
contributed by different category groups (Le Roux and Rouanet 2010b).  Eigenvalues are the 
measurements of variance between coordinates, the average variation for each dimension is 
represented by mean eigenvalue for that dimension (axis) and the sum of all eigenvalues is the 
total variation in the cloud (Le Roux and Rouanet 2010c).  Ascending hierarchical clustering 
applied to a cloud of points within the variance criterion is considered the companion method 
of MCA, that identifies “nested partitions” (in this situation, groups of cases) within the cloud 
(Le Roux & Rouanet 2010a).  The hierarchical clustering method uses the coordinates described 
through MCA and places the associated observations into “new” outcome variables that take 
the dimensions and their percentage variance contribution into account.  Components of MFA 
and hierarchical cluster analysis have been used to define and evaluate animal health 
syndromic surveillance methods in abattoirs and wildlife pathology (Dupuy et al, 2013b; Warns-
Petit et al, 2010). 
 
To evaluate the impact of pathologists assigning multiple additional diagnoses to pathology 
submission outcomes, clusters of diagnoses were evaluated using MCA on submissions with up 
to 2 additional diagnoses or up to 4 additional diagnoses. When submissions did not have any 
additional diagnoses, they were assigned as “missing”.  Two approaches to conducting MCA on 
pathology diagnoses outcomes were considered, both using frequently assigned organ system 
categories, including the “Other” category, from the data evaluation:  In the first method, 
additional diagnoses were included only if an organ systems category was assigned.  In the 
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second method, all additional diagnoses were included, with “missing” treated as an additional 
category.  For the second method, the primary diagnosis would still have only one of the 
frequently assigned organ system categories as there was never a “missing” primary diagnosis.  
However, each additional diagnosis could have one additional outcome, “missing” if there were 
no further diagnoses identified by the pathologists.   Coordinates for submissions were 
obtained for three dimensions using standardized or principal normalization, based on the 
percent contribution to principal inertia (Le Roux & Rouanet 2010c).  The contributions of 
organ system categories in each dimension were described from the MCA.  Cluster analysis on 
the submissions, using the MCA coordinates, was completed using Ward’s hierarchical 
agglomerative linkage method (Le Roux & Rouanet 2010c; Stata Press 2009).  Cluster analysis 
was conducted using coordinates from the principal inertias across three dimensions.  The 
statistical software weighted the coordinates based row scores (inertias from organ system 
categories) and dimension scores (inertias from diagnoses categories). If missing values were 
included (by including the “missing” category), cluster analysis was conducted on both row and 
dimension scores.  An alternative approach to missing values was to exclude them from the 
analysis . Cluster analysis was conducted on row scores only, since excluding the “missing” 
category excluded dimension scores from submissions without additional diagnosis.   
 
3.3 Results 
3.3.1 Overall Submissions 
VDS’ LIMS system data set had a total of 115,108 cases involving 906,184 specimen/test result 
combinations for the 2003-2009 time period (approximately 8 specimen/test per case).   For 
each submission the tests were coded into one of 301 possibilities and the specimens were 
coded into one of 347 possibilities.  Twenty one thousand six hundred and sixty five (21665) 
porcine cases were extracted from data set, representing 19% of the total case submissions.  
The porcine submissions included 492,775 specimen/test result combinations, 54% of the total 
specimen/test result combinations submitted (approximately 23 specimen/test results per 
case).  There was an average of 3494 porcine cases per year; with 4726 (21.8 percent) 
pathology submissions and 16,939 (78.2 percent) non-pathology submissions (Table 3).   
 
The extracted submission information was not complete when compared to the recommended 
minimum data set(Kloeze et al, 2012); Geographic location was limited to postal code.  Farm 
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type and group type were collected but not present in the data extract.  The total population of 
animals tested, number sick and number dead were provided by practitioners in less than 5% 
of the submissions.  Disease classification by the practitioner was reported to be provided in 
case histories included with laboratory submission forms.  However, case histories were not 
included in the syndrome categories within the LIMS because they occur as free text, making it 
extremely difficult and time consuming for VDS staff to enter the information .  Surrogate 
variables such as the test(s) performed, the specimen(s) submitted and the organ system 
classification for pathology cases were available.  The test results, the disease agent(s) 
identified and codified final pathology diagnoses for pathology submissions were available.  
Final laboratory diagnoses for non-pathology submissions were restricted to results and 
comment fields.  No specific coding for these outcomes was utilized. 
 
An average of 289 porcine cases were submitted per month with a standard deviation of 69.9 
and a range of 126 to 433.  While pathology submissions were consistent throughout the time 
period, non-pathology submissions varied greatly, year over year (Figure 1).  The highest level 
of monthly submissions occurred from 2005 to 2007.   Seasonal variation was observed on 
average submissions per week, with a greater number of submissions occurring in winter and 
fall.  However, this variation appeared consistent year over year (Figure 2). 
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Table 3: Porcine submissions by year; Total submissions, submissions with pathology diagnoses and submissions with no pathology 
diagnosis. 
 Frequency Percent of total cases Cum. Percent 
Year Total Pathology Submission 
Non 
Pathology 
Submission 
Total Pathology Submission 
Non 
Pathology 
Submission 
Total Pathology Submission 
Non 
Pathology 
Submission 
2003 2,505 679 1,826 11.56 3.13 8.43 11.56 3.13 8.43 
2004 2,785 694 2,091 12.85 3.20 9.65 24.42 6.34 18.08 
2005 3,703 717 2,986 17.09 3.31 13.78 41.51 9.65 31.86 
2006 4,366 961 3,405 20.15 4.44 15.72 61.66 14.08 47.58 
2007 4,329 933 3,396 19.98 4.31 15.68 81.64 18.39 63.25 
2008 3,313 624 2,689 15.29 2.88 12.41 96.94 21.27 75.67 
20091 664 118 546 3.06 0.54 2.52 100.00 21.81 78.19 
Totals 21,665 4,726 16,939 100.00 21.81 78.19    
1. Cases up to March 15, 2009 
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Figure 1: Monthly porcine submissions to Veterinary Diagnostic Services from January 1, 2003 to March 
15, 2009. 
 
 
 
Figure 2: Weekly porcine submissions to Veterinary Diagnostic Services, by year from January 1st, 2003 to 
December 31st, 2008. 
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3.3.2 Pathology Submissions – Test requests & Specimen type distributions 
Porcine pathology submissions included 65 test codes and 79 specimen codes.  The most 
common 25 test requests accounted for greater than 95 percent of all test requests and the 
most common 25 specimens submitted accounted for greater than 93 percent of all specimen 
types submitted (Table 4).  Figure 3 represents the distribution of specimens submitted and 
test requests for all pathology submissions. The distributions suggest a reasonable number of 
specimen types and tests were conducted on each case.  However, predominant test requests 
and submitted specimens were not specific (histology, necropsy, aerobic culture, fixed tissue 
and carcass) and were not easily classified into syndrome categories.  Appendix I represents 
further distributions of specimen type and test distributions by the most common organ 
systems groups.  As with the overall distribution, there were many specimen types and test 
requests that are non-specific.  Additionally there were several specimen types and test 
requests that would normally be thought of as organ system specific that were frequent in 
more than one organ system.  For example, lung specimens and swine influenza virus (SIV) 
tests were common in both respiratory and multisystemic organ system groups.  However, 
organ systems such as gastrointestinal (GI) had a more intuitive pattern where specimen types 
such as intestine and tests such as electron microscopy and fecal smears were more 
predominant than in other organ systems.  All tests requests (pathology and non-pathology 
submissions) had up to 6 result fields per requested test and specimen submitted 
(specimen/test combination).  PCR and ELISA test results had a single outcome (positive or 
negative) per specimen/test combination.  The additional result fields included optical density 
values and s/p ratios for ELISA or CT values for PCR.   Tests with more than one possible 
outcome had multiple outcomes per specimen submitted (multiple specimen/test result 
combinations).  The most common and most complex of these were microbial culture results.   
“Negative” culture results had outcomes such as “no organisms cultured” or “non-significant 
organisms”.   Positive cultures results included non-pathological or opportunistic pathogens 
such as some serotypes of E. coli or species of  Streptococcus.  The additional culture result 
fields included a score representing the number of colonies per organism identified and a 
comment field.  Antimicrobial sensitivities were not included in the data extract.  No further 
evaluation of test results was conducted for pathology submissions, since their outcomes 
contributed to the pathology diagnosis. 
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Table 4: 25 Most common test requests & specimen submitted for Pathology submissions 
Tests Freq. Per. Cum. Per Specimens Freq. Per. Cum. Per 
Histology 4565 16.05 16.05 Fixed Tissue (NSP1) 4540 22.34 22.34 
Aerobic Culture 4312 15.16 31.22 Lung 3086 15.18 37.52 
PCR PRRS 2520 8.86 40.08 Carcass / Live animal 2509 11.64 49.16 
Necropsy - Porcine 2426 8.53 48.61 Pooled lung / tonsil 1360 6.69 55.85 
PCR PCV 2318 8.15 56.77 Small Intestine 1295 6.37 62.22 
PCR SIV H1N1 1834 6.45 63.22 Spleen 1171 5.76 67.98 
PCR Mycoplasma 
 hyopneumoniae 1797 6.32 69.54 Large Intestine 991 4.88 72.86 
PCR SIV H3N2 1446 5.09 74.62 Feces (fixed) 857 4.22 77.08 
Anaerobic Culture 885 3.11 77.73 Heart 631 3.1 80.18 
Electron Microscopy 863 3.04 80.77 Intestine (NSP1) 620 3.05 83.23 
F4 (K88) serotyping 682 2.4 83.17 Culture tube 380 1.87 85.1 
PCR Lawsonia spp 559 1.97 85.13 Brain & Spinal cord 359 1.77 86.87 
Direct smear  398 1.4 86.53 Kidney 353 1.74 88.61 
Coccidia Fecal Smear 359 1.26 87.8 Swab - joint 324 1.59 90.2 
PCR Brachyspira  
pilosicoli 342 1.2 89 Liver 311 1.53 91.73 
PCR C perfringens 
typing 282 0.99 89.99 Fetus 172 0.85 92.58 
ELISA Clostridium 
difficile 273 0.96 90.95 Swab - brain 151 0.74 93.32 
PCR Brachyspira  
 hyodysenteriae 231 0.81 91.76 
Pooled lung / 
lymph node 142 0.7 94.02 
Gram stain 220 0.77 92.54 Synovial membrane 119 0.59 94.61 
FAT TGE 194 0.68 93.22 Nasal swab 118 0.58 95.19 
Microminerals 188 0.66 93.88 Fetal stomach contents 116 0.57 95.76 
Necropsy – Porcine 
Fetus 181 0.64 94.52 Tonsil 114 0.56 96.32 
PCR PRRS typing 155 0.55 95.06 Skin 111 0.55 96.87 
PCR Circovirus typing 142 0.5 95.56 Joint tissue 109 0.54 97.41 
PCR Cytomegalovirus 
(CMV) 142 0.5 96.06 
Female Reproductive 
tissue 105 0.52 97.93 
1 Not specified 
 
 
3.3.3 Pathology Submissions – Diagnoses & Organ systems distributions 
All pathology submissions had a primary diagnosis with up to 9 additional diagnoses.   86.4 % of 
pathology submissions had a primary diagnosis only, one additional diagnosis (primary + 
secondary) or 2 additional diagnoses (primary + secondary + tertiary) (Figure 4).  There were 
548 diagnostic codes used 9768 times across the 4726 pathology submissions.  Ten diagnostic 
codes were the most frequently used and accounted for 34.0% of all diagnostic coding. 
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Systemic PCV2 infections or positive PCR tests for PCV2 (without histological signs) were the 
two most common codes (11.2%).  Five pneumonia codes were included in the most frequent 
coding: Broncho, broncho-interstitial, interstitial, porcine respiratory and reproductive 
syndrome (PRRS) virus related and Mycoplasma hyopneumoniae related (14.7 percent, 
collectively).   Atrophic enteritis (2.2 %), positive PCR tests for PRRS (2.9%) and “No Specific 
Diagnosis” (3.0%) were the remaining three frequently used codes. 
 
Figure 3: Distributions of Specimen types and Test requests for 4726 Pathology Submissions. The mean 
number of specimen types per submission was 4.5 with a standard deviation of 2.0 and a range of 1 to 
15.  The mean number of test requests per submission was 6.0 with a standard deviation of 2.5 and a 
range of 1 to 18.  
 
 Figure 4:  Distribution of 9768 pathology diagnoses across 4726 porcine pathology submissions (cases).  
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Three organ systems were predominant in pathology submissions across all diagnoses 
categories: Multisystemic, Lower Digestive and Respiratory (Figure 5).   The separate 
distributions of organ system assignment for primary, secondary and tertiary diagnoses 
demonstrated the same pattern, with the three organ systems predominating.   These findings 
supported merging Upper and Lower Digestive into a GI system and all of the less common 
organ systems into an “Other” organ system for further analysis.  Note that endocrine system 
was not assigned to any porcine submissions for any diagnostic category. 
 
 
Figure 5: Distribution (by percent) of pathology submissions across all organ systems; for all diagnoses 
across all categories (9768), for the primary diagnoses category (4726), the Secondary diagnoses 
category (2636) and the Tertiary Diagnosis category (1362).  Note that each diagnosis category is a 
subset of the category before and each porcine pathology submission has at minimum a primary 
diagnosis.  
 
To compare with the diagnoses observed across all submissions, Figure 6 shows the 30 most 
common diagnoses for the grouped organ system classes across the primary diagnoses 
category. Four, seven and nine distinct diagnostic codes accounted for greater than 50% of the 
primary diagnosis assigned Multisystemic, Respiratory and GI organ systems, respectively.  Ten 
distinct codes accounted for greater than 40% of the primary diagnosis assigned “Other” organ 
systems.  The ten most common diagnostic codes across the additional diagnoses categories 
(secondary, tertiary, etc) matched well with the most common codes used in primary 
diagnoses; PCV2 and “No Specific Diagnosis” codes occurred under the multisystemic category 
for additional diagnoses. Five of the seven most common primary diagnoses respiratory codes 
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were also among the ten most common codes across all additional diagnoses.  Finally, the most 
common primary diagnoses GI code, Atrophic enteritis, was also among the ten most common.  
Due to the combination of many different, less frequently assigned organ systems, the “Other” 
organ systems did not have a single code or groups of codes that predominated and did not 
have a code assigned that was represented in the ten most common codes in the additional 
diagnoses categories.  The most common code in “Other”, Streptococcus suis meningitis, did 
not exceed 7% of the primary diagnoses assigned. 
  
Additional review was conducted of “No Specific Diagnosis”, since similar coding has been used 
in other surveillance systems to detect emerging disease (Gibbens et al, 2008).  “No Specific 
Diagnosis” was the primary diagnosis in 246 cases and all were categorized as multisystemic. 
Eighteen had additional diagnoses and of those, nine were PCV2 positive.  When compared 
year over year, “No Specific Diagnosis” in pathology submissions increased from 3.7% and 3.0% 
in 2003 and 2004 to 6.6%, 6.1% and 5.9% in 2005 to 2007, respectively. By 2008, “No Specific 
Diagnoses” had decreased to 5.1%. 
 
3.3.4 Pathology Submissions – Clustering of Organ systems categories & Diagnoses variables 
Exploratory clustering techniques indicated that additional diagnoses had a significant impact 
on the grouping of pathology submissions by organ system classification.  A three way cross 
tabulation of the organ system classifications in the primary, secondary and tertiary diagnoses 
variables supported the likelihood that additional diagnoses may have an impact on the organ 
system grouping, especially for respiratory and multisystemic categories (Table 5, in yellow):  A 
primary respiratory diagnosis was more likely to have additional secondary and tertiary 
diagnoses that were either multisystemic or respiratory.  In fact the primary respiratory 
diagnoses often had a secondary respiratory diagnosis (466 cases, 35.7%).   A primary 
multisystemic diagnosis was more likely to have secondary diagnoses of multisystemic (164 
cases, 14.1%) or respiratory (250 cases, 19.1%).  An additional tertiary respiratory diagnosis 
was also common (176 cases, 15.1 %) and occurred most frequently with the secondary 
respiratory or multisystemic diagnoses.  A primary GI diagnosis was most likely to have another 
GI diagnoses as secondary diagnosis (404 cases, 33.6%).  A primary “Other” diagnosis was the 
least likely to have a secondary diagnosis.  The most 
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Figure 6: The most common diagnostic codes (in percent) of the primary diagnoses in each of four organ system categories.  Diagnostic codes that 
were used in 4% or more of pathology submissions were included and accounted for 50% or greater of submissions that occurred in each organ 
system. The exception was “Other” organ systems where diagnostic codes that occurred in 2% or more of cases were included.  These accounted for 
40% of the total within the “Other” organ systems category.
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Table 5: Cross tabulation of organ system categories from secondary and tertiary diagnoses for 
each primary diagnosis. Percent represents percentage of primary diagnosis 
 i) Respiratory Primary Diagnosis: ii) Multisystemic Primary Diagnosis: 
 
Tertiary Diagnoses 
  
Tertiary Diagnoses 
     GI  MS  Resp.  Other  None Total GI  MS  Resp.  Other  None Total 
Secondary 
 Diagnoses 
           GI Freq.  19 13 8 6 40 86 23 1 19 7 45 95 
 
%  1.5 1.0 0.6 0.5 3.1 6.6 19.7 0.1 1.6 0.6 3.9 8.1 
MS Freq.  18 62 53 18 99 250 16 16 57 17 58 164 
 
%  1.4 4.7 4.1 1.4 7.6 19.1 1.4 1.4 4.9 1.5 5.0 14.1 
Resp. Freq.  34 80 122 32 198 466 27 39 72 36 76 250 
 
%  2.6 6.1 9.3 2.5 15.2 35.7 2.3 3.3 6.2 3.1 6.5 21.4 
Other Freq.  15 12 12 20 56 115 9 2 28 14 58 111 
 
%  1.2 0.9 0.9 1.5 4.3 8.8 0.8 0.2 2.4 1.2 5.0 9.5 
None Freq.  0 0 0 0 389 389 0 0 0 0 546 546 
 
%  ----- ----- ----- ----- 29.8 29.8 ----- ----- ----- ----- 46.8 46.8 
Total Freq.  86 167 195 76 782 1,306 75 58 176 74 783 1,166 
 
%  6.6 12.8 14.9 5.8 59.9 100.0 6.4 5.0 15.1 6.4 67.2 100.0 
  
Pearson chi2(16) = 459.40   Pr = 0.000 Pearson chi2(16) = 597.0310   Pr = 0.000 
 iii) Gastro-Intestinal Primary Diagnosis iv)  “Other” Primary Diagnosis 
 
Tertiary Diagnoses 
  
Tertiary Diagnoses 
 
 
    GI  MS  Resp.  Other  None Total GI  MS  Resp.  Other  None Total 
GI Freq.  82 26 24 13 259 404 6 1 4 10 27 48 
 
%  6.8 2.2 2.0 1.1 21.5 33.6 0.6 0.1 0.4 1.0 2.6 4.6 
MS Freq.  11 6 13 2 44 76 3 18 11 6 66 104 
 
%  0.9 0.5 1.1 0.2 3.7 6.3 0.3 1.7 1.0 0.6 6.3 9.9 
Resp. Freq.  7 11 17 3 31 69 12 17 18 14 51 112 
 
%  0.6 0.9 1.4 0.2 2.6 5.7 1.1 1.6 1.7 1.3 4.8 10.6 
Other Freq.  5 4 6 7 34 56 10 21 13 54 134 232 
 
%  0.4 0.3 0.5 0.6 2.8 4.7 1.0 2.0 1.2 5.1 12.7 22.1 
None Freq.  0 0 0 0 597 597 0 0 0 0 556 556 
 
% ----- ----- ----- ----- 49.7 49.7 ----- ----- ----- ----- 52.9 52.9 
Total Freq.  105 47 60 25 965 1,202 31 57 46 84 834 1,052 
 
%  8.7 3.9 5.0 2.1 80.3 100.0 3.0 5.4 4.4 8.0 79.3 100.0 
  
Pearson chi2(16) = 393.17   Pr = 0.000 Pearson chi2(16) = 402.28   Pr = 0.000 
 
common secondary diagnose with a primary “Other” diagnosis was also “Other” (232 cases, 
22.1 %), followed by multisystemic (66 cases, 6.3%) and respiratory (51 cases, 4.8%) diagnoses.  
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Tertiary diagnoses were less likely to occur with either primary GI or “Other” diagnoses 
categories, than with primary respiratory or multisystemic.  When they did occur, they tended 
to be in the same category as the primary diagnoses.  While the 3 way tabulation did indicate 
considerable secondary and tertiary diagnoses, the evaluation also indicated that the singular 
most frequent occurrence for all four primary diagnoses was no additional diagnoses (None).  
The values ranged from 389 cases (29.8%) for respiratory to 556 cases (52.9%) for “Other”.   
The results from the MCA and cluster analysis indicate the impact additional diagnoses had in 
organ system clustering depended on the number of additional diagnoses categories included 
and the weight given to additional diagnoses “missing” for each case submission.  The inclusion 
of 4 additional diagnoses and “missing” additional diagnoses suggest that submissions cluster 
on whether there is primary diagnosis only or additional diagnoses, regardless of what organ 
system was assigned (Figure 7).  The MCA explained greater than 85% of the total inertia in 6 
dimensions.  The first dimension inertia contributed the most at 69.5%.  Clustering on the first 
dimension axis in the MCA plot appeared to be primarily based on the presence or absence of 
any additional diagnoses; missing values cluster nearest primary diagnoses and are farthest 
from the third and fourth additional diagnoses.  The missing values (sysmiss) are also closest 
(on the first dimension axis) to “Other” and GI, which have the highest percentage of primary 
diagnosis only.  Clustering of primary diagnosis only (regardless of organ system category) 
versus additional diagnoses is further demonstrated in cluster group 1 (Cluster Analysis, 
squared dissimilarity measure cut point at 5000), which has a very distinct branch on the 
dendrogarm and includes most of the primary diagnosis category, across all assigned organ 
systems (15000 squared dissimilarity measure). Note that the higher the squared dissimilarity 
measure of the branches, the greater likelihood that the clusters are truly distinct. These 
findings correspond to the high percentage of primary diagnosis only in the cross tabulations 
(Table 5).   Clustering effect of actual additional diagnoses appears to have much less impact.  
The second dimension inertias contributed only 8.2% and the clustering of additional diagnoses 
appears to occur primarily on this axis.  However, some effect can be noted as respiratory and 
multisystemic and “Other” organ system assignments for 1 additional and 2 additional 
diagnoses cluster near primary respiratory and primary multisystemic organ systems.  
Additional GI diagnoses are also seen to occur at similar 2 dimension axis values as primary GI 
diagnoses. To limit the impact of too many “missing” diagnoses, further MCA and cluster  
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Organ system clusters1, Primary Diagnosis 
Cluster      
Diagnosis G1 G2 G3 G4 G5 Total 
Respiratory (Resp) 931 60 161 70 84 1306 
Gastro  Intestinal (GI) 738 309 29 24 102 1202 
Multi Systemic (MS) 856 65 99 72 74 1166 
Other (Oth) 868 32 43 80 29 1052 
Total 3393 466 332 246 289  
1. Cluster on dimensions scores; MCA – Burt matrix, standard  normalization.  Cluster analysis  – Ward’s Linkage 
Figure 7: MCA/Cluster analysis using dimension coordinates, 4 additional diagnoses with 
missing values included (sysmiss).  3 dimensions included (2 displayed)  
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analysis was limited to the primary plus 2 additional diagnoses or conducted by excluding 
missing values or both (most pathology submissions were concluded with 2 additional 
diagnoses or less, see figure 5).  Cluster analysis on dimension coordinates appeared to place 
too much emphasis on missing values in the additional diagnoses variables even if the 
additional diagnoses were limited to 2.  The results (not shown) were similar to those from 4 
additional diagnoses displayed in Figure 7.  Subsequent cluster analyses were limited to row 
scores. 
 
The results from MCA and cluster analysis using row coordinates from up to 2 additional 
diagnoses, excluding and including missing values are presented in Figure 8.  With missing 
values for additional diagnoses included, 85% and 86% of the total inertia was explained within 
third and fourth dimension respectively.  The second dimension values contributed over 20% to 
the total inertia, suggesting a greater contribution from the real additional diagnoses.  The 
MCA plot suggested “Other” and GI diagnoses were more distinct than in the previous analysis.  
Respiratory and multisystemic diagnoses appear to have emerged as one cluster.   The missing 
values (sysmiss) seem to still have an impact as the primary diagnosis variables tend to align 
between these values and existing additional diagnoses.   The cluster analysis (squared 
dissimilarity measure cut point of 2000) produced 4 distinct groups with significant branches 
occurring above 5000.  Even with the relatively low cut point, missing values had a significant 
impact, with the largest group (group 4) having missing values in all the additional diagnoses 
variables.  The other groups did each tend to have a predominant organ system but also had a 
significant number of submissions with other organ systems present.   With missing values for 
additional diagnoses excluded, greater than 94% of the total inertia was explained within 3 
dimensions.  The second dimension inertias contributed more in this analysis (31.8%) than in 
the previous analysis.  The greater emphasis on existing organ systems assignments in the 
additional diagnoses variables appears to have had a significant impact on the MCA. The MCA 
plot shows three distinct groups where multisystemic and respiratory primary diagnoses cluster 
together as one group while GI and “Other” remains distinct.  The plot is comparable to the 
high number of respiratory and multisystemic additional diagnoses for both respiratory and 
multisystemic primary diagnoses seen in the cross tabulation.  Also similar to the cross 
tabulation was the distinct groups of primary GI plus additional GI and primary “Other” plus 
additional “Other” diagnoses.  The cluster analysis (squared dissimilarity measure cut point of 
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5000) produced four distinct groups, with significant branches occurring above 10000.  Group 1 
was predominantly a respiratory group as it included all primary respiratory diagnoses.  It also 
included the majority of the additional diagnoses that were either respiratory or multisystemic.  
GI and Other primary diagnoses in group 1 were unique in that at least one of the additional 
diagnoses was not the same organ system as the primary diagnoses.  The multisystemic 
primary diagnoses in group 1 were not as well defined.  Although it had additional diagnoses, 
some submissions were all multisystemic.   Adjusting the dissimilarity measure cut point to 
3000 split group 1 into two new groups; the majority of the primary respiratory diagnoses and 
a small number of primary multisystemic diagnoses separated into a new group.  The remaining 
group was made up of primary diagnoses that had at least one additional diagnosis that was a 
different organ system than the primary diagnoses.  Excluding the missing analysis allowed the 
existing additional diagnoses to have a greater impact on the overall inertia and subsequent 
clustering.   Lowering the cut point allowed the generation of a separate respiratory group 
suggesting that submissions with primary respiratory diagnoses are affected the most by 
additional diagnoses.  The results from the MCA/cluster analysis with row scores and excluding 
missing values results provide two possible sets of outcomes for further syndromic 
classification of pathology submissions, depending on the dissimilarity cut point used. 
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Organ System Clusters by Primary Diagnosis 
 Cluster, missing excluded Cluster, missing included 
Diagnosis G1 G2 G3 G4 Total G1 G2 G3 G4 Total 
Resp 1,306 0 0 0 1,306  614 132 171 389 1,306  
GI 264 0 0 938 1,202  0 531 74 597 1,202  
MS 204 962 0 0 1,166  318 131 171 546 1,166  
Oth 308 0 744 0 1,052  64 0 432 556 1,052  
           
Total 2,082 962 744 938 4,726  996 794 848 2,088 4,726  
Figure 8:  Side by side comparison of MCA and cluster analysis of row coordinates from up to 2 additional 
diagnoses (Primary, Secondary and Tertiary diagnoses variables) using 3 dimensions (2 displayed).  Missing 
values excluded (left) and missing values included (Right). 
 
 
3.3.5 Non-Pathology Submissions 
Porcine non-pathology submissions included 66 test codes and 85 specimen codes.  The most 
common 25 test requests accounted for greater than 96% of all test requests and the most 
common 25 specimens submitted accounted for greater than 95% of all specimens submitted 
(Table 6).  The median number of specimen types submitted was 1, the 25th and 75th 
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percentiles were also 1 and the range was 1 to 15.  As evident with the limited distribution of 
specimen types (Figure 9), the majority of non-pathology submissions involved a single 
specimen type.  The predominant specimen type was sera, which accounted for over 52% of 
the specimen types and corresponded to the specimen of choice for 6 of the top 7 test 
requests in table 6.  The average and median numbers of sera samples per non-pathology 
submission was 32 and 20 respectively.  The non-pathology test requests were also limited, 
with a median number of test requests per submission of 2, with a 25th percentile of 1, a 75th 
percentile of 3 and a range of 1 to 13.  
 
The predominant test requests were more specific and focused on significant endemic 
diseases, especially for respiratory/reproductive diseases such as PRRS and respiratory diseases 
such as Mycoplasma hyopneumonia and Swine Influenza Virus.  These tests make up 10 of the 
top 13 test request for non-pathology submissions.  Tests for Transmissible Gastroenteritis 
(TGE) and Porcine Circovirus (PCV) were also frequently recorded.  Besides test request for 
separate diseases, the frequency of different types of tests for a specific disease was also 
noted. Two testing methods for the same disease maybe requested for the same submission 
(e.g. PCR and ELISA testing for PRRS). As noted for pathology submissions, test results had one 
or multiple outcomes depending on the test requested.   
 
Unlike pathology submissions, there were no additional outcomes (pathology diagnoses) to 
determine if a non-pathology submission was positive or negative for a specific disease.  For 
example, many culture results were positive for ubiquitous or opportunistic organisms that 
may or may not be the cause of disease.  Tests such as ELISA may have been positive in 
response to vaccination instead of disease.  Additional submission information, such as clinical 
history or reason for submission, was not available to further determine if a test result was 
significant for a non-pathology submission.  Test sensitivities and specificities for tests such as 
ELISA and PCR, were available, as well as the numbers of specimens submitted.  In combination 
with estimated disease prevalence for certain diseases in the Manitoba swine population, these 
values were used to extrapolate whether a non-pathology submission involving those tests was 
positive.  The results are not presented in this study. 
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Table 6: 25 Most common test requests & specimen submitted for Non-pathology submissions 
Tests Freq. Per. Cum. Per Specimens Freq. Per. Cum. Per 
PCR RT PRRS 7866 21.43 21.43 Serum 10599 52.54 52.54 
ELISA PRRS1 7659 20.86 42.29 Swab (PRRS specific) 2300 11.4 63.95 
ELISA M. 
Hyopneumoniae 5328 14.51 56.8 Lung 1184 5.87 69.81 
ELISA TGE / Respiratory 
coronavirus 2339 6.37 63.17 Semen (Fresh) 1166 5.78 75.59 
Aerobic Culture 2322 6.33 69.5 Semen (Extended) 520 2.58 78.17 
ELISA Porcine SIV H1N1 1854 5.05 74.55 Fixed Tissue (NSP2) 442 2.19 80.36 
ELISA Porcine  SIV H3N2 1149 3.13 77.68 Environmental sample 342 1.7 82.06 
PCR PRRS 911 2.48 80.16 Nasal Swab 289 1.43 83.49 
IFA PRRS 909 2.48 82.64 Feces (fresh) 287 1.42 84.91 
PCR SIV H1N1 801 2.18 84.82 Carcass 264 1.31 86.22 
PCR PCV 793 2.16 86.98 Spleen 246 1.22 87.44 
PCR M. hyopneumoniae 666 1.81 88.79 Heart 199 0.99 88.43 
PCR SIV H3N2 648 1.77 90.56 Small Intestine 196 0.97 89.4 
Histology 438 1.19 91.75 Pooled lung / tonsil 177 0.88 90.28 
Necropsy - porcine 268 0.73 92.48 Large Intestine 127 0.63 90.91 
Semen evaluation 223 0.61 93.09 Feces (fixed) 125 0.62 91.53 
Other Reference 
Laboratory 
Referrals3 
196 0.53 93.62 Fecal Swab 123 0.61 92.14 
PCR PRRS typing 188 0.51 94.14 Bacterial culturette Swab 106 0.53 92.66 
PCR Lawsonia 188 0.51 94.65 Intestine (NSP2) 106 0.53 93.19 
F4 (K88) serotyping 170 0.46 95.11 Liver 103 0.51 93.7 
Anaerobic Culture 160 0.44 95.55 Culture tube 95 0.47 94.17 
Fecal flotation 131 0.36 95.9 Urine 79 0.39 94.56 
Electron Microscopy 125 0.34 96.24 Swab - joint 74 0.37 94.93 
PCR Brachyspira 
pilosicoli 95 0.26 96.5 Kidney 68 0.34 95.27 
General Chemistry 89 0.24 96.74 Brain & Spinal cord 55 0.27 95.54 
1 Includes both Dako and Idexx PRRS ELISA test kits 
2 Not specified 
3 VDS includes test codes for common diagnostic tests sent not conducted at VDS, such as Electron Microscopy.  
Less common referrals to another laboratory are placed in an “Other” category 
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Figure 9: Distributions of Specimen types and Test requests for 16939 Non-pathology Submissions. The 
median number of specimen types per submission was 1, with the 25th and 75th percentiles  also equal to 
1 and a range of 1 to 15.  The median number of test requests per submission was 2 with a 25th 
percentile of 1, a 75th percentile of 3 and a range of 1 to 13. 
 
 
3.4. Discussion 
Evaluation and analysis of a laboratory data source conducted in this chapter follows the 
approaches taken by others in developing, implementing and validating syndromic surveillance 
methods in animal health (Dorea et al, 2011; Dupuy et al, 2013a).   The data source and focus 
on a regional swine population is an example of how the broad range of activities in animal 
health, especially in food animal production, plus the increase in electronic data capture have 
provided a variety of sources to draw data from for syndromic surveillance.  However, it is also 
an example of how the wide range in species and associated diseases, the semi-structured 
nature of the data, the lack of a generally accepted standardized disease nomenclature and the 
multi level clustering of food animal populations are complexities that have led to a variety of 
approaches to syndromic surveillance in animal health (Dorea et al, 2011; Dupuy et al, 2013a).   
 
A syndromic surveillance system should be sensitive, efficient and timely in order to be 
effective; it should be able to consistently identify real disease clusters early enough for an 
effective response (Guasticchi et al, 2009).  Two key assumptions that underlie a syndromic 
surveillance system are: a) significant disease information from the population under 
surveillance is in the data available (Dorea et al, 2011); the data are either representative 
enough of the population or at minimum, representative for the at risk groups within the 
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population;  b)  Real disease clusters within the population under surveillance are detectable by 
the syndromes established within the system.  Syndrome classification and validation are 
important methods that assist in supporting the assumptions and developing a syndromic 
surveillance system (Chapman et al, 2005b; Guasticchi et al, 2009; Kashiouris et al, 2013; Leal 
and Laupland, 2008).  Appropriate classification of syndromes identify significant disease 
clusters and are established (or limited) by the data source and type (Buehler et al, 2004).  The 
comparison of syndromes to representative groups of diagnostic outcomes establishes the 
sensitivity and specificity of the syndromes (Chapman et al, 2005b; Guasticchi et al, 2009; Van 
Metre et al, 2009).  The evaluation of porcine submissions to VDS has provided information of 
the availability and limitations of the test requests and specimen types for syndrome 
classification.  The analysis has also provided the basis for grouping pathology diagnoses into 
usable clusters for syndrome validation. 
 
The review of yearly and seasonal trends observed in porcine submissions to VDS indicated 
variations that were not unexpected and may have occurred for several possible reasons.  
Porcine circovirus associated disease (PCVAD) caused by a variant strain of PCV2 significantly 
impacted the health of the Canadian swine herd from 2004 to 2008 (Carman et al, 2008; 
Gagnon et al, 2007; Poljak et al, 2010).  In Manitoba, the number of farms reporting PCVAD 
increased from 13 in 2005 to 172 in 2006 and 159 in 2007.  In response to the outbreak, a 
government sponsored Porcine Circovirus inoculation program was available to Canadian pork 
producers in 2007.  The program required diagnostic testing and veterinary confirmation of 
disease for the producer application.  PCVAD and diagnostic testing for the inoculation program 
were likely contributors to the increase in non-pathology submissions from 2004 to 2007.  The 
introduction of PCVAD vaccine and the vaccine uptake supported by the inoculation program 
were likely contributors to the decrease in submissions that followed.  A follow up review of 
monthly submission data from VDS supported this conclusion; PCVAD testing peaked at over 30 
submissions per month in the fall of 2005 with a secondary peak of over 20 submissions per 
month from January to April 2007, corresponding to the initial introduction of the vaccine 
program (and subsequent test requirements).  By June 2007 PCVAD testing had declined to less 
than 10 submissions per month and by March 2008 the average fell to less than 5 per month.  
Additional contributors to the overall decrease in submissions were three key economic factors 
that negatively impacted swine production in Manitoba in 2008 and 2009: a) A high Canadian 
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dollar, which has been demonstrated to significantly alter porcine submissions to another 
regional animal health laboratory (O'Sullivan et al, 2012).  b) Full implementation of Country of 
Origin Labeling (COOL) legislation in the US in 2008 (Thevenaz 2011).  c) elevation of corn prices 
in the main North American pork feeding sectors (Hofstrand 2009).  Finally an environmental 
review of the Manitoba swine industry in 2007 led to tighter regulatory control and an overall 
decrease in production in subsequent years (Anon 2007).  Overall, the VDS submission rate 
trends suggest that a significant disease event (PCVAD) may be detectable within the data. 
However, factors outside of animal health, such economic viability, environmental 
sustainability and regulatory control may impact veterinary involvement with swine health and 
subsequent submission rates to a regional laboratory (O'Sullivan et al, 2012). The impact 
appears greater for non-pathology submissions; non-pathology submissions include non-
diagnostic testing (testing for confirmatory health status, sale/export, vaccination response) 
which is likely impacted more by external factors that affect swine farm profitability.  
Awareness and consideration must be given to these external factors when considering 
submission trends and the use of non-pathology submissions for syndromic surveillance.  
 
The results of the evaluation indicate that test requests and specimen types from pathology 
submissions may form the basis of pre-diagnostic groups for syndrome development.  The 
distribution of test requests and specimen types indicated there were several specific tests (e.g. 
PCV, PRRS, and Electron Microscopy) and specimens (Lung, Intestine) that occurred more 
frequently in some pathology diagnoses than in others.  As well pathology submissions on 
average appeared to have adequate numbers of both specimens and tests to draw 
classifications from.  Both of these findings support the use of test requests and specimen 
types for syndrome classification.  However, it is recognized that many of the test requests and 
specimen types were very common and non-specific, such as carcass, fixed tissue, histology and 
necropsy.  As a result, classification methods that utilize combinations and patterns of 
specimen types and test requests, plus allow additional elements such as number of specimens 
submitted are likely the appropriate approach to syndrome development. 
 
Utilizing organ systems to cluster pathology or clinical diagnoses into outcome groups for 
syndrome validation or comparison is consistent with other syndromic surveillance approaches 
using animal health laboratory data (Amezcua et al, 2013; Dorea et al, 2013; Gibbens et al, 
2008; Hyder et al, 2011).  For example, Amezcua used the most common reported organ 
80 
 
systems, Respiratory, Digestive and Reproductive to compare a practice based swine syndromic 
surveillance system to laboratory submissions (Amezcua et al, 2013).  The analysis of pathology 
diagnoses has identified three possible options for outcome clusters based on organ system 
assignment:  Four groups based on primary diagnoses only, four groups (G1-G4) based on 
cluster analysis branched at a squared dissimilarity measure of 10000 (Ward’s linkage) and five 
groups (G1-G5) branched at a squared dissimilarity of 5000 (Ward’s linkage).  Diagnostic 
outcomes based on primary diagnoses only do have merit, since the primary diagnoses were 
considered the most significant.  However, this method ignores patterns in the pathology data 
where a primary diagnoses may be consistently linked to a secondary diagnosis.  For example, 
primary respiratory diagnoses were often followed by a secondary multisystemic diagnoses, 
which on closer inspection, was often linked to PCVAD.  The four group cluster and the five 
group cluster offer the better diagnostic outcome options as both clusters recognize that the GI 
and “Other” organ system classifications occur primarily as single diagnoses or with secondary 
diagnoses of the same organ system.  Both clusters also identify a considerable number of 
multisystemic as a separate group.  A separate multisystemic organ system group that includes 
submissions with a primary multisystemic only or primary multisystemic plus secondary 
multisystemic may be important for emerging disease detection;  it would include all “No 
Specific Diagnoses” and a considerable number of the PCVAD diagnoses.  However, the 
inclusion of a fifth group that is primarily respiratory may be an artifact of the cluster method 
for several reasons; the branching occurred at considerably lower values than the other groups, 
it is not supported by the MCA, (which appeared to suggest three groups) and, as evident from 
the 3 way cross tabulation, the primary respiratory diagnoses did tend to occur with more 
additional diagnoses than the other primary organ system diagnoses.  It appears that the most 
appropriate diagnoses outcome group from the MCA and hierarchical analysis was four clusters 
(G1-G4) with “missing” diagnoses excluded.  On closer inspection, cases within the first cluster 
(G1) were consistent with cases that had a primary respiratory diagnosis alone or with 
additional diagnoses, as well as with cases that were primarily multisystemic, GI, or “Other” but 
had additional diagnoses that were not equivalent to those primary diagnoses. Cases within the 
clusters G2 to G4 were consistent with cases that had both a primary and additional diagnoses 
of multisystemic, “Other” and GI respectively. 
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Methods that excluded “missing” diagnoses from MCA and hierarchical clustering provided a 
more accurate representation of diagnostic outcomes. The impact of “missing” diagnoses was 
due to the hierarchical nature of the diagnoses variables; a pathology submission typically only 
needed up to 2 additional diagnoses (86.4% of all submissions) and the inclusion of each 
additional diagnosis increased the number of “missing” diagnoses significantly.  The cluster 
analysis with “missing” diagnoses included does appear to support a case definition of primary 
diagnoses only, since single large clusters occurred that included all organ systems within them.   
This is likely because the “missing” diagnoses dominated the inertia in the first dimension in the 
MCA, leading the cluster analysis to appear to give equal or greater weight to a branching 
based on “missing” versus non missing diagnoses instead of what the diagnoses actually were.  
Applying equal or greater weight to “missing” diagnoses is not representative of how the 
diagnoses are reported in the data set.  It was noted that when missing values were included, 
cluster analysis on row scores appeared more realistic than on dimensions scores.  Row scores 
put greater weight on observations and less on variables so additional diagnoses variables are 
not over weighted. 
  
Creating an “Other” category for organ systems that are assigned at a lower frequency poses 
problems for identification of significant reportable or emerging diseases using laboratory 
based syndromic surveillance.  For diseases such as pseudorabies and classical swine fever 
specimen types and test requests may indicate neurologic and skin pathology.  In theory a 
laboratory based syndromic surveillance system may not be sensitive enough to detect these 
diseases if the submissions are mixed with a large diverse organ system case definition.  
However, many of these diseases also exhibit respiratory and multisystemic components.  
Perhaps more importantly, reportable diseases tend to spread very rapidly and have significant 
clinical signs in naive populations.  If multiple types of surveillance are in place, such as clinic 
based and abattoir base surveillance, then there is a greater likelihood disease such as these 
would be detected by other means (Amezcua et al, 2013; Dupuy et al, 2013b).  
 
Specific diagnostic coding of disease conditions (Figure 6) in the VDS’ LIMS data provide an 
alternative method of clustering diagnostic outcomes not explored in this study.  Using the 
larger number of more specific disease codes would provide two opportunities for syndromic 
surveillance.  First, the analysis of clusters within diagnostic codes may have provided more 
refined pathology outcomes to validate syndrome classification from submitted test requests 
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and specimen types.  Similar techniques have been used to group diagnostic codes for 
validation in public health syndromic surveillance systems (Betancourt et al, 2007; Chapman et 
al, 2005b; Guasticchi et al, 2009; Ivanov et al, 2002).  Second, the diagnostic codes may also 
provide a means of evaluating and grouping pathology outcomes into effective indicators or 
syndromes for early warning surveillance, instead of using pre-diagnostic syndromes.  This 
approach is similar to those proposed in studies that have evaluated full and partial carcass 
condemnation data from abattoirs for the purpose of grouping condemnation outcomes into 
syndromes (Alton et al, 2010; Alton et al, 2012; Dupuy et al, 2013b). In one study, 
condemnation outcomes including coded reasons for condemnation, condemned portions, 
slaughter date, animal factors (age, production type, sex) and abattoir factors (location, days 
operating, mean number slaughtered per day) were clustered into syndromes using MFA, 
including MCA and hierarchical clustering (Dupuy et al, 2013b).  Even more importantly, the 
approach has been applied in the United Kingdoms’ Veterinary Diagnostic Analysis System 
where diagnostic outcomes from animal health laboratory submissions are grouped for 
surveillance purposes.  The UK system uses established disease codes to conduct surveillance 
on the incidence of known diseases and conditions as well as “Diagnosis Not Reached” codes 
for new and emerging diseases (Gibbens et al, 2008; Hyder et al, 2011; Kosmider et al, 2011).  
Following the UK example, a combination of disease and organ system codes in the VDS LIMS 
may also provide more refined method of evaluating “No Specific Diagnoses”.  This is an 
important consideration since “No Specific Diagnosis” may have been an early indicator of 
PCVAD in Manitoba; the yearly trend data suggested that during the initial emergence of 
PCVAD, the “No Specific Diagnosis” code was reported at almost twice the rate; 6.3% for 2005-
2007 compared to 3.4% for 2003-2004.  While the diagnostic coding within the VDS LIMS is 
worth exploring using either of the two approaches described above, a key limitation compared 
to other systems must be considered.  VDS disease codes do not follow any specific 
standardized disease nomenclature mentioned earlier (e.g. LOINC) and the rules for the 
inclusion or exclusion of codes are not externally reviewed.  Diagnostic codes may be added or 
removed based on a less formalized internal review process.  This is consistent with one 
inventory of veterinary syndromic surveillance systems, where the use of internal coding 
systems was the norm if coding systems were used at all (Dupuy et al, 2013a).  However, it is 
generally accepted that formal, standardized methods of disease coding in public health and in 
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the UK Veterinary Diagnostic Analysis System provide a more stable disease nomenclature for 
surveillance purposes (Dorea et al, 2011; Dupuy et al, 2013a).   
 
The use of non-pathology submissions for early indications of emerging or re-emerging disease 
in swine herds will be more complex because additional factors such as reason for submissions 
and specific diagnoses are not available.  Surveillance using laboratory submission data without 
specific diagnoses has relied on reason for submission (Gibbens et al, 2008), specific counts of 
test results (Shaffer et al, 2008), text mining of case descriptions and laboratory comments, 
and/or identification of pathogen specific tests (Dorea et al, 2013).  Coded reasons for 
submissions and submitter comment fields were not available in the data extract for use.  
However, if submitting veterinarians provided a detailed case history, then text mining of 
additional fields within the LIMS could be used to identify key words and mapped to rule-based 
syndromes using a supervised classification algorithm (Chapman et al, 2005a; Dorea et al, 
2013).   Using counts of positive test results or isolates of specific microorganisms to establish 
case outcomes are more difficult to interpret when the health event is measured at the herd or 
group level.  To account for herd level effects, the number of samples submitted per event, 
estimates of herd level prevalence and the sensitivity/specificity of the tests involved need to 
be included in the case definition.  Additionally, submission bias is more likely to occur from 
swine herd level testing because the reason(s) for non-pathology submissions are frequently 
non-diagnostic.  For example, PRRS testing is frequently used to confirm the stability of the 
virus in a positive herd without clinical signs, to estimate the effect of a vaccination strategy or 
to confirm negative herd status for sale or export.  In these cases, the selection bias arises for 
syndromic surveillance because the samples are submitted from healthy animal groups, not 
diseased groups.  Without identifying the reason for submission, submission bias would 
significantly affect both counts of tests results and identification of pathogen specific tests.   It 
may be possible to modify the syndrome selection criteria to identify submission patterns that 
are typically non-diagnostic and decrease selection bias.  For example, a case submission with 
50-100 sera samples for limited testing is more likely conducted for sale or export where 
individual animal status is as important as herd status.  As well, there are specific sampling 
protocols that are meant for herd status determination and less for diagnostics (Holtkamp et al, 
2010).  Identifying non-pathology submissions with these patterns as “non-diagnostic” may 
benefit a syndromic classification scheme in the absence of reason for submissions.   
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Unfortunately, methods of evaluating diagnostic outcomes and pre-diagnostic data for 
syndrome classification and validation cannot be easily transferred to other animal health 
laboratory or veterinary data bases. The data source in this study is another example of a key 
reason why; the lack of standardization in disease nomenclature across all animal health data 
bases.  The consistent use of standardized disease nomenclature in public health databases has 
improved the ability to establish syndromic systems in similar data sources and has made the 
interoperability of multiple syndromic systems possible (Heffernan et al, 2004; Lombardo et al, 
2004; Wagner et al, 2004).  In Canada, the establishment of broad based animal health 
networks on a public health platform and the recommendation of a minimum data set for 
collation and analysis of diagnostic laboratory data are seen as steps to address the lack of 
standardization across many animal health data sources (Kloeze et al, 2010; Kloeze et al, 2012).   
The objectives within these steps also recognize that even when data sources and data coding 
may be similar, different methods may be necessary due to differences in data structure and 
availability, differences in animal populations between regions, or differences between species 
of animal under surveillance (Kloeze et al, 2012).  For example, Dorea evaluated an animal 
health laboratory data source in Ontario, Canada for syndrome classification of bovine 
submissions.  The evaluation led to the exploration of rule-based and automated machine 
learning methods applied to 75% of all bovine test requests instead of pathology submissions 
only (Dorea et al, 2013).  However, it was recognized that further research was necessary to 
establish ongoing validation of the classification methods.  By comparison, the evaluation 
conducted in this study led to a focus on pathology submissions as there was support in the 
data and the literature for an assumption these were more representative of clinical cases in 
swine, including atypical ones and less influenced by external non-disease factors (Amezcua et 
al, 2013; Dorea et al, 2011; Gibbens et al, 2008; O'Sullivan et al, 2012).  The evaluation also 
recognized that clustering pathology diagnoses into defined outcomes provided a simplified 
practical basis for syndrome validation and updating of syndrome classification.  However, it is 
recognized that further research is needed into syndromic methods applied to non-pathology 
submissions as they represent the bulk of swine submissions and the assumption regarding 
clinical cases will not always apply.  
 
The overview, evaluation and analysis of the VDS laboratory data has described the information 
available for the development and implementation of syndromic surveillance methods. It is 
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important to note that the chapter did not specifically evaluate the timeliness of syndromic 
methods over conventional reporting for either pathology or non-pathology submissions.  
Further research into the timeliness of the data as part of time series analyses and aberration 
detection methods would be considered necessary.  However, the chapter purpose has been 
specifically addressed in the following ways:  
• From the yearly and seasonal trends, it is possible that changes in the health of the 
regional swine population may be detected from the data source over time, specifically 
the incursion of PCVAD and subsequent animal health program response.  However, 
the trends also demonstrated potential impacts of three economic and one regulatory 
factor.   
• From the description of laboratory submission data, it was noted that requirements to 
meet a minimum data set for surveillance were not readily available (Kloeze et al, 
2012).  In particular, cases were not classified by the submitter into body system 
classifications for syndromic surveillance.   However, consistent with the evaluation of 
other laboratory data sources, the test requests and specimen types were instead the 
most structured and useful components available to form syndrome groupings.   
• From the evaluation test requests and specimen types between pathology and non-
pathology submissions, the greater numbers and types of specimens and test requests 
in pathology submissions supported the expectation of differences in reasons for 
submissions and the greater likelihood of submission bias in non-pathology 
submissions.  The differences also support the assumption that pathology submissions 
are more representative of typical (and atypical) clinical swine cases.   From the 
assessment of laboratory results and pathology diagnoses, grouping laboratory results 
from non-pathology submissions into diagnostic outcomes for syndrome validation 
would involve more complex exploratory and analytical methods that would rely 
heavily on expert opinion and/or disease prevalence estimates that are difficult both to 
maintain outcome accuracy and to automate for regular updating.  Alternative 
comparative approaches that would include improved collection of the non-pathology 
submission information to align with the minimum data set, specifically the inclusion of 
disease classification and/or reason for submission by the submitter, would provide 
greater opportunities for both syndrome classification and validation.   
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• Finally, the evaluation and analysis of the diagnostic outcomes from pathology 
submissions into meaningful clusters using MCA and hierarchical cluster analysis 
provided a reasonable way of ongoing syndrome validation.  Based on multiple organ 
system diagnoses and comparable to other groups of clinical swine conditions, four 
viable pathology diagnoses clusters were established for syndrome validation, primarily 
respiratory (G1), primarily multisystemic (G2), primarily gastro intestinal (G4) and 
primarily ”other” (G3). 
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Chapter 4: Syndrome classification using laboratory test requests and 
specimen types from porcine cases submitted for pathology diagnoses. 
 
4.1 Introduction 
Effective syndromic surveillance depends on the classification of pre-diagnostic indicators, such 
as clinical signs, pharmaceutical sales or laboratory test orders, into “syndromes” that can be 
used to indicate significant health events for timely and accurate assessment (Dórea et al, 
2013; Hiller et al, 2013; Hoinville et al, 2013; Katz et al, 2011).   As such, syndrome classification 
is an essential element in the development and implementation of the syndromic surveillance 
components of early warning surveillance systems (Hoinville et al, 2013; Ivanov et al, 2002; Reis 
and Mandl, 2004).  The process of syndrome validation is also an important consideration that 
utilizes diagnostic outcomes or traditional surveillance methods to confirm syndrome accuracy 
(Betancourt et al, 2007; Chapman et al, 2005a; Ivanov et al, 2002; Kleinman and Abrams, 2008). 
Appropriate validation of syndrome classifications contributes utility and efficiency to a 
syndromic surveillance system by ensuring high sensitivities and positive predictive values 
when compared to real clusters of disease (Guasticchi et al, 2009; Kleinman and Abrams, 2008).   
 
In public health, consideration has been given to two categories of syndrome classification 
based on the purposes of the syndromic methods (Katz et al, 2011).  Syndromes may be 
“syndrome based” and targeted to specific disease conditions such as influenza-like illness (ILI), 
severe acute respiratory syndrome (SARS) or potential bioterrorism events such as anthrax.  
Significant increases in the occurrence of a targeted syndrome are similar in approach to 
hazard specific surveillance described for animal health in Chapter 1.  This type of surveillance 
may lead more directly to mitigation and intervention, as the sensitivities may be sufficient to 
limit the need for further confirmation and investigation.  Alternatively, syndromes may be 
“syndromic non-specific” and developed from multiple types of data sources with the intent of 
detecting unusual patterns in a broad range of health-related behaviours.   The focus is 
therefore not on a specific risk event but rather on “at risk” health-related behaviours that may 
indicate a change in the health of the associated population and lead to additional investigation 
and confirmation.  Syndrome classification in this category comes from preclinical data 
intended for other purposes, such  as telehealth, ambulance dispatch, pharmaceutical sales, or 
laboratory test orders (Buehler et al, 2004; Heffernan et al, 2004; Katz et al, 2011; Kleinman 
and Abrams, 2008; Sintchenko and Gallego, 2009).  For the purposes of public health, 
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veterinary medical records are also placed in this category (Katz et al, 2011).  The disadvantage 
of the syndrome non-specific category, compared to the syndrome based approach, is that it 
may be less sensitive to known risk events such as ILI, especially if multiple data types (e.g. 
emergency department, laboratory, pharmacy) are not combined in the surveillance methods.   
However, the syndrome non-specific category has the advantage of identifying emerging or 
changing diseases, because all cases from all data types involved for the population under 
surveillance are included.   In addition, conducting syndrome classification under a non-disease 
specific purpose adapts to different data types and can better utilize semi-structured data or 
free text (Dórea et al, 2013; Katz et al, 2011). Generally, syndromic surveillance for use in 
animal health has focused on methods that fit the “syndromic non-specific” category because 
(a) the purposes are often to enhance early warning surveillance for emerging or re-emerging 
diseases, and (b) the approach is more amendable to the inclusion of the multiple data types 
and data structures typically found in veterinary medicine information systems (Dórea et al, 
2011; Dupuy et al, 2013b; Gibbens et al, 2008; Hoinville et al, 2013).   A recent inventory of 
veterinary syndromic surveillance initiatives in Europe identified 25 syndromic surveillance 
systems either implemented or under development (Dupuy et al, 2013a).  Consistent with the 
purposes of the “syndrome non-specific” category, the majority of the initiatives had multiple 
surveillance objectives for general animal health, used data collected for other purposes, 
included multiple data sources and had data structures with either internal disease coding or 
no coding at all. 
 
In both public and animal health, the expanding capabilities of basic computing systems, plus 
increased volume and scope of electronic data capture of health information have greatly 
improved syndrome classification from pre-diagnostic data collected for other purposes.  Rule-
based methods to classify syndromes in public health are common as they have had excellent 
sensitivity and predictive values when validated, and are easily understood among 
collaborating health experts (Betancourt et al, 2007; Farkas and Szarvas, 2008; Heffernan et al, 
2004; Ivanov et al, 2002; Reis and Mandl, 2004).  However, considerable effort is required to 
automate rule-based methods, as they require extensive mapping of pre-diagnostic indicators 
and frequent domain expert review to maintain significance (Buehler et al, 2004; Farkas and 
Szarvas, 2008; Sosin and DeThomasis, 2004).  To this end, public health has benefited from 
standardized disease nomenclature, such the International Classification of Disease coding, and 
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from the multiple collaborations among many domain experts in reviewing syndrome 
classification rules (Betancourt et al, 2007; Buehler et al, 2004).  To take advantage of the 
volume of available data and to effectively utilize standardized disease nomenclature across 
large data sets, syndrome classification has expanded to include more advanced machine 
learning methods; Naive Bayes classifiers, Decision trees and others have been especially useful 
when coding free text or semi-structured data in large data sets across multiple sources to 
standardized nomenclature (Chapman et al, 2005a; Dórea et al, 2013; Dupuy et al, 2013a; Reis 
and Mandl, 2004).  In animal health, the limited application of standardized nomenclature, the 
lower volume of data and the difficulty in maintaining expert review have made the long-term 
application of rule-based methods more difficult. There are some animal health surveillance 
systems, such as the United Kingdom’s Veterinary Investigation Diagnosis Analysis system 
(VIDA) and Purdue University’s National Companion Animal Surveillance Program (NCASP), that 
have greater success because these systems have established linkages between multiple data 
sources, routine expert review and analysis, data standardization and ongoing validation 
(Gibbens et al, 2008; Glickman et al, 2006; Paiba et al, 2007).  Many other animal health data 
sources, such as diagnostic laboratories and abattoir inspection systems, have established 
nomenclature with resident domain expertise and as such should be amendable to either 
method.  However, these sources also have considerable free text or semi-structured data 
types, have limitations in terms of expert resources for syndrome review and require a 
considerable degree of automation.  For syndrome classification in animal health, these 
limitations make the use of advanced machine learning methods appealing, either alone or in 
combination with more traditional rule-based approaches (Dórea et al, 2013; Dupuy et al, 
2013b; Farkas and Szarvas, 2008).   
 
Validation of syndromic surveillance provides assurance of meaningful, representative 
approaches of “at risk” populations or the capacity to detect true biological events. The 
sensitivity, specificity and predictive values of early warning surveillance are important to 
detect significant disease events in a timely and accurate fashion while ensuring that limited 
resources are not expended on investigating too many false alarms (Bourgeois et al, 2006; 
Bravata et al, 2004; Katz et al, 2011; Kleinman and Abrams, 2008; van den Wijngaard et al, 
2008).  Validation of syndromes is a critical component of syndrome classification and requires 
an alternative high quality data component for comparison; data from traditional surveillance 
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methods, from diagnostic outcomes (e.g. laboratory results, case discharge codes) or from 
domain expert classification (Chapman et al, 2005b; Dórea et al, 2013; Hiller et al, 2013; Ivanov 
et al, 2002).  The data may be collected retrospectively from the same sources through random 
allocation into training and test subsets or may involve prospective studies where 
representative subsets are further analyzed at time of collection (Bourgeois et al, 2006; 
Kashiouris et al, 2013; van den Wijngaard et al, 2008).  Syndrome validation may use a variety 
of analytical methods, including accuracy measures (e.g. F-score), agreement metrics (e.g. 
kappa measures), general linear models (GLM), general linear mixed models (GLMM), and 
analysis of variance (ANOVA) (Kleinman and Abrams, 2008; Leal and Laupland, 2008).  In animal 
health syndromic surveillance, the use of validation methods has not progressed to the level of 
those in public health.  Many animal health syndromic surveillance systems have not been 
operating long enough to accumulate syndromic surveillance data from multiple sources for 
validation.  In addition, the complex syndrome classification methods required for the 
disparate data types and structures make validation more difficult (Dórea et al, 2011; Dupuy et 
al, 2013a).  A survey of veterinary syndromic surveillance systems in Europe did not specifically 
report validation methods used in the 27 systems that were represented by respondents. 
Epidemiologists in the VIDA system conducted a form of verification and investigation of the 
system’s laboratory diagnostic coding through additional analysis of non-randomly assigned 
cases (Hyder et al, 2011; Kosmider et al, 2011).  Amezcua compared syndrome counts from a 
practitioner based swine surveillance system with counts of laboratory cases using negative 
binomial regression (Amezcua et al, 2013).  The method evaluated the impact of external 
factors, such as season and year. Dórea compared machine learning and rule-based syndrome 
classification methods from animal health laboratory submissions using accuracy measures but 
noted that further validation would be beneficial (Dórea et al, 2013).   
 
The purpose of this chapter was to classify meaningful syndrome variables from specimen 
types and test requests from porcine cases submitted for diagnostic pathology and to assess 
their utility for syndromic surveillance.  The approach was to first identify patterns of test 
requests and specimen types that cluster together in the data and utilize these clusters as 
“syndromes”.  Second, the approach was to estimate the ability to detect significant disease by 
using the syndromes as variables to predict pathology diagnoses for the submitted cases.  The 
syndrome clusters were identified using agglomerative hierarchical cluster methods applied to 
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the case submission data within the Laboratory Information Management System (LIMS).  A 
multinomial regression model was used to estimate specific syndrome prediction of diagnostic 
outcomes for cases previously assigned to one of four possible pathology diagnoses.  Each 
pathology case was previously clustered into one of these four possible pathology outcomes 
based on organ system involvement (Chapter 3). 
 
4.2 Methods 
4.2.1 Data description 
The data source was the Veterinary Diagnostic Services (VDS) LIMS described in Chapter 3. The 
LIMS data structure is based on observations that are individual results for each test request / 
specimen type combination.  Each pathology case therefore has multiple observations.  
However, the primary diagnoses and the additional diagnoses were assigned at the case level, 
not the test request level.  Tests and specimens submitted to VDS are automatically coded 
when entered into the LIMS, using a coding system specific to the database.  At the case level, 
the number of unique test requests and specimen types available in the data set were 
determined and the case counts of where each occurred at least once were calculated.  The 
most common test requests and specimen types were selected based on a wide range of 
conditions and body systems covered, as well as frequency of use.  Test requests that 
represented post diagnostic follow up at external reference laboratories were excluded as the 
pathology diagnoses would have already been determined (e.g. virus sequencing).  
 
Each pathology case was previously classified based on the primary and additional diagnoses by 
the attending pathologist.  The classification was conducted through Multiple Correspondence 
Analysis (MCA) and the diagnoses were grouped into one of four outcomes based on the 
primary organ system (OS) involved: primarily Respiratory (G1 from Chapter 3), primarily 
Multisystemic (G2 from Chapter 3), primarily Gastro-Intestinal (G4 from Chapter 3) and “Other” 
(G3 from Chapter 3).  
 
4.2.2 Syndrome Classification 
Syndrome classification was conducted using agglomerative hierarchical cluster analysis to 
select, extract and reduce the test requests and specimen types into syndrome components.  
Agglomerative hierarchical clustering measures the similarity (or dissimilarity) between sets of 
observations, generated from pair-wise distances among observations (Hastie et al. 2001). 
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Agglomerative means the clusters are formed in a “bottom up” process, starting from a single 
pair of observations.  Hierarchical clustering in binary data can be explored using different 
similarity or dissimilarity measures to weight the pair-wise distances among observations.  
Matrices of the different measures are generated across binary variables and the distances 
between groups are measured using the following linkages: nearest neighbor(single), furthest 
neighbor (complete), group average, weighted average,  group median, group centroid and 
minimum variance (Ward’s linkage) (Hastie et al 2001).  The technique has been used to 
evaluate a variety of biological data, such as cancer diagnoses and DNA analyses (Hastie et al 
2001). All matrices and cluster analyses were conducted using multivariate statistical tools in 
the statistical software (Stata Statistical Software: Release 11, 2009). 
 
In order to classify syndromes based on test requests and specimen types, individual binary 
variables representing each test request and specimen type were mapped to the case level 
pathology submission data using internal coding.  Syndromes were generated by first 
evaluating the relationships between the test and specimen variables.  Matrices were 
generated using 11 different binary dissimilarity measures.  The key measures used were those 
that provided greater weight to similarities (variables equal to one).  Hierarchical cluster 
analysis was conducted on each matrix using 5 different cluster linkages; simple, complete, 
average, weighted average and Ward.  The Duda-Hart and Calinski-Harabasz cluster stopping 
rules were used to indicate the most significant number of natural clusters in each analysis.  
The selection of clusters was based on natural clusters within the data that had the greatest 
agreement between the two stopping rules.  The natural clusters with the greatest agreement 
were tabulated and compared across all measures and linkages.   The natural clusters were 
then evaluated for relevancy and consistency to ensure they represented real world clinical and 
pathology scenarios.  The most relevant and consistent clusters were assigned to syndromes 
and mapped in the statistical software to individual cases using the internal LIMS coding.   Each 
case had to have a minimum of one test request from the syndrome in order to be assigned a 
syndrome.  Since the intent of the study was to determine the predictability of each syndrome 
for pathology diagnoses across all cases, individual cases could be assigned more than one 
syndrome. 
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4.2.3 Multinomial logistic regression 
The purpose of the syndrome classification model was to estimate which syndromes had the 
most significant predictability for the four diagnostic outcomes.   The full dataset was randomly 
allocated into a training dataset (60% or 2835 cases) for syndrome prediction and a test dataset 
(40% or 1891 cases) for syndrome validation.  The statistical analyses were conducted using 
Stata (Stata Statistical Software: Release 11, 2009).  A multinomial logistic regression model 
was used because the outcome variable consisted of four OS diagnoses.  The data were 
considered nominal as each diagnostic outcome was considered independent of the other 
categories and no assumptions could be made about the order of the outcome categories.  The 
““Other”” OS group was considered the baseline category as it represented all other organ 
system diagnoses.   
 
Variables representing influential factors on the number of cases submitted and variables 
representing factors that may correlate with the selection of tests or specimen types were also 
included in the regression model.  The evaluation and analysis of the data source in Chapter 3 
noted considerable variation in the number of submissions over the time-frame of the dataset.  
In order to control for case submission variation over time within the data set three different 
measures were used; case submission dates, year of submission and equal time periods were 
separately evaluated.  The equal time period was a categorical variable with three 25-month 
time periods, separating the data set into equal parts.  The effects of seasonal quarters (Q1 
represented January – March, Q2: April – June, Q3: July – September, Q4: October – December) 
and day of week were also considered, and included in the model as categorical variables.  It 
was considered likely that the number of tests requested and number of specimen types per 
case could correlate with different diagnoses and the selection of specific syndromes, as certain 
syndrome clusters would naturally include more specimen types and test requests.  Both 
factors were therefore included in the model as continuous variables. 
 
Model development was carried out using a step-wise approach.  Individual variables were first 
assessed for significance through univariate multinomial models using Wald and likelihood 
ratio tests.   Full and reduced models were compared using likelihood ratio tests (if one model 
was nested in another), Akaike’s information criteria (AIC) and the Bayesian information criteria 
(BIC) (Dohoo et al. 2009). Model diagnostics were conducted through a variety of means.  The 
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model fit was evaluated using a generalized Hosmer – Lemeshow goodness of fit test for 
multinomial logistic regression models in groups of 30, 20, 15, 12 and 10 (Fagerland and 
Hosmer, 2012).    Regression diagnostics through individual logistic regression models were 
used to assess outliers and observations with undue influence (Dohoo et al 2009).   
 
The predictive power of the model was assessed using difference in predictions adjusted for its 
standard error (Stata Press 2009).  Sensitivity and specificity for each outcome were also 
assessed at different cut points. 
 
4.2.4 Syndrome validation 
The purpose of the syndrome validation step was to determine if the predictive model 
developed through the training data set had similar predictions in the test data set.  Two 
measures were used to validate the predictive ability of each syndrome between the two data 
sets.  The relative risk ratios for each syndrome between pairs of OS diagnoses were calculated 
(Long and Freese utilities) and compared.  The effect that the presence of each syndrome had 
on the probability of observing an OS diagnosis (adjusted predictions) were calculated and 
compared using the post estimation margins command in the statistical software.  Finally, the 
margins calculations were used compare the predictive probabilities of groups of syndromes at 
their set values.  This approach evaluated which syndromes grouped together to predict an OS 
diagnosis as well as validated the syndrome groups between the two data sets. 
 
4.3 Results 
4.3.1 Data Description 
The data set for syndrome classification contained 4726 pathology cases with 49977 unique 
test requests and specimens submitted for use in syndrome classification: The number of 
unique test requests per case across all cases was 28434.  The median number of test requests 
per case was 6 with a 25th percentile of 4, a 75th percentile of 8 and a range of 1 to 17.  The 30 
most common test requests occurred at a cut point of 0.3% of cases and represented 98% of 
the total unique test requests.  Test requests below this value were either extremely rare (e.g. 
lead toxicity) or were dependent on other more frequent tests.  The number of unique 
specimen types per case across all cases was 21543. The median number of specimen types 
submitted per case was 4 with a 25th percentile of 3, a 75th percentile of 6 and a range of 1 to 
13.   The 34 most common specimen types occurred at a cut point of 0.3% of cases and 
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represented 97% of the total unique specimen types submitted.  The specimen types below 
this value tended to be rare and/or non-specific (e.g. limb, feed sample).  The data set included 
1408 submission days, averaging 3.36 cases per submission day.   The 25-month time periods 
included 30% of cases in the first period, 38% in the second and 32% in the third.  For seasonal 
quarters, there were 29% of cases in Season 1, 24% in Season 2, 19% in Season 3 and 28% in 
Season 4.  For day of week, 15% of cases were submitted on Monday, 22% on Tuesday, 23% on 
Wednesday, 21% on Thursday and 19% on Friday.    The proportion of organ system (OS) 
diagnoses in the full data set was 44.1% Respiratory, 20.4% Multisystemic, 19.9% 
Gastrointestinal and 15.7% “Other”.   
 
4.3.2 Syndrome Classification  
From cases with pathology diagnoses, the 30 most common test requests and the 34 most 
common specimens submitted were included in the hierarchical cluster analysis.  From an 
earlier systematic review of public health syndromic surveillance it was estimated that any 
number greater than 15 syndromes would not be reasonable for surveillance purposes 
(Chapter 2).  The stopping rules were utilized to estimate the most relevant clusters within 
each analysis.  Typically, groups of 5, 7, 9, 10 and 12 clusters were the preferred sizes across 
most measures and analyses.   Measures that weighted agreement (variables equal to 1) 
appeared to produce the most reasonable clusters.  These measures included Jaccard, Dice, 
Yule and Anderberg.  Figures 1a, 1b and 1c are examples of the types of dendrograms and 
group descriptions that resulted from the cluster analysis with different dissimilarity measures 
and linkages. The branches of the dendrograms indicate which groups have greater similarity 
(lower dissimilarity measure) and therefore are more likely to cluster together.  Likewise, the 
higher the dissimilarity measure, the greater the distance between branches, the less similarity 
between groups.   
 
There was not perfect agreement across all hierarchical cluster analyses. However, several 
distinct groups of test requests and specimens submitted were consistent across multiple 
measures.  Several of these distinct groups are also consistent with typical clinical diagnostic 
approaches to swine diseases (Pedersen et al, 2010; Zimmerman et al. 2012).  Test requests 
and specimen types for specific clinical conditions related to porcine reproductive disease 
(Figure 1a, Group 9; Figure 1b, Group 10; Figure 1c, Group 12), porcine respiratory disease 
(Figure 1a, Group 5; Figure 1b, Group 4; Figure 1c, Group 3), neonatal diarrhea (Figure 1a, 
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Group 1&2; Figure 1b, Group 1; Figure 1c, Group 5&6), chronic diarrhea in grow/finish pigs 
(Figure 1a, Group 3; Figure 1b, Group 3; Figure 1c, Group 7) and severe lameness in growing 
pigs (Figure 1a Group 7; Figure 1b, Group 6; Figure 1c, Group 8) consistently grouped across 
multiple measures.  Furthermore, branches with groups of greater clinical similarity also 
clustered in the analysis. For example, Groups 4-6 in Figure 1a had a low dissimilarity measure 
(<1.5) and were consistent with gastrointestinal conditions. 
 
Certain non-specific groups of test requests and specimen types, such as carcass, fixed tissue, 
necropsy, histopathology and bacterial cultures did not consistently group in distinct clusters 
across the different measures.  Specific test requests for common endemic and multisystemic 
swine diseases such as porcine reproductive and respiratory syndrome (PRRS) and porcine 
circovirus associated disease (PCVAD) tended not to form any distinct group or groups.  
However, there was a greater tendency for the test requests for these two diseases to cluster 
with respiratory conditions.  
 
The cluster analyses were reviewed for relevance, both from a clinical and surveillance 
perspective. Based on this review, the 14 syndromes listed in Table 1 were selected for 
prediction.  Histology, aerobic culture and fixed tissues were considered nonspecific and 
common across all pathology submissions.  As a result these were considered more as 
confounders than predictive variables.  Necropsy was also held distinct as a confounder 
because it differentiated necropsies conducted by veterinary pathologists in contrast to field 
necropsies conducted by clinical veterinarians.  The respiratory category was adjusted to 
include respiratory specific specimens and tests.  PRRS and PCVAD were considered significant 
swine diseases with a variety of clinical and pathology presentations (Carman et al, 2008; 
Madec et al, 2008; Young et al, 2010) and therefore were assigned specific syndromes based on 
test requests.  Through the cluster analyses, lymphatic tissue submissions did not consistently 
cluster with any one group of test requests or other specimen types. 
 
While some specific lymphoid tissues may be submitted for specific diagnoses, lymphatic tissue 
is generally included in most submissions because of its use in diagnosing many different 
diseases.  For similar reasons to histopathology/culture and necropsy, Lymph node submissions 
were assigned to a separate syndrome as they may be seen as confounding of other   
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Figure 1a: A 10 syndrome group outcomes from cluster analysis on 30 test requests and 34 specimen 
submissions, using Yule dissimilarity measure and complete linkage. 
 
Group 10 Lymph node (Not specified), tonsil, brain swab, skin  
Group 9 FAT for Porcine parvovirus. Fetal necropsy, fetus, fetal tissue, fetal stomach contents, female reproductive tissue 
Group 8 PCR for Cytomegalovirus.  Nasal swab, body fluid (Not specified) 
Group 7 PCR for M. Hyosynoviae. Gram stain, joint tissue, synovial membrane, joint swab 
Group 6 Streptococcus suis typing. Carcass, neurologic tissue, heart, kidney, spleen, pooled liver/spleen, pooled lung/spleen, pooled lung/tonsil 
Group 5 PCR tests for swine influenza (H3N2 & H1N1), M hyopneumoniae, PRRS & PCV, Genotyping for PCV or PRRS. Lung tissue 
Group 4 Micromineral analysis. Liver tissue, serum  
Group 3 E. coli K88 serotyping, PCR tests for B. hyodysenteriae, B. pilosicoli, L. Intracellularis.  Intestine (Not specified), fixed tissue 
Group 2 Necropsy, aerobic culture, anaerobic culture, PCR for C. perfringes.  Live animal submission, Small intestine, Culture tube, smear 
Group 1 
Histology, FAT for Porcine corona virus (Transmissible Gastroenteritis), ELISA for C 
difficile, Serotyping for E coli, Electron Microscopy, Coccidial smear.  Large intestine, 
feces(fixed)  
  
Group 1
n=9
Group 2
n=9
Group 3
n=6
Group 4
n=3
Group 5
n=9
Group 6
n=9
Group 7
n=6
Group 8
n=3
Group 9
n=6
Group 10
n=4
0 .25 .5 .75 1 1.25 1.5 1.75 2
Yule dissimilarity measure, Complete linkage. 10 groups
10 groups had the greatest agreement between stopping rules
Cluster Analysis Dendrogram for Test Requests & Specimen Types
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Figure 1b: A 10 syndrome group outcome from cluster analysis of 30 test requests and 34 specimen 
submission variables, using Yule dissimilarity measure and Ward linkage. 
 
Group 10 FAT for Porcine parvovirus. Fetal necropsy, fetus, fetal tissue, fetal stomach contents, female reproductive tissue 
Group 9 Streptococcus suis typing. Carcass, neurologic tissue, heart, pooled liver/spleen, pooled lung/tonsil, brain swab 
Group 8 Lymph node (Not specified), skin  
Group 7 Serotyping for E coli, Micromineral analysis. Liver tissue, kidney tissue, spleen tissue, pooled lung/spleen. 
Group 6 PCR for M. Hyosynoviae. Gram stain, body fluid (Not specified), joint tissue, synovial membrane, joint swab 
Group 5 PCR for Cytomegalovirus.  Nasal swab, serum 
Group 4 PCR tests for swine influenza (H3N2 & H1N1), M hyopneumoniae, PRRS & PCV, Genotyping for PCV or PRRS. Lung tissue 
Group 3 PCR tests for B. hyodysenteriae, B. pilosicoli, L. Intracellularis.  Intestine (Not specified), fixed tissue 
Group 2 Necropsy, Live animal submission, feces 
Group 1 
Histology, FAT for Porcine corona virus (Transmissible Gastroenteritis), ELISA for 
C difficile, PCR for C. perfringes, E. coli K88 serotyping, Electron Microscopy, 
Coccidial smear, smear.  Large intestine, feces(fixed), aerobic culture, anaerobic 
culture, Small intestine, Culture tube. 
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Group 3
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Group 4
n=9
Group 5
n=4
Group 6
n=6
Group 7
n=6
Group 8
n=3
Group 9
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Group 10
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0 5 10 15 20
Yule dissimilarity measure, Ward linkage.  10 Groups
10 groups had the greatest agreement between stopping rules
Cluster Analysis Dendrogram of Test Requests & Specimen Types
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Figure 1c: A 12 syndrome group outcome from cluster analysis of 30 test request and 34 specimen 
submission variables, using the Jaccard dissimilarity measure and Ward linkage.
 
Group 12  FAT for Porcine parvovirus, Fetal necropsy. Fetus, fetal tissue, fetal stomach 
contents, female reproductive tissue 
Group 11  Streptococcus suis typing. Neurologic tissue, brain swab, heart, spleen, kidney 
Group 10 Genotyping for PCV or PRRS. Serotyping for E coli, PCR for Cytomegalovirus. 
Feces, lymph node (Not specified), pooled liver/spleen, pooled lung/spleen, tissue 
(Not specified), Body fluid (Not specified) Nasal swab, tonsil, serum, skin 
Group 9 Micromineral analysis.  Liver tissue.  
Group 8  PCR for M. hyosynoviae. Gram stain, joint tissue, synovial membrane, joint swab 
Group 7 PCR tests for B. hyodysenteriae, B. pilosicoli, L. Intracellularis 
Group 6 PCR for C. perfringes. Culture tube 
Group 5 FAT for Porcine corona virus (Transmissible Gastroenteritis). Fecal smear  
Group 4 Electron Microscopy, anaerobic culture, ELISA for C difficile, E. coli K88 
serotyping.  Feces (fixed),  coccidial smear. Live animal submission,  all intestinal 
tissue 
Group 3 PCR tests for swine influenza (H3N2 & H1N1), M hyopneumoniae, PRRS & PCV. 
Lung tissue 
Group 2 Necropsy.  Carcass, pooled lung/tonsil 
Group 1 Histology, aerobic culture. Fixed tissue  
  
Group 1
n=3
Group 2
n=3
Group 3
n=6
Group 4
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Jaccard dissimilarity measure, Ward linkage.  12 Groups
12 groups was the largest number as determined by stopping rules
Cluster Analysis Dendrogram of Test Requests & Specimen Types
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Table 1: List of Syndromes 
Syndrome Description 
Histology/Culture1 Specimens submitted included all fixed tissue not specifically identified 
Tests requests were for histology and/or anaerobic culture 
Necropsy2  Full necropsy conducted by pathologists at laboratory on submitted 
carcasses 
Respiratory  Specimen submitted was Lung tissue  
Test request were PCR tests for Mycoplasma hyopneumoniae, Swine 
Influenza H1N1 or Swine Influenza H3N2 
PRRS Test requests were PCR tests for PRRS, and/or sequencing / genotyping 
for PRRS virus strains. 
PCV PCR test requests for PCVAD, +/- genotyping for PCV 
Lymph Node 
Submission 
Specimens submitted were for lymph node tissue, including tonsil and 
lymph nodes pooled with lung. 
GI syndrome 1 Specimens included were live animal submissions2 , all intestinal 
submissions, plus formalin fixed fecal samples. 
Test requests included electron microscopy, parasite detection 
(especially for coccidiosis), anaerobic culture, and specific tests for 
Porcine Coronavirus (Transmissible Gastroenteritis), Clostridium 
difficile, Clostridium perfringes, and Escherichia coli K88 
GI syndrome 2 Subset of GI syndrome 1 where cases included test requests for 
Lawsonia intracellularis, Brachyspira hyodysenteriae and/or Brachyspira 
pilosicoli  
Reproduction Specimens included are fetal tissues plus female reproductive tissue 
Test request was for porcine  parvovirus 
Joint Specimens included are any joint tissue, including synovial membranes 
and joint swabs. 
Test requests were for PCR tests for Mycoplasma hyosynoviae and gram 
stains 
Hepatic Specimen type included liver 
Test requests were for micronutrient analysis 
Circulatory Specimen type only; Heart, kidney, spleen 
Neurologic Specimens included any neurologic tissue including spinal cord, 
meninges and swabs of brain 
Test requests included Streptococcus suis typing 
Rhinitis  Specimen type included nasal swabs 
Test requests included PCR test for Cytomegalovirus  
1. Histology / culture may be conducted on tissues submitted from field necropsies or from full necropsies 
conducted by pathologists at the laboratory. 
2. Necropsy excluded live animals submitted to the laboratory for euthanasia and subsequent necropsy.  
These cases clustered more with the GI syndromes. 
 
syndromes.  GI syndrome 1, Reproduction, Joint, Hepatic, Circulatory and Neurologic were 
syndromes that consistently clustered through the analysis and individually had strong clinical 
relevance.  GI Syndrome 2 and Rhinitis were seen as more specific subsets of GI Syndrome 1 
and Respiratory, respectively.  Through the cluster analyses, both of these tended to cluster 
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either within or adjacent to their “parent” syndromes.  Clinically each syndrome represents 
specific disease conditions within their “parent” category; GI Syndrome 2 represents test 
requests and specimen types expected for chronic diarrhea in grow/finish pigs.  Rhinitis 
represents severe upper respiratory tract infections in nursing piglets. 
 
Further comparisons and linkages of the 14 syndromes were conducted through cross 
tabulations of cases in full data set.  The most frequently occurring syndromes are listed in 
Table 2.  The table also includes the percentage of each syndrome’s cases that also have more 
commonly occurring syndrome, if the percentage exceeded 50%.  The cross tabulations 
confirmed Histology/Culture as a very common, nonspecific component of all submissions, 
since it occurred in almost 98% of all pathology cases.  Laboratory necropsies conducted on 
submitted carcasses were associated with 51% of all cases and aligned with Histology/culture. 
74% of lymph node submissions occurred together with necropsy submissions, indicating that 
lymph node submissions mostly occurred when a pathologist conducted the necropsy.   
 
The respiratory syndrome was the most frequent disease related syndrome and was associated 
with 67% of all submissions.  Many cases with the respiratory syndrome also had other 
syndromes such as PCV, PRRS, Circulatory and Rhinitis.  PCV and PRRS syndromes were strongly 
linked to the more general respiratory syndrome as well as to each other; 43% of all cases 
included both PCV and PRRS syndromes, and over 90% of the cases with either or both of these 
syndromes also included the respiratory syndrome.  The cross tabulation confirmed that the 
rhinitis syndrome was primarily a subset of respiratory with only 4% of the cases with the 
syndrome not also having the respiratory syndrome.  The rhinitis syndrome occurred in 5% of 
all cases and 7% of all respiratory syndrome cases. 
 
Cases with the GI syndromes did not frequently include other syndromes.  The cross tabulation 
confirmed the secondary, more specific GI syndrome was a subset of the primary GI syndrome 
with 100% correlation.  The GI Syndrome 2 was included in approximately 13% of all cases and 
in 26% of cases that included GI Syndrome 1.  
 
The other syndromes (Joint, Neurologic, Reproduction and Hepatic) ranged between 12% and 
5% of all cases.  The cross tabulation supported the cluster results in that these syndromes also 
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did not frequently occur together.  In particular, the reproductive syndrome and the joint 
syndrome remained distinct. 
 
Table 2: Frequency of syndromes variables across all pathology cases 
Syndrome % of all 
submissions 
Occurrence with more 
frequent syndromes 
% of syndrome cases with 
more frequent syndrome 
Histology/Culture 97.9% ----------------------------- ------- 
Respiratory  67.0% ----------------------------- ------- 
PRRS  54.1% Respiratory  92.1% 
GI Syndrome 1 52.6% ----------------------------- ------- 
Necropsy  51.0% Histology/Culture 96.5% 
PCV  49.1% Respiratory 90.2% 
Circulatory  34.5% Respiratory 87.7% 
Lymph Node  34.0% Necropsy 74.2% 
 
4.3.3 Multinomial Logistic Regression 
Using random allocation, the full data set was divided once into a training data set of 2835 
cases and a test data set of 1891 cases for syndrome prediction. Table 3 contains the results 
from the multinomial logistic regression model with “Other” OS diagnosis as the baseline. 
Syndromes with significant positive coefficients (positive influence) for an OS diagnoses 
indicated that the presence of the syndrome in a case increased the probability of that OS 
diagnoses actually occurring in the case.  Likewise, syndromes with significant negative 
coefficients (negative influence) for an OS diagnoses indicated that the presence of the 
syndrome decreased the probability of that OS diagnoses actually occurring in the case.  The 
likelihood ratio and Wald tests were used to assess the overall significance of each syndrome 
and confounder in the model (Dohoo et al 2009).  Rhinitis was the only syndrome that did not 
have overall significance in the model.  However, this syndrome was retained because it 
improved overall model fit. 
 
Unconditional associations were evaluated for all variables.  All syndrome variables were 
significant in univariate multinomial logistic regression models with the “Other” OS diagnosis as 
the baseline.  This indicated that each individual variable predicted one or more of the 
outcomes significantly better than the null model.  Long and Freese utilities were further used 
in the univariate models to determine if pairs of outcome diagnoses were not significantly 
different from each other, through Wald and Likelihood ratio tests (Fagerland et al, 2008).  All 
four diagnosis outcomes were significantly different from each other in univariate models with 
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Respiratory, Reproduction, PRRS, PCV and Circulatory syndromes as the univariate predictors.   
Two of the four outcomes were not significantly different from each other in two sets of 
univariate models; Respiratory and Multisystemic diagnoses were not significantly different 
with Histology/Culture, Necropsy, GI1, GI 2, Lymph node, or Joint syndromes as the predictors.  
Multisystemic and “Other” diagnoses were not significantly different with Neurologic syndrome 
as the predictor.  Finally, two univariate models with either Hepatic or Rhinitis syndromes as 
the predictors had three of the four outcomes (Multisystemic, Gastrointestinal and “Other”) 
not significantly different from each other. 
  
Season was significant, but year and day of the week were not.  The 25-month time period and 
submission date were significant. However the univariate model with the 25-month time 
period variable had a better fit to the data.  This variable was used in the full model to 
represent variations in submissions over time.   
 
The number of unique specimen types per case and number of unique test requests per case 
had overall significance in univariate multinomial models with “Other” OS diagnosis as the base 
outcome.  The number of test requests remained significant in pair wise comparisons between 
respiratory, gastrointestinal and multisystemic OS diagnoses. However, the number of 
specimen types per case was not significant between these OS diagnoses.  This is reflected in 
the greater change in probability of the OS diagnoses observed for each outcome with the 
number of test requests (Figure 2). There is a substantial change in probability over the number 
of test requests than over the number of specimen types, especially for Respiratory and 
“Other” diagnoses.  Only the probability of “Other” diagnosis appears to decrease significantly 
with an increase in the number of specimen types. The linearity of both continuous variables 
was assessed using simple logistic models for each outcome.  Linearity could not be achieved 
across all outcomes, but was achieved for two or more outcomes by using a quadratic 
transformation corrected for colinearity by centering on the means.  Categorical, polynomial 
and fractional polynomial transformations of both variables were also attempted.  However, 
squared transformations centered on means had the best overall model fit. 
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Table 3: Results from multinomial logistic regression model; “Other” diagnosis group and time period 1 are the reference 
categories.  Coefficients with p value<0.05 or greater included. 
 
Respiratory Group Multisystemic Group  Gastrointestinal Group 
Syndrome/Variable Coef. SE 95% CI Coef. SE 95% CI Coef. SE 95% CI 
Respiratory 1.32** 0.19 0.94, 1.69 1.19** 0.20 0.80, 1.57 -1.05** 0.26 -1.55, -0.55 
PRRS 
      
-0.92** 0.32 -1.54, -0.30 
PCV 
   
0.46 0.23 0.01, 0.90 -0.92** 0.31 -1.52, -0.32 
Rhinitis 
         Gastrointestinal 1 
      
2.62** 0.39 1.86, 3.37 
Gastrointestinal 2 1.39* 0.54 0.33, 2.45 1.54* 0.55 0.46, 2.46 1.54* 0.55 0.46, 2.61 
Circulatory 
   
0.43 0.20 0.04, 0.83 -1.14** 0.29 -1.70, -0.57 
Hepatic -0.84** 0.26 -1.35, -0.33 
   
-1.24** 0.38 -1.98, -0.50 
Joint -1.33** 0.21 -1.74, -0.92 -1.13** 0.22 -1.55, -0.70 -4.19** 0.49 -5.16, -3.22 
Neurologic -0.88** 0.20 -1.28, -0.48 
   
-1.85** 0.39 -2.62, -1.07 
Reproductive -2.82** 0.32 -3.45, -2.18 -1.58** 0.31 -2.18, -0.98 -4.00** 0.87 -5.70, -2.31 
Histology/Culture 
   
1.21 0.57 0.10, 2.32 -2.80** 0.61 -4.00, -1.61 
Necropsy (Pathologist) -0.53* 0.19 -0.91, -0.16 -0.44* 0.20 -0.83, -0.06 -1.09** 0.26 -1.60, -0.57 
Lymph Node 0.42 0.21 0.00, 0.84 0.72** 0.22 0.29, 1.15 -0.64 0.32 -1.27, -0.02 
Period 2 
   
0.54** 0.18 0.18, 0.90 
   Period 3 
   
0.46* 0.19 0.10, 0.83 
   tTests / Case 0.62** 0.07 0.49, 0.75 0.29** 0.07 0.16, 0.43 0.63** 0.08 0.46, 0.80 
t(Tests /Case)2 
   
0.04 0.02 0.01, 0.07 
   tSpecimens / Case 
   
-0.17 0.09 -0.33, 0.00 0.34** 0.11 0.12, 0.56 
t(Specimens / Case)2 0.05** 0.02 0.02, 0.09 
      Intercept 1.16 0.67 -0.16, 2.47 -2.05* 0.76 -3.54, -0.57 4.71** 0.83 3.07, 6.34 
* Coefficients with p values <  0.01, **Coefficients with p < 0.001.  
t Counts of unique Test requests and specimen types per case have been centered on means and squared to adjust for linearity and colinearity. 
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Figure 2: Probability of organ system diagnoses by number of tests requested and specimen types per 
case. 
 
 
Possible two-way interactions were determined from the data and subject area knowledge.  
Additionally, pairs of syndromes that a significant influence on the same OS diagnoses were 
also considered (e.g. neurologic and hepatic positively influence “Other” and Multisystemic OS 
diagnoses).  The interaction terms evaluated were as follows:  (i) Histology/culture and 
Necropsy submissions; (ii) GI syndrome 1 and 2; (iii) Respiratory and Rhinitis; (iv) Respiratory 
and PRRS; (v) Reproductive and PRRS; (vi) PCV and Lymph node submission, (vii) Neurologic 
and Hepatic; (viii) Neurologic and Circulatory; and, (ix) Hepatic and Circulatory.  Two-way 
interactions were excluded from the final model because the interactions evaluated were not 
significant in the overall model and the models with interaction terms did not improve the fit 
of the model to the data.  However, three interaction terms were significant, in each case for 
one of the four OS diagnoses;  
• Including the interaction between the neurologic and hepatic syndromes further 
decreased the probability of a respiratory OS diagnosis when each occurred separately.  
The interaction of the two syndromes was positive indicating that when they occurred 
together, the probability of a respiratory OS diagnosis increased instead.  
• The interaction of the PRRS and respiratory syndromes increased the probability of a 
respiratory OS diagnosis attributed to the respiratory syndrome alone.  The interaction 
of the two syndromes was negative, indicating that when they occurred together, the 
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probability of the respiratory OS diagnosis decreased.  The PRRS syndrome remained 
non-significant for respiratory OS diagnosis. 
• The probability of Multisystemic OS diagnosis increased through the interaction of 
neurologic and circulatory syndromes.  The interaction caused the neurological 
syndrome alone to decrease the probability of the diagnosis, while the circulatory 
syndrome alone no longer significantly predicted the diagnoses.  Without the 
interaction term, the neurological syndrome did not significantly predict the 
multisystemic OS diagnosis while the circulatory syndrome significantly increased the 
probability of the diagnosis.  The influence of the circulatory syndrome on the 
multisystemic diagnoses appears to be only when both syndromes are present in a 
case. 
 
The expected and observed frequencies for all groups in the Hosmer – Lemeshow goodness of 
fit test were not significantly different, indicating the model fit the data.  The quadratic terms 
used for number of test requests and specimen types were necessary to obtain model fit.  
Reduced models were significantly different than the final model, whereas full models 
improved over the final model only with the inclusion of rhinitis. 
 
Outliers and observations with undue influence were evaluated through individual logistic 
regression models for each outcome as there are no comparable methods for multinomial 
regression models.  The purpose was to identify what observations did not fit or had excessive 
influence on the multinomial model.  Since the data set was a complete census of laboratory 
data and the overall purpose was to validate the predictability of syndromes, no observations 
were removed.  Instead, the outliers and influential observations were further explored where 
possible to estimate reasons for the influence.   60-70 highly leveraged observations with only 
one test request and one specimen type submitted had influence on all four diagnostic 
outcomes.  Approximately 60% of the cases had a necropsy submission where the pathologist 
made a diagnosis during the necropsy and no further testing was required.  These were slightly 
more common in gastrointestinal OS diagnoses than the other three and corresponded to 
acute traumatic gastrointestinal events, such as stomach ulcers.  The remaining 40% were 
single specimen types submitted for bacterial culture or histopathology and a diagnosis was 
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provided from the single test.  These values may have impacted the overall fit of the 
multinomial model. 
 
Outliers and influential observations with a gastrointestinal OS diagnosis: The multinomial 
model strongly supports the GI syndrome as the single predominant predictor for a 
gastrointestinal OS diagnosis.  Cases that did not have a GI syndrome, do not have a syndrome 
selected nor had multiple syndromes selected, were the most pronounced outliers.  A single 
predominant outlier was an individual case without a GI syndrome and with multiple other 
syndromes, including reproductive, respiratory, circulatory, neurologic, PRRS and PCV.  The 
reproductive syndrome especially is a negative predictor for Gastrointestinal OS diagnosis 
(Table 3).  Seven other cases did not have any syndromes selected.  These were cases had been 
submitted for specific, rare test requests that were not included in any of the syndromes.  
 
Outliers and influential observations with a respiratory OS diagnosis:  The multinomial model 
indicates that the respiratory syndrome is a strong predictor for a respiratory OS diagnosis.  
Outliers included 17 cases with a respiratory OS diagnoses and without a respiratory syndrome.  
Many of these cases also included GI 1 and GI 2 syndromes, as well as circulatory or neurologic 
syndromes.  Observations with leverage values included 6 cases with respiratory and rhinitis 
syndromes, but a multisystemic OS diagnosis.  These cases tended to include PRRS and PCV 
syndromes as well, suggesting a true multisystemic involvement.  Others included respiratory 
cases without a respiratory syndrome and/or a strong negative predictor such as reproductive 
or GI 1 or MS with a respiratory syndrome.  Both sets of observations could have impacted the 
multinomial model fit, but the overall number of cases was low. 
 
Outliers and influential observations with a multisystemic OS diagnosis:  The respiratory and 
the GI 2 syndromes were the strong predictors in the multinomial model for a Multisystemic 
OS diagnosis (Table 3). The cross comparisons between all four diagnostic outcomes in Table 5a 
indicate that PCV syndrome and lymph node submissions were the two that had the most 
predictive value.  Circulatory, neurologic and respiratory had lesser predictive influence.  The 
largest Pearson residuals in the multisystemic logistic model were all positive (> 4).  The 
observations matched to cases with a multisystemic outcome, but had syndromes that were 
stronger predictors for other diagnoses; respiratory, GI 1, joint and reproductive.  One set of 
high residual observations were GI 1 syndromes with a multisystemic OS diagnosis and linked 
112 
 
to cases from several farms submitted by a single practitioner over a 3 day time period in May 
2005.  Highly leveraged values occurred in 97 cases with respiratory syndrome, PRRS syndrome 
and PCV syndrome and a respiratory OS diagnosis.  The observations highlight the syndromes 
that have positive influence on both respiratory and multisystemic OS diagnoses. 
 
Outliers and influential observations with an “Other” OS diagnosis: In table 3, the joint and 
reproductive syndromes are the two syndromes that predominantly predict “Other” OS 
diagnosis (negative predictors for all gastrointestinal, respiratory and multisystemic with 
“Other” as the baseline).   High Pearson and deviance residual values were cases with “Other” 
OS diagnosis, but had two or more of the following syndromes selected; respiratory, GI 1, PRRS 
or PCV. 
 
The overall sensitivity and specificity of the multinomial model was evaluated at different cut 
points for each of the OS diagnoses.   Figure 3 contains the Receiver Operator Characteristic 
curves (ROC) and thresholds that optimized sensitivity and specificity.  The optimal thresholds 
were close to the proportions of each OS diagnosis in the full data set.  At the optimized 
thresholds, the sensitivity and specificity for Respiratory diagnosis were approximately equal 
with a positive predictive value (PPV) of 70.1% and a negative predictive value (NPV) of 79.2%.  
The area under the curve was greater than 0.8, supporting a good level of predictability.  The 
model also has good sensitivity and specificity for Gastrointestinal and “Other” diagnoses.  In 
these cases, the areas under the curve were close to or above 0.9, supporting excellent 
predictability.  The PPV and NPV for Gastrointestinal was 71.9% and 96.4%.  The NPV for 
“Other” was very similar to gastrointestinal at 96.0%.  However, the PPV for “Other” was much 
lower at 49.0%.  The sensitivity and specificity of Multisystemic diagnosis were lowest of all the 
OS diagnoses in the model.  The overall predictability appeared moderate with an area under 
the curve of 0.7.  The NPV was good at 86.1%, but the PPV was very low at 33.3%.  The model 
had a moderate ability to predict non multisystemic cases as non multisystemic, but was 
relatively poor at accurately predicting true multisystemic cases and had a relatively high false 
positive rate. 
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Figure 3: Overall sensitivity and specificity of multinomial logistic regression model with table 
of ideal thresholds for each Group diagnosis, sample data set. 
 
Group Diagnoses Threshold Sensitivity Specificity Correctly classified Ratio 
Respiratory >=0.50 74.96% 74.95% 74.96% 2.99 
Multisystemic >=0.25 55.99% 70.86% 67.80% 1.92 
Gastrointestinal >= 0.25 86.42% 91.58% 90.55% 10.26 
“Other” >=0.20 80.59% 84.65% 84.02% 5.25 
 
To further evaluate the model prediction, the difference in linear predictions was used to 
compare with the observed OS diagnoses.  The difference in linear predictions allowed 
estimation of whether specific OS diagnosis misclassifications occurred primarily with another 
diagnosis or were nonspecific (ambiguous).  The results in Table 4a and Table 4b were used to 
compare the difference in linear predictions of the model with either “Other” or Multisystemic 
set to be the baseline. Misclassifications of Respiratory, Gastrointestinal or “Other” OS 
outcomes tended to be primarily ambiguous with either baseline.  As noted with the sensitivity 
and specificity, gastrointestinal predictions contained, proportionally, the fewest 
misclassifications.  The linear predictions also supported the high false positive rate for 
“Other”, as the number of ambiguous predictions decreased considerably when the model 
baseline was changed from “Other” to Multisystemic.  Finally the differences in linear 
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predictions indicated that the model misclassified Multisystemic OS outcomes as respiratory 
more than any other, including multisystemic and ambiguous. The two outcomes were 
significantly different in the model, but a misclassified respiratory prediction tended to be 
multisystemic and the overall ability of the model to predict Multisystemic OS diagnosis was 
low. 
 
Table 4a: Linear predictions with “Other” as baseline. 
 Model Prediction 
OS Outcomes Respiratory Multisystemic Gastrointestinal Ambiguous Total 
Respiratory Group 794 44 51 357 1,246 
Multisystemic Group 269 79 28 208 584 
Gastrointestinal Group 39 4 437 87 567 
“Other” Group 68 66 18 286 438 
Total 1,170 193 534 938 2,835 
Table 4b: Linear predictions with Multisystemic as baseline 
 Model Prediction 
OS Outcomes Respiratory Gastrointestinal “Other” Ambiguous Total 
Respiratory Group 888 50 52 256 1,246 
Multisystemic Group 363 25 79 117 584 
Gastrointestinal Group 46 437 18 66 567 
“Other” Group 75 14 239 110 438 
Total 1,372 526 388 549 2,835 
 
 
4.3.4 Syndrome Validation 
The overall model predictability was re-assessed for the test data set.  Figure 4 contains the 
ROC curves and thresholds that optimized sensitivity and specificity in the test data set.  The 
optimal threshold, sensitivity, specificity, PPV, NPV and area under the curved for Respiratory 
diagnosis were very similar to those values for the sample data set.  The optimal thresholds for 
sensitivity and specificity occurred at lower thresholds for the Multisystemic, Gastrointestinal 
and “Other” diagnoses groups.  These thresholds were still close to the actual proportions of 
each diagnoses group in the full data set.  Additionally, the sensitivities, specificities, NPVs and 
areas under the curve for Gastrointestinal and “Other” were very similar to those from the 
sample data set.  The PPVs dropped slightly to 67.3% for Gastrointestinal and to 46.1% for 
“Other”.  The optimal threshold for Multisystemic in the test data supported a higher 
sensitivity (less false negatives) and a lower specificity (more false positives).  However, as 
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expected the PPV, NPV and the area under the curve changed very little at the lower threshold.  
The test data reinforced the model’s relatively high false positive rate for multisystemic cases.  
Figure 4: Overall sensitivity and specificity of multinomial logistic regression model with table 
of ideal thresholds for each Group diagnosis, test data set. 
 
Group Diagnoses Threshold Sensitivity Specificity Correctly classified Ratio 
Respiratory >=0.50 76.67% 74.60% 75.52% 3.02 
Multisystemic >=0.20 70.63% 62.66% 64.25% 1.89 
Gastrointestinal >= 0.20 86.79% 90.07% 89.42% 8.74 
“Other” >=0.15 84.31% 81.32% 81.81% 4.51 
 
The relative risks ratios (RRR) of different syndromes were very similar between the training 
and test datasets for pairings of OS diagnoses (Table 5a and Table 5b).   Five syndromes had 
RRR that were significantly higher for one OS diagnosis over all the others; PCV (Multisystemic), 
GI 1, (Gastrointestinal), Joint (“Other”), Reproductive (“Other”) and Necropsy (“Other”).  The 
Respiratory syndrome also had a RRR that was significantly higher for the Respiratory OS 
diagnosis over the other three in the test data, but not significantly different from 
Multisystemic OS diagnosis in the training data.  Two syndromes, Hepatic and Neurologic, were 
significantly higher for Multisystemic or “Other” OS diagnoses over Gastrointestinal or 
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Respiratory.  The same pattern occurred with the Circulatory syndrome, but only in the test 
data set. 
 
The marginal effects (ME) of having each syndrome were estimated and the most influential 
syndromes determined for each OS diagnosis in both the training and test data sets (Table 6).  
The adjusted predictions due to the most influential syndrome groups were also explored 
(Table 7).   
 
For the Respiratory OS diagnosis, the average marginal effects in either the test or training data 
for significant syndromes were within the confidence intervals from the opposite data set 
(Table 6).   The marginal effects of the rhinitis syndrome did not remain significant in the test 
data.  The respiratory syndrome was the best predictor of a respiratory OS diagnosis: Having 
the respiratory syndrome increased the average probability of a respiratory diagnosis in both 
the training and test data (0.20 and 0.26 respectively).   Alternatively, having a Reproductive, GI 
1, Neurologic or Hepatic syndrome decreased the average probability of a respiratory 
diagnosis.   The average adjusted predictions for groups of syndromes from the test data where 
within the confidence intervals of the training data (Table 7).  The exception was the 
respiratory / rhinitis combination that was not significant in the training data.  The adjusted 
prediction for a Respiratory OS diagnosis was predominantly due to the respiratory syndrome, 
were cases with the syndrome had average predictions of 0.59 (training data) or 0.60 (test 
data).  Including the rhinitis syndrome, but excluding reproductive and GI 1 syndromes did 
increase the adjusted predictions considerably (> 0.73).  However, the majority of the 
prediction still came from the respiratory syndrome.  The adjusted predictions for respiratory 
OS outcome for cases that included respiratory syndrome but excluded GI1 and reproductive 
only increased by 0.035.  Rhinitis had a significant marginal effect in the training data (table 6) 
and impacted the adjusted predictions of syndrome groups in the test data (Table 7).  As noted 
earlier, it also improved overall model fit.  However, the rhinitis syndrome was not consistently 
significant across the test and training data sets. Overall, the respiratory syndrome performed 
best at predicting a respiratory OS diagnosis.  For surveillance purposes, the results indicate 
that predictions can be further refined for cases that include respiratory and specifically 
exclude GI 1or reproductive syndromes. 
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For the Multisystemic OS diagnosis, the average marginal effects of syndromes significant in 
both data sets were within the confidence intervals from the opposite data set (Table 6). The 
PCV syndrome had the highest average positive marginal effect across both data sets and was 
specific to the Multisystemic OS diagnosis.  However, the positive marginal effects were lower 
overall compared to those for the Respiratory OS diagnosis.  Several syndromes that had 
significant marginal effects in one data set were not significant in the other data set.  Histology 
/ culture, Respiratory and Lymph node submissions had significant marginal effects in the 
training data but not in the test data.  Likewise, hepatic and reproductive syndromes had 
significant marginal effects in the test data but not in the training data. 
 
The marginal effects presented in Table 6 indicate that the neurologic, circulatory and hepatic 
syndromes may have positive marginal effects in the “Other” OS diagnoses or the 
Multisystemic OS diagnosis: As with the RRR, the neurologic syndrome had a significant 
positive average marginal effect in the “Other” OS diagnoses and the Multisystemic OS 
diagnosis, for both data sets.   The circulatory syndrome had a positive marginal effect for 
Multisystemic OS diagnosis in both data sets, but was only significant in the test data set for 
the “Other” OS diagnoses.  Conversely, the hepatic syndrome had a positive marginal effect for 
the “Other” OS diagnoses in both data sets, but was only significant in the test data for the 
Multisystemic OS diagnosis.  Across the entire analysis, it is important to note that when the 
average positive marginal effects of a syndrome significantly predicted more than one 
diagnosis it was always Multisystemic and “Other”.  
  
PCV alone had an adjusted prediction of 0.24 and 0.26 for the training and test data 
respectively. The adjusted predictions of syndrome combinations for Multisystemic OS 
diagnosis ranged between 0.31 and 0.42 regardless of the data set, with the exception of the 
PCV/lymph node combination (Table 7).  The magnitude of the adjusted predictions depended 
on syndrome significance within a data set.  With lymph node and respiratory syndromes not 
significant in the test data set, the adjusted prediction of any combination with these 
syndromes in it dropped compared to those in the training data set.  For example, the 
syndrome combination of PCV with Neurologic, Circulatory, Lymph node and Respiratory had 
adjusted predictions better than the combination of PCV, Neurologic and Circulatory in the 
training data, but not so in the test data.  The adjusted prediction of Neurologic and Circulatory 
syndromes increased within either data set by a minimum of 0.053 due to the addition of the 
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Hepatic syndrome (Table 7).   Including the Hepatic syndrome individually with either the 
Neurologic or Circulatory syndrome had different results.  The adjusted prediction of the 
combination of Neurologic and Hepatic syndromes was very close to the adjusted prediction of 
the three together in either data set.  However, the adjusted prediction of the Circulatory and 
Hepatic combination was only similar to the three together in the test data set, not the training 
data set where Hepatic syndrome was not significant for the Multisystemic OS diagnosis (Table 
7).   
 
As noted above, neurologic, circulatory and hepatic had varying positive marginal effects on 
“Other” and Multisystemic OS diagnoses, depending on the test or training data sets.  When 
significant adjusted predictions of combinations of the three syndromes are compared for the 
“Other” OS diagnoses, it is noted that the combinations that specifically excluded circulatory 
syndrome or did not involve the circulatory syndrome at all were the only ones with significant 
adjusted predictions (Table 7).  This differed significantly from the adjusted predictions of the 
combinations with the Multisystemic OS diagnosis. 
 
The GI 1 syndrome was the only syndrome that had a significant positive marginal effect for 
the gastrointestinal OS diagnosis across both data sets (Table 6).  Respiratory, reproductive and 
joint syndromes had the most significant negative marginal effects.  The adjusted predictions 
were highest when GI 1 was included with respiratory, reproductive and joint syndromes 
excluded (Table 7).  Most of the adjusted prediction was due to inclusion of GI 1 syndrome and 
the exclusion of the respiratory syndrome.  Excluding the other two syndromes only increased 
the adjusted predictions for training data set by 0.065 and 0.046 for the test data set.  
 
The reproductive and joint syndromes had the greatest positive marginal effects for the 
“Other” OS diagnoses within both data sets (Table 6).  The positive marginal effects of 
neurologic and hepatic syndromes were described previously.  Necropsy syndrome was the 
final syndrome to have a low positive marginal effect.  GI 1 and respiratory had the greatest 
negative marginal effects.  In combination the two syndromes increased the adjusted 
predictions to 0.692 and 0.765 for the training and the test data set respectively.  Excluding 
syndromes with significant negative influence, the GI 1 and the respiratory syndrome, 
increased the adjusted predictions to over 0.90 within both data sets.  However, it should be 
noted this would represent a small number of cases.   
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The results of several other syndromes are also important to note. In particular, Histology / 
culture did significantly increase the marginal effects of a Multisystemic OS diagnosis and 
significantly decreased the marginal effects of a Gastrointestinal OS diagnosis in the training 
data set.  However, Histology / culture is not disease specific and it occurs in over 98% of 
submissions.  Additionally, the difference appears to be due to a small number of cases that 
had a gastrointestinal OS diagnosis without histology or culture.  Monitoring this syndrome 
would likely provide little advantage in early detection over simply monitoring total pathology 
case submissions.  The GI 2 and rhinitis syndromes were not significant in the test data set.   
The linkages with GI 1 and respiratory respectively could not be validated in spite of how 
specific these syndromes were.  The PRRS syndrome does not significantly affect the marginal 
effects of any one diagnostic outcome.  However, unlike all other syndromes besides PCV, it is 
a disease specific syndrome for a disease that can occur across all the diagnostic groups.  
Furthermore it has an overall significant impact on the model. It may be worth utilizing the 
syndrome to monitor for PRRS.   
 
Overall, the syndrome validation classified the respiratory, GI 1, PCV, reproductive and joint 
syndromes as strongly significant syndromes linked to specific OS diagnoses.  Necropsy also 
linked to a specific OS diagnosis, but did not have high marginal effects.  Neurologic, hepatic 
and circulatory syndromes linked to two OS diagnoses with the predictive ability for one or the 
other OS diagnosis improved, depending on the combinations of the syndromes.
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Table 5a: Relative Rate Ratios (RRR) of syndromes for pairings of diagnostic outcomes, Training data.  Syndrome RRRs > 1 are in bold.  Syndrome 
RRRs with p values < 0.05 or greater included. 
 
Diagnostic Outcomes Pairs: 
 
Respiratory Group Multisystemic Group Gastrointestinal Group “Other” Group 
Syndromes: MS Grp GI Grp Other Grp Resp Grp GI Grp Other Grp Resp Grp MS Grp Other Grp Resp Grp MS Grp GI Grp 
Respiratory 
 
10.66** 3.73** 
 
9.37** 3.28** 0.09** 0.11** 0.35** 0.27** 0.31** 2.86** 
PRRS 
  
2.22* 
 
2.15* 
 
0.45* 0.47* 0.40* 
  
2.50* 
PCV 0.52** 2.05* 
 
1.93** 3.96** 1.58 0.49* 0.25** 0.40* 
 
0.63 2.51* 
Rhinitis 
            GI 1 
 
0.08** 
  
0.11** 
 
11.82** 9.39** 13.71** 
  
0.07** 
GI 2 
  
4.02* 
  
4.65* 
  
4.65* 0.25* 0.21* 0.22* 
Circulatory  3.74** 
  
4.80** 1.54 0.27** 0.21** 0.32** 
 
0.65 3.12** 
Hepatic 0.57* 
 
0.43* 1.76* 2.63* 
  
0.38* 0.29* 2.31* 
 
3.44* 
Joint 
 
17.43** 0.26* 
 
21.34** 0.32** 0.06** 0.05** 0.02** 3.78** 3.09** 65.94** 
Neurologic 0.48** 2.62 0.41** 2.09** 5.48** 
 
0.38** 0.18** 0.16** 2.42** 
 
6.33** 
Reproductive 0.29** 
 
0.06** 3.44** 11.28* 0.21** 
 
0.09* 0.02** 16.74** 4.86** 54.81** 
Histology/Culture  17.13** 
  
55.38** 3.35 0.06** 0.02** 0.06** 
 
0.30 16.51** 
Necropsy 
 
1.74 0.59* 
 
1.90* 0.64 0.57 0.53* 0.34** 1.70* 1.55 2.96** 
Lymph Node 0.74 2.90** 
 
1.35 3.91** 2.05** 0.34** 0.26** 0.52 
 
0.49** 1.91 
* p>z equals  0.01, **p>z equals 0.001 
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Table 5b: Relative Rate Ratios (RRR) of syndromes for pairings of diagnostic outcomes, Test data set.  Syndrome RRRs > 1 are in bold.  Syndrome 
RRRs with p values < 0.05 or greater included. 
 
Diagnostic Outcomes Pairs: 
 
Respiratory Group Multisystemic Group Gastrointestinal Group “Other” Group 
Syndromes: MS Grp GI Grp Other Grp Resp Grp GI Grp Other Grp Resp Grp MS Grp Other Grp Resp Grp MS Grp GI Grp 
Respiratory 1.97* 9.39** 4.47** 0.51* 4.76** 2.27** 0.11** 0.21** 0.48* 0.22** 0.44** 2.10 
PRRS  2.51*   2.63*  0.40* 0.38*     
PCV 0.46** 2.62**  2.16** 5.65** 2.22* 0.38** 0.18** 0.39*  0.45* 2.55 
Rhinitis   0.45      0.20 2.24  4.89 
GI 1  0.10**   0.14** 1.94* 9.75** 6.99** 13.53**  0.52* 0.07** 
GI 2             
Circulatory 0.65 3.52** 0.55 1.54 5.42**  0.28** 0.18** 0.16** 1.83*  6.43** 
Hepatic 0.39**  0.26** 2.57** 5.17**   0.19** 0.13**  3.84** 7.72** 
Joint  12.85** 0.19**  16.15** 0.24** 0.08** 0.06** 0.01** 5.32 4.23** 68.32** 
Neurologic 0.56* 3.42* 0.35** 1.77* 6.07**  0.29* 0.16** 0.10** 2.88  9.84** 
Reproductive   0.03**  16.71 0.06*  0.06 0.00** 32.29 16.78** 280.40** 
Histology/Culture         0.26   3.84 
Necropsy   0.49*   0.41**   0.31** 2.05 2.46** 3.18** 
Lymph Node  2.31*   2.69*  0.43* 0.37* 0.38*   2.61 
* p>z equals  0.01, **p>z equals 0.001 
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Table 6: The difference in prediction (marginal effects) of syndromes.  All cases are treated as with or 
without the syndrome, with other syndromes held constant. Predictions with p values > 0.05 listed 
 
 
Training Data (2835 cases) Test Data (1891 cases) 
Re
sp
ira
to
ry
 G
ro
up
 Syndrome M.E. SE 95% CI M.E. SE 95% CI 
Respiratory 0.198 0.028 0.145,  0.252 0.261 0.034 0.195, 0.327 
Rhinitis 0.214 0.042 0.131, 0.296    
Reproductive -0.234 0.040 -0.313, -0.156 -0.257 0.044 -0.341, -0.173 
GI 1 -0.110 0.027 -0.163, -0.057 -0.110 0.031 -0.172, -0.049 
Neurologic -0.088 0.027 -0.140, -0.035 -0.069 0.034 -0.135, -0.003 
Hepatic -0.081 0.033 -0.145, -0.016 -0.135 0.040 -0.212, -0.057 
       
M
ul
tis
ys
te
m
ic
 G
ro
up
 Histo/Culture 0.150 0.030 0.092, 0.208    
Neurologic 0.100 0.026 0.049, 0.151 0.067 0.032 0.003, 0.130 
PCV 0.098 0.021 0.058, 0.139 0.130 0.026 0.079, 0.182 
Lymph node 0.076 0.022 0.033, 0.120    
Respiratory 0.076 0.022 0.033, 0.119    
Circulatory 0.064 0.021 0.024, 0.104 0.066 0.025 0.016, 0.116 
Hepatic 
   
0.105 0.041 0.025, 0.186 
Reproductive 
   
-0.076 0.038 -0.150, -0.002 
        
G
as
tr
oi
nt
es
tin
al
 G
ro
up
 
GI 1 0.161 0.022 0.117, 0.205 0.169 0.026 0.117, 0.220 
Histo/Culture -0.225 0.053 -0.329, -0.122    
Rhinitis -0.205 0.005 -0.215, -0.196    
Respiratory -0.180 0.021 -0.220, -0.139 -0.166 0.024 -0.213, -0.119 
Joint -0.173 0.016 -0.204, -0.141 -0.168 0.017 -0.202, -0.134 
Reproductive -0.132 0.036 -0.202, -0.062 -0.176 0.025 -0.224, -0.128 
Circulatory -0.087 0.017 -0.119, -0.054 -0.102 0.019 -0.141, -0.064 
Neurologic -0.078 0.020 -0.118, -0.038 -0.101 0.024 -0.148, -0.054 
Lymph node -0.067 0.017 -0.100, -0.033 -0.062 0.022 -0.106, -0.018 
PCV -0.059 0.017 -0.091, -0.026 -0.086 0.023 -0.132, -0.040 
PRRS -0.053 0.018 -0.088, -0.018 -0.064 0.024 -0.110, -0.018 
Hepatic -0.041 0.018 -0.077, -0.006 -0.080 0.024 -0.127, -0.032 
Necropsy -0.040 0.013 -0.065, -0.015 -0.036 0.017 -0.069, -0.002 
        
“O
th
er
” 
 G
ro
up
 
Reproductive 0.307 0.044 0.220, 0.394 0.509 0.052 0.408, 0.610 
Joint 0.179 0.024 0.133, 0.226 0.231 0.036 0.161, 0.301 
Neurologic 0.066 0.019 0.028, 0.104 0.103 0.028 0.048, 0.159 
Hepatic 0.060 0.024 0.013, 0.106 0.109 0.035 0.041, 0.177 
Necropsy 0.048 0.014 0.019, 0.076 0.075 0.019 0.039, 0.112 
GI 2 -0.096 0.025 -0.145, -0.047    
Respiratory -0.095 0.018 -0.130, -0.060 -0.100 0.024 -0.146, -0.053 
GI 1 -0.059 0.017 -0.092, -0.026 -0.079 0.021 -0.121, -0.038 
Lymph node -0.035 0.017 -0.068, -0.001    
Circulatory 
   
0.057 0.022 0.015, 0.099 
123 
 
Table 7: The adjusted predictions of the influential syndrome combinations on OS 
diagnoses, Training and Test data sets 
  Predicted probabilities** 
 Syndrome Combinations* Training data Test data 
Respiratory 
Group 
Respiratory + Rhinitis  
- GI 1 - Reproductive 
0.810 
(0.747, 0.870) 
0.734  
(0.641, 0.828) 
 Respiratory + Rhinitis   0.654 
(0.562, 0.746) 
 Respiratory - GI 1  
- Reproductive 
0.625 
(0.598, 0.652) 
0.635 
(0.602, 0.668) 
Multisystemic 
Group 
PCV + Lymph node + Neurologic + 
Circulatory + Respiratory 
0.421  
(0.355, 0.488) 
0.369  
(0.283, 0.455) 
 PCV + Neurologic + Circulatory   0.404 
(0.342, 0.466) 
0.373 
(0.293, 0.453) 
 PCV + Lymph node  0.281  
(0.253, 0.310) 
0.267 
(0.232, 0.301) 
 Neurologic + Circulatory 0.348  
(0.297, 0.399) 
0.318  
(0.250, 0.382) 
 Neurologic + Circulatory + Hepatic 0.401  
(0.305, 0.496) 
0.406 
(0.291, 0.521) 
 Circulatory + Hepatic 0.329  
(0.256, 0.402) 
0.401 
(0.310, 0.492) 
 Neurologic+ Hepatic 0.376  
(0.286, 0.467) 
0.380 
(0.275, 0.486) 
Gastrointestinal  
Group 
GI 1 - Respiratory  
- Reproductive - Joint 
0.761  
(0.732, 0.790) 
0.710  
(0.673, 0.747) 
 GI 1 - Respiratory 0.696  
(0.670, 0.723) 
0.664  
(0.629, 0.699) 
“Other”  
Group 
Reproductive + Joint  
- GI 1 - Respiratory 
0.910  
(0.864, 0.956) 
0.903  
(0.840, 0.967) 
 Reproductive + Joint 0.692  
(0.613, 0.775) 
0.765  
(0.664, 0.865) 
 Neurologic + Hepatic 0.310 
(0.231, 0.389) 
0.311  
(0.218, 0.403) 
 Neurologic + Hepatic 
 - Circulatory 
0.375 
(0.276, 0.475) 
0.476  
(0.355, 0.596 
 Neurologic - Circulatory 0.294 
(0.242, 0.345) 
0.276 
(0.217, 0.335) 
 Hepatic - Circulatory 0.264 
(0.212, 0.317) 
0.307 
(0.236, 0.378) 
*Influential syndrome combinations in model are set as included (+) or excluded (-) to determine adjusted predictions.  All 
other syndromes are held constant (at existing values) 
**95% Confidence Intervals in brackets 
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4.4 Discussion 
4.4.1 Overview of syndrome classification methods 
The syndrome classification method in this chapter included the effective use of a simple 
analytical approach, agglomerative hierarchical clustering, to group laboratory test requests 
and specimen types from a regional animal health laboratory (VDS) into syndromes for 
surveillance.  The classification method also included a thorough evaluation of the 
predictability and validity of the syndrome groups through multinomial regression analysis of 
training and test data.   The intent behind this study was to establish validated syndromes for 
potential use in the VDS data source regionally and to enhance the contribution of regional 
swine laboratory data to a national surveillance initiative (Kloeze et al, 2010).  Several 
influencing factors were considered; (a) Syndrome classification focused on the available 
structured data, as the ability to capture additional data was impacted by limited resources at 
both VDS and the submitting veterinary clinics.  (b) The availability of domain knowledge 
experts to contribute to rule-based or direct mapping methods was limited, leading to the 
alternative approaches to syndrome classification. (c) While the data structure was coded, the 
options of obtaining and modifying a rule-based syndrome classification from another source 
were not viable as few were available and VDS was not using a standardized disease 
nomenclature.  (d) A simplified method utilizing existing technical capacity, including for 
automation, was preferred. (e) Finally, a regional multisource approach to early warning 
surveillance in swine health was considered a long-term goal that would be approached 
incrementally.  The evaluation and analysis of pre-diagnostic indicators from swine pathology 
submissions for syndromic surveillance was considered a small step in this incremental process.   
 
The syndrome classification method in this study used components that have not been 
commonly included in animal health syndromic surveillance, such as the hierarchical 
algorithmic cluster analysis. The challenges, benefits and rational of different syndrome 
classification methods in animal health contributed to the study approach and are discussed in 
remainder of this section:  Previous syndromic surveillance work has focused on rule-based, 
direct mapping or supervised learning methods to establish syndrome groups from pre-
diagnostic indicators (Dórea et al, 2013; Glickman et al, 2006; Shaffer et al, 2008).  One other 
study was identified as having incorporated hierarchical clustering into syndrome classification, 
although as part of a multiple factor analysis (Dupuy et al, 2013b).  Within animal health 
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syndromic surveillance systems that have a high degree of data standardization and access to 
domain expertise, simple rule-based methods have performed well for syndrome classification 
(Dórea et al, 2013; Hyder et al, 2011; Kosmider et al, 2011).  Rule-based methods can also be 
automated to accommodate the mapping of large numbers of diagnostic or clinical codes into 
classification schemes (Farkas and Szarvas, 2008; Gibbens et al, 2008). As in public health, these 
methods are used in systems that are highly structured with standardized nomenclature 
applied to the data sources involved.   Additionally, the systems often have greater access to 
knowledge experts and are often connected into larger surveillance networks, particularly 
those in public health (Paiba et al, 2007).  From the perspective of early warning surveillance, 
especially in public health, the use of rule base methods has an advantage in the network 
approach as the syndrome classifications remain consistent across different data sources and 
types (Katz et al, 2011; Kloeze et al, 2010).  However, the degree of standardization necessary 
may limit the data sources and types available.  In addition, the manual input required to 
establish and maintain Rule-based methods increases the demand on expert resources and 
decreases the level of portability and flexibility for application across different data types and 
structures (Dórea et al, 2013). Both of these limitations are of particular concern for syndromic 
surveillance based on veterinary medical data.   
 
Supervised machine learning methods, including text mining techniques, have been 
successfully used to incorporate free text fields from animal health laboratory data into 
syndrome classification (Dórea et al, 2013).  Algorithms that can evaluate the large volumes of 
free text and semi-structured data components from the multiple data types and/or data 
sources found in animal health, provide great opportunity to improve syndrome coverage, 
sensitivity and performance (Kashiouris et al, 2013; Wagner et al, 2004).  While not commonly 
used in animal health, the flexibility of these learning algorithms has been very useful in 
providing broad syndromic surveillance coverage from multiple data sources and types in 
public health (Heffernan et al, 2004; Tsui et al, 2003).  However, the more common approaches 
to machine learning methods in syndrome classification utilize input from knowledge experts to 
establish rules for classification.  Additional limitations include a higher degree of complexity 
for implementation and a decreased transparency for review of the classification process 
(Chapman et al, 2005a; Dórea et al, 2013). 
 
4.4.2 Syndrome collation through agglomerative hierarchical cluster analysis  
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The structured format of specimen types and test requests in the VDS LIMS allowed for both to 
be included in the cluster analysis without having to utilize free text fields or to capture any 
additional case data for syndrome classification.  The example of cluster analysis conducted in 
this study also allowed syndrome classification on structured data that lacked a standardized 
nomenclature.  Finally, it provided a means, through an unsupervised method, to conduct 
syndrome classification in situations where resources may limit the availability of domain 
experts to establish and maintain rule-based methods or establish the case prediction data 
necessary for supervised learning methods (Hastie et al 2001).  The method fit with the existing 
opportunities and resource implications in the region’s animal health surveillance; improving 
the level of surveillance with existing data while supporting an incremental approach to 
develop individual components over time with the intent of eventual integration (Hasler et al, 
2011; Katz et al, 2011).     
 
An additional advantage of the syndrome classification algorithm in this study is that it 
provided a simple means to establish multiple syndromes per case for potential identification 
of complex animal health events.  In swine production, as in many animal populations, health 
events arise from multilevel data where the observation (e.g. laboratory submission) occurs at 
the animal level, but is representative of and impacted by groups, herds, and regions from 
which the animals come (Dohoo et al 2009).  The result is that disease or other health 
conditions tend to cluster within multilevel populations, affecting multiple animals in multiple 
production types (e.g. age groups).  Clinical responses in these circumstances lead to evaluation 
of groups and/or herds with subsequent laboratory case submissions containing representative 
samples from the multiple animals and production types.  As an example, significant swine 
diseases such as PRRS and PCVAD have a variety of clinical presentations that can differ within 
the same groups as well as across production types (Cho and Dee, 2006; Madec et al, 2008).  
The impact on syndromic surveillance with animal health laboratory sources is that cases 
invariably have multimorbidity, where multiple syndromes may be representative of complex 
health events.  Similar algorithms have been used in the evaluation of complex case 
management strategies and automated pathogen characterization from high volume data sets 
(Mi et al, 2012; Newcomer et al, 2011).   
 
The majority of syndrome clusters of test requests and specimens submitted in this study 
supported the expectations for clinical expressions of swine diseases.  The unsupervised 
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learning algorithms consistently placed respiratory specimens (e.g. lung tissue) and tests for 
respiratory pathogens (Mycoplasma hyopneumoniae, swine influenza) in the same cluster 
(Pasma and Joseph, 2010; Sibila et al, 2009).  Similar clusters were noted for gastrointestinal 
diseases, reproductive diseases including abortion and musculo-skeletal conditions such as 
infectious arthritis.  Several syndrome groups (Respiratory, Reproductive and GI 1) were 
consistent with an evaluation of clinic based swine syndromic surveillance in swine (Amezcua et 
al, 2013). In addition, two algorithm patterns were noted in the cluster analysis; First, the most 
effective measures of distance between cases were from dissimilarity matrices that weight 
agreement (what two groups have in common) and ignore differences (e.g. Jaccard).  
Additionally, the more effective cluster linkages were ones that minimized the variance 
between cluster groups (e.g. Ward), producing more stable clusters.  These patterns are 
consistent with another study where clustering of clinical conditions identified similar 
expressions of disease in humans and led to improved management and intervention strategies 
(Newcomer et al, 2011).  
 
The cluster analysis did not consistently cluster three groups of test requests and/or specimen 
types; PRRS, PCVAD and lymphatic tissue.  Clinical assessment and literature review were 
utilized to establish these separate syndromes.   Unlike non-specific test requests and specimen 
types (e.g. necropsy, bacterial culture, carcass), test requests for PRRS and PCVAD were 
targeting specific diseases.  The likely reason for the algorithm failure to cluster these groups of 
test requests is that both diseases have multiple clinical and pathological expressions across 
different production types, leading to their inclusion with a variety of other test requests and 
specimen types (Carman et al, 2008; Madec et al, 2008; Young et al, 2010).   Similarly, 
lymphatic tissue is a common specimen type submitted for the diagnostics of a variety of 
diseases, even though it represents a specific organ system.   
 
A limitation to the methods used in this study is that direct analytical comparisons of 
classifications from the cluster algorithms relied on post cluster validation of diagnostic 
outcomes using additional statistical methods, such as regression models.  This is because 
hierarchical cluster algorithms are primarily descriptive and are not amendable to quantitative 
analysis (Hastie et al 2001).  In other machine learning methods, the syndrome cluster 
algorithms are more amendable to quantitative methods that can assess algorithm 
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performance through comparisons between the training and test data sets. (Dórea et al, 2013; 
Hastie et al 2001). For example, more advanced methods can better utilize rules initiated from 
knowledge experts, allowing the classification algorithms to undergo a more direct, robust 
comparisons and evaluations through measures such as F-scores.  In animal health laboratory 
data, if reasons for submission, case histories, or diagnostic pathology outcomes are not 
included in the case level data, then the cluster algorithms used in this study cannot be easily 
validated.  The lack of additional case information limited the data available to pathology cases 
that had defined outcomes for validation.  To use the hierarchical method for syndrome 
classification of non-pathology submissions, case definitions (for validation) could have been 
estimated from the numbers of samples submitted per event, herd level disease prevalence 
and sensitivity/specificity of the tests involved.  This approach, while possible, would be highly 
dependent on ongoing, accurate estimates of prevalence of swine diseases.  However, 
regardless of what cluster algorithim is used for classification of non-pathology submissions, it 
would be more effective and efficient to capture the minimum data necessary for evaluation in 
the submission process (Kloeze et al, 2012).   
 
As discussed in Chapter 3, the use of non-pathology submissions for syndrome surveillance may 
be less valuable to detect emerging or re-emerging swine diseases and more prone to selection 
bias as the submissions may be for non-diagnostic reasons (Amezcua et al, 2013; O'Sullivan et 
al, 2012).  However, these non-pathology cases represent the bulk of swine submissions to VDS 
and assumptions regarding their lesser significance may not always apply.  Exploring an 
alternative approach that could be applied to non-pathology submissions would be a long-term 
consideration. 
 
4.4.3 Syndrome prediction and validation through multinomial regression 
The syndrome prediction and validation were effective at estimating the most effective 
syndromes for use in syndromic methods with the laboratory data.  The methods also indicated 
combinations of syndromes that could be used to increase syndrome sensitivity of complex 
biological events.  The overall predictive ability of the multinomial regression model was 
moderate to excellent for three of the four organ system diagnoses; Respiratory, 
Gastrointestinal and “Other”.  However, it is important to note that as observed outcomes, the 
organ system groups are generalized pathology diagnoses for the predictive model and 
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therefore lack specificity.  The lack of “robust” specificity is generally accepted in syndromic 
surveillance methods because the syndromes precedes diagnostic results with limited 
additional clinical information (Dórea et al, 2013). The lack of specificity also contributes to 
inclusion of additional steps that assure cautious interpretation and routine re-evaluation of 
syndromic methods.   
 
Optimizing the threshold for Respiratory diagnoses to maintain a high specificity would avoid 
classifying too many false positives, as this would place additional demand on resources for 
investigations and response. This is counter to approaches taken in hazard-specific surveillance 
where targeted diagnostic testing maximizes sensitivity in order to avoid missing a significant 
disease event (Dohoo et al 2009; Hoinville et al, 2013).    The predictive syndrome model had 
limited sensitivity and specificity for multisystemic organ system diagnosis and the model 
tended to misclassify multisystemic as respiratory.   As noted among influential observations, 
PRRS, PCV, and Respiratory syndromes all had positive influence on both respiratory and 
multisystemic outcomes.  The pathophysiology of several multisystemic swine diseases, such as 
PRRS and PCVAD, often include a respiratory component or secondary infections with 
respiratory pathogens (Madec et al, 2008; Young et al, 2010; Zimmerman et al 2012). 
Differential diagnoses may include respiratory diseases such as swine influenza and M. 
hyopneumoniea, leading to respiratory testing and a predictive model outcome of respiratory.  
This explanation is consistent with the multiple correspondence analysis (MCA) results (Chapter 
3) where a primary multisystemic diagnosis frequently had additional respiratory diagnoses, 
leading to low dimensional variation between primary respiratory and multisystemic diagnoses.   
The low dimensional variation likely contributed to inclusions of primary multisystemic 
diagnoses in the respiratory organ system group used for validation.  The significant positive 
impact of increasing numbers of test requests on the likelihood of predicting a respiratory OS 
outcome also supports the explanation, as the number of test requests for such complex cases 
would be higher.   
 
The syndrome validation using a test data set and comparison of adjusted predictions was very 
effective in identifying the significant syndromes developed through the unsupervised learning 
algorithms.  Adjusted predictions allowed the evaluation of a syndrome or combination of 
syndromes while holding all other syndromes constant for the outcome of interest (Stata Press 
2009). The respiratory syndrome represented test requests for very significant swine disease 
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where early warning surveillance would be useful.  In particular the syndrome included swine 
and pandemic influenzas that have zoonotic disease implications (Pasma and Joseph, 2010).  
The model prediction did not indicate a significant difference in the relative risk for the 
respiratory syndrome between the respiratory and multisystemic diagnoses in the training 
dataset.  However, the adjusted predictions within the test and training data sets indicated that 
the respiratory syndrome had a considerably better prediction for a respiratory diagnosis.  
Similarly, the necropsy syndrome was generally a non-specific syndrome that indicated only 
whether a pathologist or clinical veterinarian conducted the initial necropsy.  The relative risk 
of an “Other” diagnosis for necropsy was significantly different than for the other three 
diagnoses.  However, the adjusted predictions for the necropsy syndrome were quite low, 
suggesting that most of its impact was related to inclusion with other more disease specific 
syndromes.  Finally, adjusted predictions of syndrome combinations such neurologic, 
circulatory and hepatic possibly provide a sensitive indicator for diseases like neonatal 
septicemia (neurologic + circulatory) and may also indicate that clustering the combinations 
into new syndromes is warranted. 
 
An important additional consideration in syndrome classification and validation is the 
sensitivity for unknown or rare events, such as bioterrorism events, foreign animal diseases or 
emerging diseases.  Evaluation and analysis of the validation data should include surrogate or 
grouped outcomes that are representative of these events as the events themselves are usually 
not found in available data (Gibbens et al, 2008; Katz et al, 2011).   In this study, several key 
validated syndromes have to potential to identify rare events.  The neurologic and respiratory 
syndromes would be important to identify foreign diseases such as pseudorabies.  The 
neurologic syndrome in particular not only includes neurologic tissue, but also testing for 
differential diagnosis such as neonatal septicemia (e.g. Streptococcus suis) (Zimmerman et al 
2012).  Similarly, the acute form of another foreign disease, classical swine fever, exhibits 
circulatory signs that may be detected through the circulatory syndrome (Zimmerman et al 
2012). 
 
Another important consideration is the impact of external factors on syndrome sensitivity and 
performance.  Seasonality of disease, changes in population demographics, incursion of an 
emerging disease and economic factors may influence both the level of activity providing the 
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surveillance data as well as the actual prevalence of diseases and in turn impact the accuracy of 
the syndrome groups (Burr et al, 2006).  The implications for this study can be noted with the 
comparative significance of the second and third 25-month time periods for multisystemic 
diagnosis (over “Other” and the first time period).  These time periods coincided with an 
increase in prevalence of PCVAD in the Canadian and Manitoba swine populations (Carman et 
al, 2008; Madec et al, 2008; Poljak et al, 2010).  The prevalence of PCVAD has since declined 
due to improved biosecurity standards and an effective vaccine (Verdon et al. 2012). The 
impact of an increasing disease prevalence within the data may have impacted the cluster 
algorithms and subsequent validation of some syndromes, most notably, the PCV syndrome.  
As discussed earlier, a limitation to unsupervised learning algorithms is the necessity to 
conduct full validation to effectively evaluate the syndrome clusters heuristic means.  The 
syndrome classification and validation would need to be repeated retrospectively on a current 
data set in order to assess the significance of the time periods on syndrome prediction.   
 
Automation of the syndrome classification within the VDS LIMS was not fully evaluated in this 
study.   The predictive modelling and validation used in this study identified the most effective 
syndromes within the historical data.  An automated process could be used to map cases to the 
key syndromes identified based on the same methods applied above.   Using the internal 
coding within the LIMS, a case would be assigned a syndrome if one or more test requests and 
one or more specimen types (if present) within the syndrome were recorded in LIMS from the 
case submission.  In order to map cases, a key step in automation would be to reduce the data 
to the case level and assign the syndromes as variables.  An additional, complex automation 
component would evaluate cases with specific combinations of syndromes.  From the marginal 
effects for both the training and test models recorded in table 7, an automated process would 
flag cases that contain multiple syndromes, such as respiratory and rhinitis syndromes, PCVAD 
and lymph node syndromes, or neurologic, hepatic and circulatory syndromes.  The 
combinations could be used to refine syndrome sensitivity or to target specific conditions.  
 
Two options have been explored for the technical implementation of automated syndrome 
mapping.  One option would utilize a formatted data set, with individual identifiers removed, 
that is automatically extracted from the LIMS on a daily basis for transfer to a national animal 
health surveillance network (Kloeze et al, 2010).  Procedures have been developed to copy the 
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extract to a secure server for further analysis, but have not been implemented.  The data 
management and analytical components for syndrome mapping have been developed using a 
statistical software package (StataCorp, 2009). The statistical software is capable of 
automation, but it is likely the mapping would need to be initiated manually.  As a result this 
option would be resource intensive and limit the timeliness of the syndrome mapping.  Since a 
key feature of syndromic surveillance methods is real time or near real time functionality, 
further work would be need for this option to be utilized (Hoinville et al, 2013; Katz et al, 2011).  
The second option was explored as part of the original intent of the study; the utilization of 
query tools developed in the national animal health surveillance network to detect meaningful 
events in multiple data sources.  The network query tools are contained in a Dynamic 
Syndrome BuilderTM (DSB) that allows users to develop syndromes from accessible data on the 
network.  The methods are rule-based and require the user to know either key terminology or 
individual codes in the data sources for syndrome mapping.  The DSBTM tools allow data to be 
reduced to the case level and allow sets of syndrome maps to be saved and rerun through a 
single step at any time.  Additionally, the tools are complex enough to incorporate 
inclusionary/exclusionary components to the syndrome mapping and allow implementation of 
syndrome combinations.  However, the component is not automated and manual extraction of 
the data would be required for further detailed analysis.  The DSBTM tools have been used 
periodically with VDS data to establish targeted, disease specific syndromes for ongoing 
monitoring (e.g. Salmonella Enteritidis in poultry, Influenza in swine).  
 
4.4.4 Conclusion 
The syndrome classification approach used in this study effectively grouped syndromes from 
the test requests and specimen types submitted to an animal health laboratory for use in 
syndromic surveillance in a regional swine population.  The algorithms demonstrated a 
repeatable and readily adaptable process to cluster structured data that contained only the 
basic submission information and lacked standardized disease nomenclature.    While a level of 
expertise was required in order to ensure the clinical relevance of the syndromes, the approach 
also decreased the domain knowledge requirements for syndrome classification.   The 
approach was able to accommodate multiple syndromes per case, which was considered more 
representative of the complex multilevel nature of swine populations.  Finally, the use of cases 
with pathology diagnosis allowed for an effective and robust syndrome validation using a 
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predictive model.  The validation step allowed for the generation of sensitivities and positive 
predictive values for syndromic methods, as well as estimations of adjusted predictions 
syndromes, individually or in combination.   The syndrome classification and validation will 
need to be manually revised and repeated on a periodic basis to ensure syndrome sensitivity 
and performance.  The methods use standard statistical software that can utilize the data 
coding structure and maintain analytical models for subsequent analysis.   
 
The limitations to the data and methods in this study include the necessity of a robust 
validation using defined case outcomes, as hierarchical cluster analysis does not provide an 
analytical means of syndrome prediction or comparison.   In the laboratory data used within 
this study, cases with pathology diagnoses were considered the most relevant for early warning 
surveillance and therefore could be used for further validation.  However, pre-diagnostic data 
in non-pathology cases, which made up the majority of submissions, could not be included in 
the syndrome classification algorithms because case definitions were not easily achievable for 
validation.  The inclusion of a recommended minimum data set within the data source would 
prospectively improve the use of non-pathology submissions, especially data fields that would 
capture disease classification by submitter (Kloeze et al, 2012). 
 
Syndrome mapping and automation are the next steps in the development of the syndromic 
components.   Two options are available for further exploration, refinement and 
implementation, including one that provides linkage to national animal health surveillance 
initiatives.  However, further work is required in both options to fully automate the mapping of 
syndromes in real time.   
 
The results of this study demonstrated a reliable and robust means of classifying and validating 
a syndrome set for the application of syndromic surveillance methods in a regional animal 
health laboratory.   The methods are incremental steps in developing the components of an 
early warning surveillance system for the detection of significant animal health events in a 
regional swine population. 
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Chapter 5: Thesis summary and future considerations 
 
Each chapter of the thesis has included findings, considerations and implications of the 
evaluations and analyses conducted.  The purpose of this chapter is to focus on several key 
areas for review and for further evaluation, analysis and/or implementation.  These will 
include: (a) The fit of animal health syndromic surveillance within a One Health framework.  (b) 
Evaluation of key factors that impact swine submissions to Veterinary Diagnostic Services (VDS) 
and potential submission improvements to meet a minimum data set for surveillance. (c) 
Alternative methods for syndromes and for syndrome classification, including the use of 
disease codes and the potential for other unsupervised and supervised classification 
algorithms.  (d) Further work in the areas of temporal analyses and aberration detection, 
including the development of baseline data.  (e) Finally, a review of the process steps and 
potential integration methods that would contribute to the incremental development of an 
early warning animal health surveillance system for a regional swine populations. 
 
5.1 The fit of syndromic surveillance methods within a One Health framework 
As stated in chapter 1, effective animal health surveillance is an essential part of evidence 
based decision making required to protect animal and public health, to provide assurance of a 
healthy food supply, to support economical and sustainable livestock production and to protect 
the intrinsic value of animals for the public good (Hasler et al, 2011; Hyder et al, 2011; Lysons 
et al, 2007).  Effective animal health surveillance is an integral part of multilevel (regional, 
national and global) approaches to managing the increasing health threats to humans, 
livestock, pets and wildlife from endemic, emerging, re-emerging and exotic diseases (Dupuy et 
al, 2013a; Hasler et al, 2011; Zinsstag et al, 2011).  The health threats to people, animals and 
the environment have arisen from complex global factors including extensive patterns of 
climate change, the rise in human and animal populations, greater interconnections between 
humans and animals, as well as the high degree of transboundary trade and travel (Dupuy et al, 
2013a; Wendt et al, 2014; Zinsstag et al, 2011).  Effective multilevel approaches to these 
threats are moving towards a cross-sector integration and collaboration in surveillance, 
mitigation and intervention as part of a “One Health” framework (Wendt et al, 2014; Zinsstag 
et al, 2011). In the context of “One Health”, the challenges for animal health surveillance are to 
effectively provide the descriptive information and detailed analysis of animal health hazards 
necessary for risk mitigation and intervention from a broad spectrum of information sources, 
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types and purposes.  Traditional hazard specific surveillance methods and disease mitigation 
programs continue to be necessary to target specific diseases in at risk populations, but are 
often too focused and resource demanding  to address multiple unpredictable threats (Dupuy 
et al, 2013a; Hoinville et al, 2013; Vrbova et al, 2010).   Using methods such as syndromic 
surveillance, early warning disease surveillance systems have been adapted to detect unusual 
or unexpected events in health related behaviours from a broad range of data types and 
sources (Dorea et al, 2011; Dupuy et al, 2013a; Hoinville et al, 2013; Katz et al, 2011; Zinsstag et 
al, 2011).  
 
In the context of public health specifically, animal health data may contribute in two ways; (1) 
As a direct source for human health surveillance, such as detection of zoonotic pathogens in 
animal populations that are usually asymptomatic in animals (e.g. Salmonella Enteritidis in 
poultry, E. coli O157:H7 in cattle) (Nesbitt et al, 2012). (2) As a indirect source where systems 
detect significant zoonotic diseases in animals that may be a risk for human health, such as in 
sentinel surveillance (e.g. Rabies programs in wildlife and domestic pets, parasite monitoring 
programs) (Blanton et al, 2008).  In the greater context of One Health, animal health 
surveillance also functions to detect diseases that may have a significant economic impact, 
such as foreign animal diseases; or that may impact the environment, such as antimicrobial 
resistance in environmental organisms (Busani et al, 2006; Gibbens et al, 2008).  To assess the 
efficacy, coverage, validity and opportunities for integration of animal health surveillance 
within the “One Health” framework, research and investigation into surveillance methods and 
systems have been identified as important actions, especially as methods such as syndromic 
surveillance become more frequent in development and use (Dorea et al, 2011; Dupuy et al, 
2013a).  The preceding chapters provide examples of addressing some of these steps.  
 
5.2 Improvements to an animal health laboratory data source for syndromic surveillance 
The evaluation of the Laboratory Information Management System (LIMS) within Veterinary 
Diagnostic Services (VDS) in Manitoba for the purposes of syndromic surveillance was 
consistent with evaluations of other animal health laboratories (Dorea et al, 2013; Shaffer et al, 
2008). In particular, the accessibility, centralization, electronic data capture and internal 
structure were comparable.  However, a key assumption that warrants further exploration is 
the use of submission information (test requests and specimen types) as effective, 
representative indicators of health related behaviours in the populations of concern.  The 
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assumption centres on the increased likelihood of practicing veterinarians submitting samples 
to a diagnostic laboratory when encountering emerging diseases, changes in endemic diseases, 
diseases that have sudden and severe clinical impacts, or have significant human health risks 
(Dorea et al, 2011). It is recognized that submission bias through the role of the practicing 
veterinarian may affect the usefulness of the data for surveillance purposes.  Submission bias is 
impacted by the experience of the submitting practitioner, convenience of laboratory 
submission, timeliness of laboratory diagnoses, relationship of veterinarian to producer 
(consultant, employee), overall herd management and current industry economics (Bartlett et 
al, 2010; O'Sullivan et al, 2012; Sawford et al, 2013).  An analysis of economic and disease 
factors affecting swine laboratory submissions in Ontario and a focused ethnographic study of 
Alberta cattle veterinarians have reported key factors that encouraged diagnostic laboratory 
submissions (O'Sullivan et al, 2012; Sawford et al, 2013).  These factors recognize that disease 
outbreaks are a significant reason for laboratory submissions.  Sawford, through qualitative 
means, reported that cattle veterinarians who encountered cases where a clinical diagnoses 
was not reached, where a reportable disease was expected, were considered atypical or 
bizarre, or were considered significant public health risks, were more likely to submit samples 
to diagnostic laboratories (Sawford et al, 2013).  Similar methods could be utilized to determine 
impacts on laboratory submission from Manitoba swine practitioners. 
 
A combination of improved submission information and improved data structure would assist 
in the use of VDS data for syndromic surveillance.  The addition of key submission information 
would provide the opportunity to improve surveillance performance and syndrome 
classification.  Based on a recommended minimum data set for the collation and analysis of 
animal health laboratory data for surveillance, several key fields in the VDS LIMS were missing, 
inconsistent or collected in a manner that made the information not readily accessible (Kloeze 
et al, 2012).  One example is the use of a farm identifier within the VDS LIMS to link an animal 
health event to a specific livestock premises.  A premises identifier provides the information 
necessary to ensure multiple health events are occurring at one location (or herd) or at 
multiple locations, an important factor in determining if related animal health events are 
impacting groups of animals on multiple locations (Kloeze et al, 2012). In the VDS LIMS, these 
location identifiers were assigned by laboratory staff based on submission information.  In the 
data used in this study, identification errors could have occurred over time if individual farms 
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were assigned different identifiers from inconsistent submission information provided by 
veterinarians.  The recent implementation of a Premises Identification Database (PID) for all 
livestock and poultry operations in Manitoba allows for the use of a coding system based on 
legal land descriptions as a standardized means of identifying individual farms within the LIMS 
while maintaining confidentiality.   
 
Another example would be the inclusion of “disease classification by submitter” as additional 
submission information to refine syndrome classification.  The inclusion of clinical diagnoses to 
improve syndrome classification have been implemented using incentivized, practitioner 
derived disease category in other animal health early warning surveillance systems (Berezowski 
et al, 2011b; Gibbens et al, 2008; Vourc'h et al, 2006). The inclusion of terminology within the 
classification list for unknown or unidentified conditions, such as “diagnosis not reached” has 
been demonstrated to improve the surveillance for emerging diseases (Hyder et al, 2011; 
Kosmider et al, 2011).  Furthermore, coded or free text practitioner submission information can 
be mapped to a standardized disease nomenclature similar to syndrome classification in public 
health syndromic surveillance (Betancourt et al, 2007; Chapman et al, 2005; Conway et al, 
2013).  Currently, VDS submissions frequently include free text clinical descriptions provided by 
veterinarians as part of case histories.  However, in common with the situation described for 
other animal health laboratory  data, the information provided was not available in the LIMS 
(Dorea et al, 2013).  If the free text case histories were to be included in the LIMS, the use of 
free text syndrome classification techniques, such as supervised learning algorithms (e.g. Naive 
Bayes), may provide improved syndrome classification (Conway et al, 2013; Dorea et al, 2013; 
Farkas and Szarvas, 2008).  However, it may be more practical and efficient to structure 
submission information into coded diagnostic categories that could be classified for syndromic 
surveillance using Rule-based methods (Dorea et al, 2013).  
 
5.3 Alternative approaches to syndrome and outcome clustering 
Unsupervised clustering methods are used to detect natural clusters in the data without 
predictive information to “train” the algorithms beforehand (Hastie et al. 2009). Unsupervised 
methods have not been commonly used for syndrome classification of pre-diagnostic 
indicators.  Association rules, K means and agglomerative hierarchical clustering are relatively 
common unsupervised methods used to classify outcomes in health fields such as diagnostic 
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imaging and genetic mapping of pathogens (Hastie et al 2009; Mi et al, 2012; Zou et al, 2013).  
For syndromic surveillance these methods are useful in circumstances where the pre-diagnostic 
indicators are less directly linked to diagnostic outcomes, as is the case with indicators from 
pharmacy sales or abattoir condemnations (Dupuy et al, 2013b; Wallstrom and Hogan, 2007).  
Without additional case history and clinical diagnoses for syndrome development, laboratory 
test requests and specimen types can be considered less directly linked to diagnostic outcomes 
when used alone for syndrome classification.  Unsupervised methods may also be useful when 
case definitions for syndrome mapping are impacted by a lack of standardized disease 
nomenclature and/or by limited resources for routine application of knowledge matter 
expertise (Chapman et al, 2005; Dorea et al, 2013). The disadvantages of unsupervised learning 
methods include: (a) less transparency and interpretability than rule-based methods which can 
impact acceptance (Dorea et al, 2013);  (b) without the comparative training/test methods 
used in supervised learning, the cluster patterns require post algorithm validation through 
statistical methods (Hastie et al 2009).  Given that pathology outcome data may often be 
available for syndrome validation, further evaluation and comparison of unsupervised (e.g. k 
means, association rules) and supervised (e.g. naive Bayes classifiers) methods could be 
conducted retrospectively with the VDS data to determine a preferred means for syndrome 
classification.  Additionally, a comparison of unsupervised and supervised methods may 
provide an opportunity to develop more meaningful syndrome classifications for non-
pathology diagnoses. 
 
Outcome clusters for syndrome validation from pathology submissions could also be developed 
from the disease diagnoses rather than the organ system diagnoses.  This approach may be 
reasonable as the evaluation conducted in Chapter 3 demonstrated that the 30 most common 
primary diagnoses codes accounted for just under 50% of all pathology cases assigned to organ 
systems in the data set (4 from Multisystemic, 7 from Respiratory, 9 from Gastrointestinal,  10 
from “Other”).  As with organ systems, clustering methods would have to account for disease 
codes used in additional diagnoses (i.e. secondary, tertiary, etc), but should offer the 
opportunity to develop more specific outcome groups.  The use of disease diagnoses would 
complicate the analysis of pathology outcomes by increasing the number of possible outcomes.  
However, other studies have utilized similar methods to address large numbers of interrelated 
outcome observations. For example, a three step procedure using Multiple correspondence 
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analysis (MCA), hierarchical clustering and a k means algorithm have been used to cluster 
abattoir condemnation and wildlife necropsy data into “syndromes” for surveillance purposes 
(Dupuy et al, 2013b; Warns-Petit et al, 2010).  
 
The use of disease instead of organ system diagnoses offers an alternative option for early 
warning surveillance: Diagnostic outcome clusters could be used as the primary indicators for a 
laboratory based early warning surveillance method.  Compared to traditional “passive” 
methods of monitoring pathology cases, clustering diagnostic outcomes into relevant groups 
would allow for temporal analysis and aberration detection, avoiding excess signal “noise”.  
Compared to pre-diagnostic indicators, diagnostic outcomes clusters represent the final 
diagnoses for individual cases, leading to greater surveillance sensitivity and specificity relative 
to real health events.  The approach would be similar to other syndromic surveillance methods 
that used “post diagnostic” data, such as abattoir condemnations and wildlife necropsies 
(Dupuy et al, 2013b; Warns-Petit et al, 2010). The approach has a further advantage of 
capturing “No specific diagnoses” as an indicator of unknown or unexpected events. As 
described in Chapter 3, “No specific diagnoses” was a disease code that exhibited an increased 
trend in pathology cases during the initial incursion of Porcine Circovirus Associated Disease 
(PCVAD) into the Manitoba swine herd.  A similar coding (“Diagnosis Not Reached”) was 
successfully used in the United Kingdom’s Veterinary Investigation Diagnosis Analysis system 
(VIDA) to identify emerging disease issues (Hyder et al, 2011; Kosmider et al, 2011).  The key 
disadvantage is the loss of timeliness, as pathologically comfirmation associated with cases may 
take from several days to a few weeks to be completed.  The approach would not meet the 
definition of syndromic surveillance as it would not use available pre-diagnostic indicators and 
the timeliness would not be “real” time (Hoinville et al, 2013). However, the approach could 
still provide an enhancement of the traditional animal health laboratory roles in surveillance 
and may provide  early warning of diseases that are slower to manifest, such as some emerging 
diseases (e.g. PCVAD) or to changes in endemic diseases (O'Toole, 2010).  
 
5.4 Temporal analysis and aberration detection 
Syndromic surveillance relies both on effective syndrome classification and on the timely 
detection of significant aberrations in syndrome clusters to indicate real disease events (Dorea 
et al, 2012; Hoinville et al, 2013).  The purpose of temporal analysis and aberration detection is 
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to compare the current case count for a given syndrome with a threshold derived from 
historical data, using analytical means to detect significant disease anomalies (Kosmider et al, 
2011).  To ensure that outbreak signals in prospective surveillance are not obscured or falsely 
elevated, historical baselines must account for cyclical temporal factors (e.g. day of week, 
season), global trends (e.g. previous outbreaks, economic factors) and/or autocorrelation (e.g. 
repeated herd testing over time) in submission patterns.  In animal health syndromic 
surveillance, baselines can be established using retrospective time series analyses based on 
regression models that account for trends in the data (Dorea et al, 2012; Hohle et al, 2009).  
Poison regression models have been found effective if the assumptions of equal variance and 
mean are met.  However, in many circumstances the Poison assumptions are not realistic, with 
the additional complication of significant time periods having zero counts.  Negative binomial 
models, with or without a zero inflation parameter, can provide effective alternatives in these 
situations (Hohle et al, 2009; Thomas-Bachli et al, 2012).  Alternative univariate methods have 
utilized a log linear regression approach to account for baseline trends and for prospective 
aberration detection (Hohle et al, 2009; Kosmider et al, 2011).  However, this method assumes 
a constant submission rate over a given time period and address seasonal trends through 
weighted averages or percentiles, and does not specifically address global trends.  
 
In order to effectively establish a temporal baseline for prospective surveillance, the 
retrospective data must be free of outbreaks (Dorea et al, 2012).  The presence of previous 
outbreaks in the baseline will influence the threshold for a syndrome such that the sensitivity 
for significant aberrations will likely be reduced.  Unfortunately, the syndrome validation 
conducted in this study (Chapter 4) identified a significant impact of Multisystemic Organ 
system diagnoses over three consecutive 25-month time periods.  The time periods were 
ordinal indicators of anomalies in submission trends and were potentially representative of the 
incursion of PCVAD into the Manitoba swine herd in 2005.  Prospective surveillance with 
syndromes that predicted Multisystemic organ system diagnoses (e.g. PCV) could lack 
sensitivity if a historic baseline were established from the data set.  Since the influence was 
significant within three 25-month periods, non parametric techniques used by others, (e.g. 
moving averages, moving percentiles) may not be sufficient to smooth the aberration (Dorea et 
al, 2012; Kosmider et al, 2011).  To account for aberrations in baseline data, Dorea utilized a 
Poisson regression model technique that detected and replaced outliers above the 95th 
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percentile of the Poisson distribution with model predicted values (Dorea et al, 2012).   This 
approach was able to address a global trend in the laboratory data related to a single year 
increase in bovine leucosis virus (BLV) testing.  A similar approach may be necessary to prepare 
a temporal baseline for syndromes that predict Multisystemic organ system outcomes from the 
VDS LIMS. 
  
The primary goal of any syndromic surveillance method is to detect accurate signals of 
significant disease events in continuously monitored data.  The process of signal detection from 
prospective monitoring of syndrome counts within the VDS LIMS requires automation of both 
syndrome assignment and signal detection.  Two options for automated syndrome assignment 
were discussed in Chapter 4.  Either option would require additional programming for the 
application of automated signal detection algorithms.  Notwithstanding the current software 
limitations, there have been several methods used in animal and public health for effective 
outbreak detection from temporal and spatial signals.  Perhaps the most common approaches 
to outbreak detection are statistical process control (SPC) methods, such as CUSUM, where 
algorithms evaluate cumulative sums over moving baseline time periods to detect if a change 
point (threshold) has been reached (Hohle et al, 2009; Shaffer et al, 2008; Tokars et al, 2009).  
The change point is derived from an analytical process (e.g. Likelihood ratios). The methods do 
not perform as well in situations with significant daily variation or with low syndrome counts, 
but are easier to implement and can accommodate season trends.  Furthermore, the simplicity 
compared to other methods, their frequency of use and the different algorithms available 
make SPC methods appealing for outbreak detection in syndromic methods applied to the VDS 
data 
 
Spatiotemporal scan statistics are also common for early warning surveillance in animal health 
when spatial data were available (Hyder et al, 2011; Odoi et al, 2009; Thomas-Bachli et al, 
2012).  These methods detect localized excess of events where a likelihood ratio is used to 
compare the number of cases within windows (in both space and time) to an expected number 
based on the cases surrounding the windows (Kulldorff et al, 2007).  An iterative maximum 
likelihood approach is used to determine the most likely cluster from multiple scanning 
windows.  Regression models can be included to establish baselines through multivariate 
retrospective analysis (Hyder et al, 2011; Thomas-Bachli et al, 2012).   With the inclusion of 
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premises identification in the VDS data, spatiotemporal analysis could be considered an option 
for outbreak detection in the syndromic methods. 
 
Additional outbreak detection methods used in syndromic surveillance include time series 
methods, such as Autoregressive Integrated Moving Averages (ARIMA), and Generalized Linear 
Models (GLM).  Adaptations of these methods for prospective outbreak detection have been 
used in public health syndromic surveillance (Murphy and Burkom, 2008; Reis and Mandl, 
2003).  While common in retrospective analysis, the methods are not commonly used for 
outbreak detection in syndromic surveillance for animal health. 
 
5.5 Review of processes required for implementation and potential for integration  
This chapter has built on the evaluation and analyses conducted in the previous chapters and 
explored several key concepts and methods that are applicable to syndromic surveillance for 
the Manitoba swine population, utilizing data from a regional animal health laboratory.  The 
further development of the research within these chapters will require strategic, incremental 
application of core concepts and processes with recognition of limited resources and time.  A 
comprehensive approach will continue to include a “One Health” framework to provide 
opportunities to address significant disease risks and health events across people, animals and 
the environment.  The approach should allow for integration and collaboration to address 
multiple disease risks for swine and humans, such as influenza, enteric infections (e.g. 
Salmonella) and antimicrobial resistance.  It should also strive to establish shared public and 
animal surveillance platforms that can address swine specific diseases, such as PCVAD and 
Porcine Epidemic Diarrhea (PED).  Examples of such shared approaches include the Canadian 
Animal Health Surveillance Network (CAHSN) and the Canadian Science Center for Human and 
Animal Health.  The latter led the development of diagnostic tools for PED during the 2014 
Canadian outbreak.  Building on the close linkages between VDS and organizations such as 
CAHSN will continue to be an important process. 
 
The process to implement laboratory based syndromic surveillance for swine should include 
several important next steps.  First, a review of the syndrome classification and validation 
methods would ensure that syndromes reflect the current laboratory data, especially the 
currently available test requests and specimen types.   K means clustering could also be 
explored as an additional unsupervised syndrome classification method as the pre processing 
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method (i.e. dissimilarity matrices) applies to both k means and hierarchical clustering.  The 
second step would involve an exploration of methods for automation through the CAHSN 
system.  Utilizing CAHSN would provide a more timely strategy than applying automation 
methods directly within the VDS LIMS.  The strategy would also allow for syndrome system 
development that would benefit both VDS and CAHSN.  The final steps would involve 
establishing a baseline for syndrome cluster detection and implementing a reliable outbreak 
detection method.  These final steps would be reliant on the successful implementation of the 
preceding steps and available resources. 
 
As a final consideration, the implementation of early warning surveillance in public health has 
benefited from the integration of multiple data sources and types (Katz et al, 2011; Nesbitt et 
al, 2012; Wendt et al, 2014). Similar approaches have occurred globally in animal health 
surveillance where integration has occurred across multiple animal health data sources and/or 
with public health systems (Dupuy et al, 2013a; Lysons et al, 2007; Paiba et al, 2007).  In 
Canada, the province of Alberta has established a broad based surveillance, intervention and 
mitigation system, which started with clinic-based data sources for cattle.  The system has 
developed signal detection methods, incorporated laboratory and abattoir data, and 
established a disease investigation response to address any significant animal health events 
identified (Berezowski et al, 2011a).  Research and analysis into early warning surveillance has 
also progressed in Ontario.  In swine, the early warning surveillance methods have included 
practitioner-based and abattoir condemnation data (Amezcua et al, 2013; Thomas-Bachli et al, 
2012).  In cattle, the methods evaluated have included laboratory submission and abattoir 
condemnation data (Alton et al, 2012; Dorea et al, 2012; Dorea et al, 2013).  In the case of the 
research outline above, the high degree of specialization within Manitoba swine practitioners 
and the availability of data from a provincial meat inspection system, provide opportunities to 
explore an early warning surveillance initiative for swine beyond the laboratory methods. 
 
In summary, the evaluation and analysis presented in these chapters support the application of 
syndromic surveillance methods to pre-diagnostic data from an animal health laboratory for 
the purpose of early warning surveillance in a regional swine population. The methods and the 
source discussed are well suited to contributing important components in the incremental 
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process of developing a regional swine surveillance system, utilizing multiple sources and 
methods, situated within a One Health framework. 
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Appendix I: Specimen type and test request distributions by organ system group 
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